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Abstract 
Although diarrhoea caused by Cryptosporidium is prevalent in livestock species 
throughout the world relatively little is known about the species and subtypes of 
Cryptosporidium found in cattle on Scottish farms. In particular, little is known 
about the shedding profiles (age when calves become infected and duration of 
shedding) of the different species found in cattle and how calves become 
infected. There are several theories about how neonatal calves first become 
infected with the parasite but the role which adult cattle play in the 
transmission of the parasite has not been fully addressed. It was previously 
thought that adult cattle did not become infected with the same species of 
Cryptosporidium which causes disease in the young calves. Some studies have 
shown that this may not be true and with the advance of new techniques to 
discriminate species this is an area which should be revisited.   
In addition, it is known that it is possible for humans to become infected with 
Cryptosporidium and show clinical disease early in life and then again later in 
adulthood. In livestock however, diarrhoea caused by the parasite is generally 
only seen in neonatal livestock while older animals tend to be asymptomatic. It 
is not known if this resistance to clinical disease at an older age is due to 
changes in the host with an increase in age or if prior infection “immunises” the 
animal and provides protection against re-infection. It is also not known if 
infection with one isolate of C. parvum will provide protection against infection 
with another or if the protection formed is species/isolate specific.  
The main aims of this thesis were to: determine the species and subtypes of 
Cryptosporidium found in calves on a study farm over a one year period from 
birth; assess the role which adult cattle play in the transmission of the parasite 
to newborn calves; develop new typing tools to enable the rapid and easy 
differentiation of Cryptosporidium species found in cattle and to examine the 
host-pathogen interactions in animals  given serial experimental challenges with 
distinct Cryptosporidium parvum isolates to determine if the resistance seen in 
older animals on farms is due to an increase in age or as a result of prior 
infection. 
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A variety of different approaches were taken to achieve these aims. Longitudinal 
experiments carried out on a study farm revealed that in calves <9 weeks of age 
the most common species of Cryptosporidium is C. parvum and that all calves in 
the group became infected with Cryptosporidium within the first two weeks of 
life. Sample collection from the same animals later in life (at 6 months of age) 
showed that contrary to most previous studies the most common species 
detected at in this age group was also C. parvum although, interestingly, the 
subtype which the calves were shedding was not the same subtype that they 
were shedding previously. 
The longitudinal study which investigated the role of adult cattle in the 
transmission of Cryptosporidium also yielded some interesting results. It was 
found that most of the adult cattle on this farm were shedding Cryptosporidium 
albeit intermittently. Speciation of the positive samples revealed that, on this 
farm, the most predominant species of Cryptosporidium in adult cattle was also 
C. parvum. This is very unusual as most previous studies have not found this 
level of infection in older cattle and C. parvum is not usually found in this age 
group. A number of different subtypes were found in adult cattle and some 
animals shed more than one subtype over the course of the study. This 
contradicts prior findings which demonstrated that only one subtype is found on 
a single farm. 
The experimental infection trial involving infection of young (<1 week old) and 
older (6 week old) lambs with distinct C. parvum isolates demonstrated that an 
increase in age at primary infection reduces the effect of clinical disease. 
Animals which were infected at <1 week of age were re-challenged at 6 weeks of 
age with either a homologous or heterologous infection. Results revealed that 
previous exposure does not protect against re-infection with the same or a 
different isolate of C. parvum. This study also demonstrated that an increase in 
infective dose leads to a shorter pre-patent period and that there are variations 
in the clinical manifestations of different isolates of the same Cryptosporidium 
species. 
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Chapter 1:  General Introduction 
1.1 Background 
Cryptosporidiosis is the disease caused by a protozoan parasite of the genus 
Cryptosporidium, which was discovered in 1910 by Edward Ernst Tyzzer in the 
gastric glands of mice. Tyzzer noticed that this parasite did not contain 
sporocysts within the oocysts and it sporulates while still attached to the host 
wall. For this reason Tyzzer named the genus Cryptosporidium, from the Greek 
kruptos meaning ‘hidden’, and the parasite that he identified in the gastric 
glands, Cryptosporidium muris. Three years later Tyzzer identified another 
species of Cryptosporidium which was not infective in the gastric glands of mice 
but only in the small intestine (Tyzzer, 1910). This second species produced 
oocysts which were smaller in size (4-5 µm) compared with C. muris oocysts (6-8 
µm), Tyzzer named this species Cryptosporidium parvum (parvum comes from 
the Latin for little). It was originally believed that there were only two different 
species of Cryptosporidium but there are now over 27 described species and 
many more genotypes (Chalmers and Katzer, 2013). 
Cryptosporidiosis, the disease caused by some species of Cryptosporidium in 
susceptible hosts generally manifests itself as profuse watery diarrhoea, weight-
loss and inappetence. Depending on the parasite and host species other clinical 
signs may be seen such as vomiting and nausea in some humans infected with 
Cryptosporidium hominis. Despite being identified in many animal species, 
cryptosporidiosis was not thought to be a very important disease until the early 
1980s and the HIV-AIDS epidemic, though it was first reported in humans in 1976 
(Nime et al., 1976). Of the first seven reported cases of Cryptosporidium 
infection in humans, six were from immunocompromised patients leading to the 
belief that if the immune system was not compromised, cryptosporidiosis would 
not pose any health risk (Bird and Smith, 1980). Of course cryptosporidiosis is 
now recognised as an important zoonotic disease, which affects many species 
(Chalmers and Katzer, 2013).  
Cryptosporidium was first associated with diarrhoea in calves in 1971 (Panciera 
et al., 1971) and since then has been identified as one of the most important 
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cause of neonatal enteritis in calves worldwide (de Graaf et al., 1999; Fayer et 
al., 1998; Thompson et al., 2005).    
1.2 Life Cycle 
Cryptosporidium is a monoxenous organism, (life cycle completed within a single 
host) which exists in the environment in thick walled oocysts. These oocysts are 
very resistant to many environmental factors such as high and low temperatures 
(Fujino et al., 2002) but they can be inactivated by desiccation (Robertson et 
al., 1992). Cryptosporidium oocysts survive well in cool, moist climates and can 
remain infective for many months (Robertson et al., 1992).  
Infective Cryptosporidium oocysts (Figure 1-1(a)) are ingested by the host and 
when triggered by the conditions in the gastrointestinal tract (low pH, body 
temperature) excystation occurs (Hijjawi et al., 2002) and four sporozoites are 
released (Figure 1-1(b)). The sporozoites attach themselves to the host 
epithelial cells at the ileocaecal junction which they then invade and become 
engulfed by the cells forming a parasitophorous vacuole. Many other protozoan 
parasites also exist within a parasitophorous vacuole but Cryptosporidium also 
contains a unique structure known as the feeder organelle, which separates the 
cell and parasite cytoplasm (Pohlenz et al., 1987).  
 After the development of the feeder organelle the sporozoite itself becomes 
more spherical in shape and forms a trophozoite (Figure 1-1 (c)). The parasite 
begins asexual reproduction and develops into a Type I meront (Figure 1-1 (d)) or 
a Type II meront (Figure 1-1 (f)). Merozoites are formed within the Type I 
meront, each Type I meront releases 6-8 merozoites which can immediately re-
infect the host, by invading neighbouring cells and beginning asexual 
reproduction again, or develop into a Type II meront (Figure 1-1 (f)). 
Type II meronts release four merozoites which initiate the sexual reproductive 
cycle (Figure 1-1 (f)). The released merozoites invade host cells and 
differentiate into either macrogamonts (Figure 1-1 (h)) or microgamonts (Figure 
1-1 (g)). Microgamonts develop multi-nuclei and release free microgametes 
which penetrate and fertilise the macrogamete, producing a zygote (Figure 1-1 
(i)). Meiosis occurs and the zygote differentiates into four sporozoites as the 
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oocyst develops and is released from the lumen. The sporozoites may be 
released directly into the lumen from thin-walled oocysts and re-infect the host 
(Figure 1-1 (k)) or thick-walled oocysts which are shed in faeces and remain 
immediately infective for other hosts (Figure 1-1 (j)).  
 
 
Figure 1-1: Life cycle of Cryptosporidium 
Reproduced from Juranek DD. Cryptosporidiosis. In: Strickland GT, editor. Hunter’s Tropical Medicine and 
Emerging Infectious Diseases, 8
th
 ed. Philadelphia: WB Saunders; 2000. Originally adapted from the life cycle 
that appears in Current WL, Garcia LS. Cryptosporidiosis. Clinical Microbiol Rev 1991; 4:325-58. 
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1.3 Species of Cryptosporidium 
There are 28 different species of Cryptosporidium currently recognised (Table 
1-1) and many more genotypes (Chalmers and Katzer, 2013; Fayer, 2010).  The 
most common species found in the UK and worldwide is the zoonotic species C. 
parvum (Chalmers and Katzer, 2013). Historically species of Cryptosporidium 
were named according to the host of origin on the assumption that most species 
were host-specific. While many of the species of Cryptosporidium do still appear 
to be host-specific others infect many different host species, for example, C. 
parvum and C. ubiquitum infect a wide variety of hosts. 
Table 1-1: Currently recognised Cryptosporidium species and the hosts they infect 
Species Name Synonym Host Species First Described By 
C. andersoni* Mouse genotype Cattle (Lindsay et al., 2000) 
C. baileyi  Birds (Current et al., 1986) 
C. bovis Genotype Bovine B Cattle (Fayer et al., 2005) 
C. canis* Canine genotype Dogs (Fayer et al., 2001) 
C. cuniculus* Rabbit genotype Rabbit (Robinson et al., 2010) 
C. ducismarci  Tortoise (Traversa, 2010) 
C. fayeri Opossum genotype 1 Marsupials (Ryan et al., 2008) 
C. felis*  Cats (Iseki et al., 1989) 
C. fragile  Toads (Jirku et al., 2008) 
C. galli C. blagburni Birds (Ryan et al., 2003b) 
C. hominis* 
Genotype 1/genotype 
H 
Humans (Morgan-Ryan et al., 2002) 
C. huwi  Fish (Ryan et al., 2015) 
C. marcopodum  Marsupials (Power and Ryan, 2008) 
C. meleagridis*  Birds (, 1955a) 
C. molnari  Fish 
(Alvarez-Pellitero and 
Sitja-Bobadilla, 2002) 
C. muris*  Mice (Tyzzer, 1910) 
C. parvum* 
Genotype 2/genotype 
C 
Mammals inc. 
humans 
(Tyzzer, 1912) 
C. ryanae Deer-like genotype Cattle (Fayer et al., 2008) 
C. scophthalmi  Fish 
(Alvarez-Pellitero et al., 
2004) 
C. scruforum  Pigs (Kvac et al., 2013) 
C. serpentis  Snakes (Levine, 1980) 
C. suis* Pig genotype 1 Pigs (Ryan et al., 2004) 
C. tyzzeri Mouse genotype 1 Mice (Ren et al., 2012) 
C. ubiquitum* Cervine genotype 
Variety of 
animals 
(Fayer et al., 2010b) 
C. varanii C. saurophilum 
Lizards and 
Snakes 
(Pavlasek and Ryan, 
2008a) 
C. viatorum  Humans (Elwin et al., 2012b) 
C. wrairi  Guinea Pigs (Vetterling et al., 1971) 
C. xiaoi C. bovis-like genotype Sheep (Fayer and Santin, 2009) 
*also infects humans 
5 
 
1.3.1 Species of Cryptosporidium in farm livestock 
Of the 27 or so Cryptosporidium species which have been identified about eight 
of these are known infect farm livestock (cattle, sheep and pigs).  
1.3.1.1 Cattle 
There are four species of Cryptosporidium which are commonly found in cattle; 
C. parvum, C. bovis, C. ryanae and C. andersoni. There are some reports of 
other species also being found; C. hominis has been reported in a 3 day old calf 
and a 6 year old cow from Scotland (Smith et al., 2005), C. suis in a calf (Fayer 
et al., 2006) and C. felis in a cow (Bornay-Llinares et al., 1999) but these reports 
are rare.  
1.3.1.2 Sheep and Goats 
Sheep and goats are predominantly infected with C. parvum, C. xiaoi, C. bovis 
and C. ubiquitum although rare occurrences of other species have been 
reported. Cryptosporidium hominis has been reported as the predominant 
species in sheep on the Scottish island of St Kilda (Connelly et al., 2013), in a 
sheep and a goat kid from a farm and petting zoo in the UK (Giles et al., 2009) 
and in a sheep in Australia (Ryan et al., 2005). Cryptosporidium scruforum and 
C. andersoni have been detected in sheep from flocks in Australia (Yang et al., 
2014) and C. fayeri has been reported in a sheep (Ryan et al., 2005) again these 
occurrences of other species are rare. 
1.3.1.3 Pigs 
The predominant species of Cryptosporidium detected in pigs are C. suis and C. 
scruforum; C. suis is prevalent in pigs worldwide but causes few clinical signs 
(Enemark et al., 2003). Cryptosporidium scruforum is a fairly new species, only 
described in 2013 (Kvac et al., 2013), again, this species does not seem to cause 
any clinical disease in pigs yet is prevalent in adult pigs worldwide. It does not 
appear infective to pigs under 8 weeks of age (Kvac et al., 2014). 
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1.3.2 Species of Cryptosporidium in poultry 
Three species of Cryptosporidium are currently known to infect birds;              
C. meleagridis, C. baileyi and C. galli. Avian cryptosporidiosis was first 
described in 1929 but was not formally recognised until 1955 when C. 
meleagridis was reported in turkeys (Slavin, 1955), C. meleagridis is found in the 
small and large intestine and bursa of infected birds. Cryptosporidium 
meleagridis has been reported in many different species of birds and also in 
humans (Ng-Hublin et al., 2013; Silverlas et al., 2012; Wang et al., 2014b). The 
second species of Cryptosporidium to be reported in birds was C. baileyi in 
chickens in 1986 (Current et al., 1986), this species is more commonly associated 
with respiratory cryptosporidiosis in broiler chickens and is the most common 
species of avian Cryptosporidium. Also described from chickens is C. galli which 
was discovered in 1999 but was redescribed in 2003 (Ryan et al., 2003a). Like C. 
meleagridis this species is also found in the small intestine, large intestine and 
in the epithelium of the proventriculus and is associated with clinical disease 
and mortality (Blagburn et al., 1991; Tumova et al., 2002). The three avian 
adapted species are morphologically different and can be distinguished by 
morphological difference in the size and shape of the oocysts.  
1.3.3 Species of Cryptosporidium in non-mammalian 
vertebrates 
1.3.3.1 Fish 
In fish three species have been reported but it is possible that there are more 
which remain undiscovered as studies into the species of Cryptosporidium found 
in fish are scarce. The first species in fish to be described was C. molnari 
infecting the stomach of gilthead sea bream and European sea bass with few 
clinical signs (Alvarez-Pellitero and Sitja-Bobadilla, 2002). The other reported 
species of Cryptosporidium infecting fish is C. scophthalmi which is found in the 
intestinal epithelium of turbot. So far it appears that juvenile fish are most 
frequently infected with Cryptosporidium while it has rarely been detected in 
adults (Alvarez-Pellitero et al., 2004). Infected fish tend to show no signs of 
clinical infection but do show intestinal distension at necropsy. A more recent 
study, has also detected C. parvum in fish from Papua New Guinea (Koinari et 
al., 2013) as well as a novel Cryptosporidium species which is also zoonotic. The 
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most recently described species of Cryptosporidium is a species identified in the 
stomach of a guppy (Ryan et al., 2015).  
1.3.3.2 Amphibians and reptiles 
Four species of Cryptosporidium have been reported in amphibians and reptiles, 
C. fragile, C. varanii, C. serpentis and C. ducismarci. As its name suggests, C. 
fragile is the most delicate species of Cryptosporidium and was first described in 
the stomach of the black-spined toad (Jirku et al., 2008) and was named due to 
its fragile nature. Unlike other species of Cryptosporidium, C. fragile will 
crumple on contact with hypertonic solutions and disintegrate after just 4 weeks 
in water (Jirku et al., 2008). Cryptosporidium has been reported in many species 
of snakes and other reptiles, the first to be identified was C. serpentis which is a 
gastric species and was found in four snake species in 1977 (Brownstein et al., 
1977). It is believed that C. serpentis may actually be a name which covers many 
other species of Cryptosporidium infecting snakes which have not yet been 
described (Fayer, 2010) as morphological data from many different species of 
reptiles indicates the possibility of multiple unique groups (Upton et al., 1989; 
Xiao and Ryan, 2004; Xiao et al., 2004). Cryptosporidium varanii was first 
described in an Emerald Monitor lizard (Pavlasek and Ryan, 2008b); it has since 
been identified in many other lizard and snake species. The most recently 
discovered Cryptosporidium species in a reptile is C. ducismarci which was 
described from tortoises (Traversa, 2010) and which caused fatal intestinal 
disease in two different species of tortoise. As with fish it is possible that many 
more species of Cryptosporidium infecting reptiles and amphibians may exist but 
not enough studies have been carried out to confirm this.  
1.3.4 Species of Cryptosporidium in humans 
In humans there are two species which are routinely diagnosed in clinical cases 
of cryptosporidiosis; these are the zoonotic species C. parvum and the human 
adapted species C. hominis (Morgan-Ryan et al., 2002). These species account 
for over 90% of human infections worldwide (Chalmers and Giles, 2010) and 96% 
of clinical cases in the UK are attributed to these two species (Hadfield et al., 
2011). Cryptosporidium parvum infections peak in the spring months while C. 
hominis is more common in the autumn months (Chalmers et al., 2009a), this is 
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thought to be related to springtime calving and lambing and an increase in 
people participating in outdoor activities at this time of year. Other species 
which commonly infect humans include; C. meleagridis (Chalmers and Giles, 
2010; Xiao and Fayer, 2008) in the UK and C. felis, C. canis and C. meleagridis in 
other parts of the world (Cama et al., 2008). Sporadic infections with other 
Cryptosporidium species have also occurred although these are not always 
associated with disease and may just be asymptomatic infections (Helmy et al., 
2013; Robinson et al., 2008; Waldron et al., 2010). While most outbreaks in the 
UK are associated with either C. hominis or C. parvum one outbreak in 2008 was 
caused by C. cuniculus (Chalmers et al., 2009b; Robinson et al., 2010). 
Cryptosporidium cuniculus was originally reported as causing infection in rabbits 
in 1979 (Inman and Takeuchi, 1979) and was believed at this time to be host 
specific. Following the human outbreak of 2008 it was discovered that C. 
cuniculus is infective to humans and rabbits and under experimental conditions 
immunosupressed gerbils and mice can become infected (Robinson et al., 2010). 
There are no clinical signs recorded for rabbits. This species is very similar to C. 
hominis at several loci including 18S SSU, heat shock protein 70 (HSP), actin, 
LIB13 and Cryptosporidium oocyst wall protein (COWP), in 2010 a redescription 
of C. cuniculus was published (Robinson et al., 2010).  In 2012 a new human 
adapted species was recognised and named C. viatorum, this species is 
associated with travellers who have visited the Indian subcontinent (Elwin et al., 
2012b). 
1.3.5 Other Cryptosporidium species  
1.3.5.1 Companion animals 
In the UK other Cryptosporidium species are commonly found in domestic pets, 
in one study it was found that 20% of cats and dogs were shedding C. felis and C. 
canis respectively (Mtambo et al., 1991). Worldwide the prevalence of 
Cryptosporidium in these companion animals ranges from 0-29.4% in cats and 
0.5-44.1% in dogs (Lucio-Forster et al., 2010), C. parvum has been detected in 
dogs previously but these animals are not thought to be an important factor in 
zoonotic transmission of the parasite (Giangaspero et al., 2006; Lucio-Forster et 
al., 2010).  
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1.3.5.2 Horses 
Cryptosporidium was first reported in horses in the late 1970s in 
immunodeficient foals (Snyder et al., 1978). At this time it was generally 
believed that in animals, as well as humans, cryptosporidiosis was only a 
problem where the host was immunocompromised in some way. Since the initial 
report of Cryptosporidium in foals there have been many reports of the parasite 
in immunocompetent horses (Santin, 2013). The most common clinical sign of 
cryptosporidiosis in foals is diarrhoea (Grinberg et al., 2009), in adult horses 
most infections tend to be asymptomatic (Majewska et al., 2004; Sturdee et al., 
2003) although diarrhoea in adult horses has been reported (McKenzie and 
Diffay, 2000). The most commonly detected species in horses is C. parvum 
(Chalmers and Grinberg, 2005; Cole et al., 1998; Perrucci et al., 2011). 
1.3.5.3 Wildlife 
In British wildlife (rabbits, rodents, foxes and deer) various species and 
genotypes of Cryptosporidium have been identified although relatively few 
studies into wildlife hosts in the UK have been carried out (Appelbee et al., 
2005). One study which examined a large number of wildlife hosts as well as 
livestock and horses identified Cryptosporidium oocysts, believed at the time to 
be C. parvum, in ~30% of faeces from small wild mammals (Sturdee et al., 2003) 
and in another study, oocysts were identified in 63% of brown rat faecal samples 
(Webster and Macdonald, 1995). A study in the UK investigating Cryptosporidium 
species in a water catchment found C. ubiquitum in deer samples and in foxes C. 
bovis and C. parvum were identified (Robinson et al., 2011). Although this study 
found no evidence of Cryptosporidium in rabbits an outbreak in humans in 2008 
was linked to the rabbit genotype, now identified as a separate species C. 
cuniculus (Chalmers et al., 2009b; Robinson et al., 2010). A recent study 
investigating Cryptosporidium species and genotypes found in livestock and deer 
in a water catchment in north east Scotland reported a prevalence of 69.23% in 
deer (80% in red deer and 33% in roe deer) the majority of the samples were 
identified as C. parvum with the remainder identified as the Cryptosporidium-
deer genotype (Wells et al., 2015). 
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In other parts of the world different species have been identified in other 
wildlife hosts; C.wrairi was first identified in guinea pigs in 1966, this species 
has only ever been identified from guinea pigs and appears to be host specific 
(Jervis et al., 1966; Vetterling et al., 1971). In marsupials two species have been 
reported, C. fayeri which was isolated from a red kangaroo (Ryan et al., 2008) 
and C. macropodum which was first reported in an eastern grey kangaroo (Power 
and Ryan, 2008) and has since been reported in other marsupials such as; swamp 
wallabies, western grey kangaroos and red kangaroos  (Power, 2010). Neither C. 
fayeri nor C. macropodum have been associated with clinical disease in 
marsupials (Yang et al., 2011).  
1.4 Diagnosis and identification of species 
Differentiation of Cryptosporidium species found in both humans and farm 
livestock is important as it enables disease epidemiology involving different 
species to be understood and in human disease cases outbreaks may be traced 
back to the original source and help inform control strategies (Chalmers et al., 
2009a; Gormley et al., 2011). Many studies have examined the epidemiology of 
Cryptosporidium in humans (Caccio, 2005; Chalmers et al., 2009a; Fayer et al., 
2000a; Xiao, 2010). However, similar studies in farm livestock are few and often 
only focus on the neonatal age group. Longitudinal studies in livestock are not 
very common though some have been carried out in France, the USA, the UK, 
Australia and Scandinavia (Brook et al., 2009; Follet et al., 2011; Robertson et 
al., 2010; Santin et al., 2008; Sturdee et al., 2003; Yang et al., 2014). During 
human outbreaks of cryptosporidiosis it is usual for the parasite to be speciated 
and even genotyped whereas in veterinary diagnosis often only the presence of 
the parasite is confirmed. The most common methods for detection of 
Cryptosporidium in the UK are; microscopy, enzyme immunoassays (EIA) and 
polymerase chain reaction (PCR) (Chalmers et al., 2010).  
1.4.1 Microscopic Identification 
Identifying only the presence of the parasite by microscopy can be problematic 
for diagnosis as many Cryptosporidium species do not cause disease in some 
hosts, for example even under experimental conditions C. ryanae and C. bovis 
do not cause diarrhoea in calves (Fayer et al., 2008; Fayer et al., 2005). There 
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are few morphological differences between Cryptosporidium species and 
internal structures cannot be easily seen and it is not possible to speciate most 
Cryptosporidium species by microscopy alone. There are some exceptions to this 
rule with some species of Cryptosporidium such as C. andersoni and C. muris 
being larger in size than the others (Lindsay et al., 2000). Many species of 
Cryptosporidium are not host specific and multiple species can often be found in 
the same host. The oocysts of Cryptosporidium are very small (3-8 µm) and 
between species there is overlap in oocyst size. Under microscopic examination 
Cryptosporidium oocysts can be difficult to distinguish from other small particles 
such as yeasts, moulds and faecal debris. Various techniques for detection of 
oocysts by microscopy exist (Figure 1-2). The most common method for 
detection of Cryptosporidium by microscopy in the UK is auramine phenol 
staining. With this method the oocysts are stained a bright greenish yellow 
against a dark background and sensitivity and specificity of this staining method 
is good (~92% sensitivity and 100% specificity). The 2nd most common method 
used in UK diagnostic laboratories for human specimens is modified Ziehl-
Neelsen (mZN). Using mZN the oocysts appear red on a blue/green background 
and the sensitivity of this method is ~75% with 100% specificity, this technique is 
also commonly applied in veterinary diagnostics as well. Finally another common 
method of detection by microscopy is 4,6’ diamidino-2-phenylindole 
dihydrochloride (DAPI) staining which stains the nuclei of viable oocysts and they 
appear blue under UV light, oocysts can also be detected without staining, using 
phase contrast microscopy, (Chalmers et al., 2011)  
 
Figure 1-2: Cryptosporidium oocysts as seen through a microscope using different staining 
methods. 
Phenol Auramine (AP) staining (A) stains the oocysts bright green, Modified Ziehl-Neelsen (mZN) (B) stains 
oocysts pink against a blue/green background, DAPI stains the nuclei of viable oocysts making them appear 
blue (C) and it is possible to visualize oocysts using phase-contrast microscopy without any staining (D). 
Images from (Robinson et al., 2010). 
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Microscopy techniques are commonly used for diagnostic purposes but most 
often in a research setting molecular tools are used instead as these are much 
more sensitive and provide far more additional information (Chalmers and 
Katzer, 2013).  Many conserved genes have been targeted for the purpose of 
species differentiation including; those encoding 18S rRNA (Xiao et al., 1999), 70 
kDa heat shock protein (HSP70) (Sulaiman et al., 2000), Cryptosporidium oocyst 
wall protein (COWP) (Xiao et al., 2000b) and the actin gene (Kim et al., 1992). 
Probably the most commonly used of these is the 18S rRNA gene as in addition to 
containing regions that vary between species there are several regions which are 
conserved within the Cryptosporidium genus. In each Cryptosporidium oocyst 
there are 20 copies of this gene (Le Blancq et al., 1997; Morgan and Thompson, 
1999) meaning that sensitivity is increased when compared with a single-copy 
gene.  
1.4.1 Enzyme Immunoassays 
Enzyme immunoassays (EIA) are very common in the UK for detection of 
Cryptosporidium in human faecal samples and are very sensitive in detecting C. 
parvum (Garcia et al., 1987) but the ability of these kits to detect other 
Cryptosporidium species has not been thoroughly assessed. Some studies show a 
reduction in sensitivity when other Cryptosporidium species (C. andersoni) are 
present (Lindergard et al., 2001). EIAs use rabbit anti-Cryptosporidium 
polyclonal antibodies to capture the Cryptosporidium antigen from the stool 
supernatant. A second set of goat anti-Cryptosporidium polyclonal antibodies 
are then added, which sandwiches the captured Cryptosporidium antigen 
(Ungar, 1990). Sometimes these assays can be combined to allow the detection 
of other parasites such as Giardia at the same time. EIA are very sensitive (100%) 
and specific (~91-93%) but can be expensive to perform (Chalmers et al., 2011) 
which may prohibit their use in large studies. 
1.4.2 Molecular detection of Cryptosporidium 
Species differentiation using molecular methods can be done in a few different 
ways; these begin with DNA extraction from oocysts and PCR amplification of the 
gene(s) of interest. DNA extracted from oocysts can be amplified using standard 
or nested PCR methods. In standard PCR one pair of forward and reverse primers 
13 
 
are used to amplify a gene or region of a gene, whereas in nested PCR two sets 
of primers are used. The first pair (external) amplify the gene of interest and in 
a second round; internal primers amplify a shorter sequence of the amplicon 
produced in the first PCR. This is useful if the sample only contains a small 
amount of DNA as it results in more DNA copies than standard PCR. The PCR 
products are separated by electrophoresis on an agarose gel and visualised by 
staining with a stain such as ethidium bromide which binds to nucleic acids and 
can be viewed under UV light. Species can be differentiated using restriction 
enzymes to digest PCR products into fragments of different sizes (PCR-
Restriction Fragment Length Polymorphism (RFLP)). These fragments can be 
visualised on the agarose gel, producing varying banding patterns depending on 
species (Spano et al., 1997; Sulaiman et al., 1999). Another commonly used 
method is DNA sequencing of the PCR products, the PCR product is purified and 
re-amplified using either the same primers in the initial PCR or primers 
specifically designed for sequencing and fluorescently labelled nucleotides. The 
labelled nucleotides emit light at specific wavelengths giving the sequence of 
the DNA fragment which can be analysed using various computer based 
programs. 
Another PCR method which can be used to detect and speciate Cryptosporidium 
parasites is real-time PCR which is considered to be the “gold-standard” for 
Cryptosporidium detection (Chalmers et al., 2011) as this method is the most 
sensitive and can detect as few as 2 oocysts per PCR (Hadfield et al., 2011). In 
real-time PCR the amplification of the DNA can be tracked in “real time” and 
the amount of DNA present can be quantified, this is an advantage over standard 
PCR which can only indicate the presence of parasite DNA but cannot quantify 
the amount. 
1.5 Cryptosporidium subtyping 
As well as speciating Cryptosporidium positive samples it can be useful to 
further subtype particular species, which can be informative in epidemiological 
studies and disease outbreaks to identify origin or source of particular subtypes 
and to study population genetics (Gatei et al., 2008; Mallon et al., 2003; 
Morrison et al., 2008; Wang et al., 2014b). Subtyping can be carried out by 
multilocus sequence typing (MLST) using several microsatellites to identify 
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alleles, assigning a parasite a multilocus genotype (MLG). MLST is useful for 
studying population genetics but it is not always necessary to examine the 
parasite in such detail. Many studies have subtyped certain Cryptosporidium 
species (C. parvum, C. hominis, C. meleagridis, C. ubiquitum and C. cuniculus) 
using the 60-kDa glycoprotein gene (gp60). This is informative enough to show 
inter-species variation and has also been linked to differences in clinical disease 
(Adamu et al., 2014; Cama et al., 2008) and, in some cases host specificity 
(Wang et al., 2014a). For example, some gp60 subtype families (IIc, IIb, IIe-IIl) of 
C. parvum have only been detected in humans but never in animal hosts. This is 
expanded on in section1.5.2.  
1.5.1 gp60 Subtyping 
The GP60 protein is expressed on the surface of invading stages of the parasite 
and is a target for neutralising antibodies (O'Connor et al., 2007). It is formed 
from two cell surface glycoproteins gp15 and gp45; gp45 is also referred to as 
gp40 and S45 (Strong et al., 2000; Strong and Nelson, 2000; Winter et al., 2000) 
and gp15 as cp17 and S16 (Winter et al., 2000). The gp60 gene is similar to a 
microsatellite as it contains multiple repeats of three tri-nucleotides (TCA, TCG 
and TCT) at the 5’ end of the gene.  
Sequence analysis of the gp60 gene is commonly used for genotyping 
Cryptosporidium species and often gp15 is used as a microsatellite marker for 
multilocus genotyping to identify Cryptosporidium subtypes (Strong et al., 
2000). In addition to variation in the number of tri-nucleotide repeats in the 
microsatellite region of gp60 there are also extensive sequence differences in 
non-repeat regions of the gene. These differences enable us to define 
Cryptosporidium species into subtype families (Sulaiman et al., 2005); the name 
of gp60 subtypes always starts with identification of the subtype family e.g. IIa 
(this is the most commonly recognised C. parvum subtype family in the UK) 
followed by the number of TCA (A), TCG (G) and TCT (T) repeats within the 
microsatellite region (Sulaiman et al., 2005). In some subtypes of C. parvum, 
either within or immediately after the microsatellite region there is a six base-
pair repeat ACATCA which is counted and represented by “R”, in addition, some 
C. hominis  subtypes have a 13 or 15 base-pair repeat (5’ –AAGACGGTGAAGG3’/ 
5’ –AGGACGGTGGTAAGG-3’) at the end of the microsatellite region also 
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represented by “R”. The most commonly identified C. parvum gp60 subtype 
found in the UK is IIaA15G2R1 which means that the parasite belongs to C. 
parvum subtype family IIa and contains 15 copies of the trinucleotide repeat 
TCA, two copies of TCG, no copies of TCT and one copy of the 6 base-pair 
sequence ACATCA (Figure 1-3). 
 
 
 
Figure 1-3: gp60 sequence showing microsatellite region with TCA, TCG and ACATCA 
repeats highlighted. 
 
The main advantage to using gp60 as a single locus marker is that extensive use 
of this gene worldwide means comparisons of subtypes can easily be made 
between studies, countries and host species. It is also possible to link gp60 
subtypes with biological characteristics and clinical disease (Xiao, 2010) as, 
unlike many of the other genes which are used for subtyping, it is a functional 
protein which is involved in host cell attachment and parasite invasion (O'Connor 
et al., 2007). One disadvantage of using this single locus is that, at present, it 
can only be used to subtype certain species (C. parvum, C. hominis, C. 
meleagridis, C. ubiquitum and C. cuniculus). 
1.5.2 C. parvum gp60 Subtype Diversity 
In many countries high subtype diversity of C. parvum has been reported from 
both human and ruminant studies. In Northern Ireland a study which analysed 
the gp60 sequence of 214 neonatal calves found 15 different subtypes all from 
the IIa subtype family (Thompson et al., 2007) and in the Netherlands 160 C. 
parvum positive bovine samples were subtyped by gp60 sequence analysis and 17 
subtypes of IIa and IIl subtype families were identified (Wielinga et al., 2008). 
Subtyping of C. parvum and C. hominis with gp60 has been used worldwide, it 
has been shown that some C. parvum subtype families (IIa and IId) are found in 
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both humans and ruminants, whereas other C. parvum subtypes (IIc, IIb, IIe-IIl) 
have only been identified in humans (Alves et al., 2003; Cama et al., 2008; 
Hijjawi et al., 2010). Even within ruminants it has been found that some C. 
parvum subtypes preferentially infect one ruminant species over another. In 
areas of Spain where both IIa and IId are found IIa predominantly infects calves 
while IId predominantly infects lambs and goat kids (Quilez et al., 2008a; Quilez 
et al., 2008b). The most common subtype of C. parvum is IIaA15G2R1 which has 
a worldwide distribution and is often found in both humans and ruminants 
(Broglia et al., 2008). Within C. hominis subtypes significant variations in clinical 
disease and virulence have also been found in certain areas of Peru and Ethiopia 
in patients suffering from HIV (Adamu et al., 2014; Cama et al., 2008; Cama et 
al., 2007). It has been previously suggested that differences in clinical 
manifestations may be due to the immune status of the infected person 
(Flanigan, 1994) but the results from these studies suggest that there are 
differences in the parasite in addition to host immune factors. Between species, 
C. parvum was likely to be the most pathogenic as it was significantly associated 
with chronic diarrhoea and vomiting while C. meleagridis was less pathogenic. 
Within species, those infected with C. hominis subtype family Id were most 
likely to suffer from diarrhoea while those infected with subtype family Ia had 
fewer clinical signs. It is also possible that some people have a genetic 
predisposition that makes them more susceptible to infection with 
Cryptosporidium. Fayer et al (2000) showed that children with B*15 HLA I allele 
and the DQB1* 0301 HLA II allele were more likely to suffer from 
cryptosporidiosis than those with a different allele. 
Although most studies subtyping Cryptosporidium species are studies examining 
human samples or outbreaks there are more and more studies being carried out 
to investigate the subtypes of Cryptosporidium infecting farm livestock. One 
cross-sectional study of neonatal calves from 41 farms in the South of England 
demonstrated that most farms have a single predominant gp60 subtype (Brook et 
al., 2009). The findings in this study tie in with other studies which show that on 
individual farms C. parvum gp60 subtypes seem stable but that there is wide 
genetic variation between farms. A study carried out in Scotland on the 
population genetics of Cryptosporidium species by microsatellite analysis of 
isolates from human, cattle and sheep sources showed that genetic diversity in 
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bovine isolates can be linked with cattle movement (Morrison et al., 2008). Some 
other studies which have looked at the C. parvum gp60 subtypes of calves have 
found similar results to this but another study in the UK found that IIaA15G2R1 
was not the most commonly detected subtype. The study examined 779 faecal 
samples collected from neonatal diarrhoeic calves from farms across Northern 
Ireland. All of the C. parvum positive samples (n=213), were subtyped at the 
gp60 locus, in total 16 different subtypes were identified all from allele family 
IIa. The most prevalent subtype in this study was IIaA18G3R1 (n=120) (Thompson 
et al., 2007) which has also been identified in humans from Northern Ireland 
(Zintl et al., 2009). 
1.6 Transmission of Cryptosporidium 
Cryptosporidium oocysts are transmitted between hosts via the faecal-oral 
route, either directly from contact with faeces of infected animals or indirectly 
through environmental contamination or from ingestion of contaminated food or 
water.  
There are some reports of veterinary students, typically from urban areas, 
becoming infected with C. parvum when they start working with farm livestock 
(usually calves) during their studies (Gait et al., 2008; Pohjola et al., 1986; 
Preiser et al., 2003) as well as outbreaks amongst members of the public 
associated with petting zoos or farm visits (Pritchard and Fleetwood, 1995) 
(Gormley et al., 2011). Drinking water outbreaks can be very serious as many 
people can become infected in a short space of time. The oocysts of 
Cryptosporidium are very small and as such it can be difficult to eliminate them 
from municipal supplies as the filters used are larger than the oocysts 
themselves. It is also not possible to chemically inactive the oocysts (Pollock et 
al., 2008) by chlorination or other methods commonly used to treat drinking 
water. More recently in some areas the use of ozone and UV light have been very 
useful in inactivation of Cryptosporidium oocysts in drinking water (Cho and 
Yoon, 2007). The world’s largest waterborne Cryptosporidium outbreak occurred 
in Milwaukee in 1993. During this outbreak ~400,000 people were affected. The 
source of the outbreak was never confirmed at the time but run-off from cattle 
pastures due to ice melt was one suggestion (Mac Kenzie et al., 1994). 
Retrospective analysis of samples collected at the time of the outbreak has 
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shown that patients were in fact infected with C. hominis rather than C. 
parvum. This indicates that the source of the infection was anthroponotic rather 
than zoonotic . Foodborne transmission of Cryptosporidium can occur when food 
items, such as vegetables and salad items are washed with contaminated water 
during processing, from contamination of food by a food handler or contact with 
infected animal faeces. Foodborne transmission of cryptosporidiosis seems to be 
much lower than waterborne transmission, this is either because there is less 
foodborne transmission or because of under reporting of outbreaks (Robertson 
and Chalmers, 2013). 
Anthroponotic transmission of C. hominis has been associated with those working 
in caring environments such as nursery and care workers who may have close 
contact with faeces from infected individuals (Joachim, 2004). There have also 
been waterborne outbreaks associated with human to human transmission via 
drinking water (Mason et al., 2010; Widerstrom et al., 2014) and recreational 
waters (Coetzee et al., 2008). 
1.6.1 Infective Dose 
Attempts have been made to quantify the minimum infective dose of 
Cryptosporidium oocysts of different species in different host species. The 
results vary between study even when the same Cryptosporidium and host 
species is being examined. One study carried out on human volunteers with C. 
parvum reported an infective dose of 132 oocysts (DuPont et al., 1995). As has 
been previously discussed variation in the outcome of clinical disease occurs 
depending on the isolate used, another paper reported differences in the 
infective dose among C. parvum isolates in human volunteers. The infective dose 
for C. parvum IOWA isolate was 87 oocysts, 1042 oocysts for C. parvum UCP 
isolate and only 9 oocysts for C. parvum TAMU isolate (Okhuysen et al., 1999). 
One study in calves (infected with C. parvum) found that the infective dose for 
oocyst shedding only was 5.8 oocysts, scour only was 9.7 oocysts and for oocyst 
shedding with diarrhoea was 16.6 oocysts (Zambriski et al., 2013b). The 
infective dose  is thought to be very low due to the rapid life cycle and ability of 
the parasite to auto-infect host cells. 
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1.6.2 Oocyst Shedding (calves) 
 Infected hosts can shed huge numbers of oocysts per day, which are 
immediately infective to other susceptible hosts (Nydam et al., 2001; Zambriski 
et al., 2013a) meaning that infection can pass very quickly between animals kept 
in close contact to one another. Infected calves will begin to shed infective 
oocysts 4-9 days after initial infection (depending on infective dose) and can 
shed large numbers of oocysts each day (Faubert and Litvinsky, 2000). Studies 
have reported oocyst shedding in calf faeces to be around 104 - 108 oocysts per 
gram of faeces (Fayer et al., 1998), the number of oocyst shed in the faeces 
depends on the initial infective dose (Fayer et al., 2010a; Rieux et al., 2013; 
Zambriski et al., 2013a). Excretion of oocysts normally lasts for 6-14 days (Fayer 
et al., 1998; Nydam et al., 2001; Zambriski et al., 2013a) and high oocyst 
excretion is more usually associated with calves younger than one month 
(O'Handley et al., 1999; Ongerth and Stibbs, 1989). Animals infected with a 
higher dose will not shed any longer than those receiving a lower dose but they 
will shed more oocysts throughout the duration of shedding (Zambriski et al., 
2013a).  
1.7 Cryptosporidiosis 
Not all species of Cryptosporidium cause similar disease manifestations. In most 
mammals’ infection with C. parvum causes self-limiting watery diarrhoea, loss of 
appetite and abdominal pain (Clark and Sears, 1996; Klein et al., 2008; Tzipori 
et al., 1983; Tzipori and Ward, 2002). In other host species different 
Cryptosporidium species will cause similar clinical disease such as; C. hominis  in 
humans, C. meleagridis and C. galli in birds, usually chickens; C. serpentis in 
snakes; C. varanii in lizards and C. xiaoi in goats whereas other Cryptosporidium 
species manifest themselves in other ways. For example, in birds the most 
common form of cryptosporidiosis is respiratory cryptosporidiosis which is caused 
by C. baileyi (Lindsay et al., 1986). Other species of Cryptosporidium appear to 
be non-pathogenic in some hosts such as C. ryanae and C. bovis, these are 
commonly found in calves but experimental infections have shown that although 
infected animals shed oocysts infection with these species is not associated with 
clinical disease (Fayer et al., 2008; Fayer et al., 2005). In some cases and in 
immunosupressed individuals disease caused by C. parvum can be severe, lasting 
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for several weeks, spreading to other areas of the body, as opposed to the 
intestines, such as the respiratory tract causing respiratory disease and may 
even lead to death (Denkinger et al., 2008; Hojlyng and Jensen, 1988; Moore and 
Frenkel, 1991; Mor et al., 2010).  
Diarrhoea caused by C. parvum can occur in two ways; malabsorptive diarrhoea 
is caused by loss of enterocytes and blunting of villi (Figure 1-4) which reduces 
the intestinal surface leading to decreased water and nutrient absorption (Klein 
et al., 2008; Tzipori and Ward, 2002). Secretory diarrhoea occurs when intestinal 
secretion is increased. Some infectious organisms produce toxins which stimulate 
intestinal secretion by invading host epithelial cells (Clark and Sears, 1996) and 
there have been reports of patients infected with Cryptosporidium suffering 
from profuse watery diarrhoea, which is very similar to the secretory diarrhoea 
that is caused by the cholera (Vibrio cholera) toxin. A study in 1994 identified 
enterotoxin-like activity in stool supernatant from C. parvum-infected calves 
(Guarino et al., 1994) and others believe that C. parvum might simulate 
proinflammatory cytokines. Intestinal damage caused by infection can lead to a 
slight reduction in growth rates but the intestinal absorption is generally 
restored three weeks after infection and no long-term damage to the gut occurs 
(Klein et al., 2008). 
 
Figure 1-4: Healthy gut villi (left) and damaged gut caused by C. parvum infection (right) in a 
calf. 
 
1.7.1 Disease in farm livestock 
Cryptosporidiosis in farm livestock usually lasts around two weeks in otherwise 
healthy animals and has no long-term implications on animal health except in 
some severe cases when lambs and chickens may suffer from a reduction in 
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growth (de Graaf et al., 1999; Goodwin et al., 1996; Sweeny et al., 2011a). The 
economic losses associated with Cryptosporidium have never been calculated 
but losses would include cost of treatment of enteritis, reduced feed conversion 
and production efficiency and, of course, losses due to animal death. 
The majority of animals infected with Cryptosporidium survive but in some host 
species animals which have been infected may have lower growth rates than 
those that have not, lambs infected with C. parvum were shown to have reduced 
growth rate, live-weight and carcass quality than those not infected (Sweeny et 
al., 2011b). 
 Despite most reports stating that cryptosporidiosis is generally self-limiting with 
no long-term health implications there are several anecdotal incidences of very 
severe cryptosporidiosis leading to high morbidity and mortality within herds and 
flocks with some farmers having no choice but to leave the industry due to lack 
of profitability.   
1.7.1.1 Cattle 
Cryptosporidiosis was first reported in cattle in the early 1970’s (Meuten et al., 
1974; Panciera et al., 1971) but the diarrhoea caused in these animals was also 
associated with other viral and bacterial infections and could not be solely 
attributed to Cryptosporidium. In 1983 neonatal diarrhoea in calves was 
reported with Cryptosporidium species as the sole infective agent (Tzipori et al., 
1983) and it is now recognised that the disease is endemic worldwide. Infection 
with C. parvum in cattle tends to be located in the small intestine at the 
ileocaecal junction but the parasite has also been found in the caecum, colon 
and duodenum (Pohlenz et al., 1978; Sanford and Josephson, 1982). Different 
species of Cryptosporidium are found in different locations. In adults infected 
with C. andersoni the parasite is found in the abomasum (Lindsay et al., 2000). 
Death of young calves caused by Cryptosporidium is usually attributed to 
dehydration due to severe diarrhoea (Sanford and Josephson, 1982).  
Different age groups of cattle are commonly infected with distinct species of 
Cryptosporidium (Figure 1-5) although there are sometimes exceptions to this. 
Clinical disease caused by Cryptosporidium is usually limited to neonatal 
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livestock with older animals (>6 weeks) exhibiting only asymptomatic shedding 
of oocysts (Fayer et al., 2006) and is caused by C. parvum; whereas the species 
that infect older calves (C. bovis and C. ryanae) have not been associated with 
any clinical disease (de Graaf et al., 1999; Fayer et al., 2008; Fayer et al., 
2005). Cryptosporidium andersoni tends to affect the abomasum of adult cattle 
but this species does not cause diarrhoea and much fewer oocysts are shed 
compared with C. parvum infection (Kvac and Vitovec, 2003), infection with this 
species tends to cause mild clinical disease and affects weight gain and milk 
production (Anderson, 1987; Esteban and Anderson, 1995; Ralston et al., 2010). 
 
Figure 1-5: Species of Cryptosporidium generally associated with different age groups of 
cattle.  
It is commonly accepted that different species of cattle-adapted Cryptosporidium species are found in different 
age groups of cattle. C. parvum is commonly found in young calves, C. bovis and C. ryanae in older calves 
and C. andersoni in adult cattle (Santin et al., 2004). 
 
1.7.1.2 Sheep and goats 
In sheep, cryptosporidiosis was first reported in lambs less than three weeks old 
suffering from diarrhoea on a farm in Australia (Barker and Carbonell, 1974). As 
with cattle, Cryptosporidium is now recognised as one of the main etiological 
agents of lamb diarrhoea and in lambs is associated with high morbidity and 
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mortality in infected flocks (de Graaf et al., 1999; Sari et al., 2009). 
Cryptosporidiosis in lambs appears to cause more mortality than in calves, this is 
perhaps because lambs can become dehydrated much more quickly than calves. 
Australia was also the first place where cryptosporidiosis of goats was reported 
(Mason et al., 1981), it is now considered a very important disease of goats due 
to the high morbidity (up to 100%) and mortality (up to 50%) in some goat herds 
(Johnson et al., 1999; Paraud et al., 2010; Vieira et al., 1997). In small 
ruminants the infection causes depression, anorexia, abdominal pain and 
diarrhoea. The diarrhoea is usually accompanied by the shedding of large 
numbers of oocysts, usually lasting three to five days but in severe cases up to 
two weeks. In small ruminants such as sheep and goats infection normally occurs 
in the jejunum and ileum but can spread to other areas in the small and large 
intestine (Snodgrass et al., 1984).  
1.7.1.3 Poultry 
In domestic poultry the most common form of cryptosporidiosis is respiratory 
rather than diarrhoeic except in turkeys. Birds are also known to suffer from 
renal and ocular cryptosporidiosis.  
Cryptosporidium meleagridis infects the intestinal tract, bursa of fabricius and 
cloaca (Ryan, 2010) in turkeys and chickens but clinical disease seems to affect 
only turkeys (Slavin, 1995), in other birds asymptomatic infections have been 
reported (Abe and Iseki, 2004). C. baileyi, in addition to infection of the 
intestinal tract, bursa of fabricius and cloaca also infects the respiratory and 
urinary tract in turkeys, chickens and ducks (Lindsay et al., 1986). It is the most 
common cause of cryptosporidiosis in poultry, especially chickens where it 
normally manifests itself as respiratory disease with only occasional intestinal 
disease. C. baileyi infection has also been associated with a lower body weight 
in broiler chickens (Goodwin, 1996). The third avian-adapted species, C. galli, 
does not develop in either the intestines or respiratory tract but instead 
develops in the proventriculus, causing diarrhoea; this species has been 
associated with high mortality in birds (Ryan et al., 2003a). 
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1.7.2 Humans 
At present it is known that humans can be infected with ~12 of the currently 
recognised species (C. hominis, C. parvum, C. viatorum, C. muris, C. felis, 
C.suis, C. canis, C. meleagridis, C. ubiquitum, C. fayeri, C. bovis and C. 
cuniculus) though some of these infections may have been transient infections 
and infections with some species have only been reported once (Elwin et al., 
2012a). Humans are most commonly infected with C. hominis and C. parvum 
(Hadfield et al., 2011) and it was originally thought that C. hominis infected only 
humans; however, there are some reports of C. hominis in other animals; a 
rhesus monkey (Ye et al., 2012); a dugong (Morgan et al., 2000); Canadian geese 
(Zhou et al., 2004); a sheep from Australia (Ryan et al., 2005); two cattle from 
Scotland (Smith et al., 2005) and a pygmy goat and a Texel lamb in the UK (Giles 
et al., 2009).  
Cryptosporidiosis in humans is prevalent worldwide in both developed and 
developing countries. Children and the elderly are more susceptible to disease 
than young adults. Children tend to acquire the infection shortly after, or during 
weaning (Tzipori, 2002). Infection of immunocompetent people with 
Cryptosporidium tends to cause self-limiting diarrhoea, however, a recent report 
showed that Cryptosporidium is the second biggest cause of infant diarrhoea and 
death in Africa and Asia (Striepen, 2013) which demonstrates that 
cryptosporidiosis is not always self-limiting and mild. Time from infection to 
clinical signs can vary depending on host variables such as age and any previous 
exposure and also on the parasite (age of oocysts, species/genotype); C. hominis 
tends to cause more severe and extra-intestinal disease than other species 
(Cama et al., 2007). Infection generally occurs in the small intestine but can 
spread through the large intestine and into the stomach. Infections concentrated 
in the small intestine of humans have a tendency to be more severe and result in 
more watery diarrhoea than infections in the distal ileum or bowel, which are 
often asymptomatic. Where diarrhoea lasts more than seven days serious 
dehydration and weight-loss may occur (Tzipori and Ward, 2002). 
Cryptosporidiosis, as with many other infectious diseases, can be much more 
severe in immunocompromised patients such as those suffering from AIDS, 
undergoing chemotherapy or those that have genetic disorders compared with 
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immunocompetent patients. One of the earliest reports of cryptosporidiosis in 
humans was in an immunocompromised patient in 1976 (Meisel, 1976). Reports 
of cryptosporidiosis in people dramatically increased during the 1980s when the 
HIV AIDS epidemic began as the infected patients were unable to fight the 
infection. People suffering from HIV AIDS who have a CD4+ T-cell count of less 
than 150/ml are very susceptible to severe persistent infection by 
Cryptosporidium with profuse and often life-threatening diarrhoea (Flanigan, 
1994; Huang and Zhou, 2007). In immunocompromised patients infection is 
rarely confined to the small intestine and can spread to the heptobilliary tract, 
pancreatic duct and also the lungs (Denkinger et al., 2008; Lopez-Velez et al., 
1995). 
1.7.3 Immunity to disease 
Despite the role of immune compromise in the development of disease in 
humans, the degree of adaptive immunity to infection and disease does not 
appear to be strong or of long duration (Okhuysen et al., 1998). Many people are 
infected whilst young and then again in adulthood (Current and Bick, 1989). A 
similar situation occurs for some primate species and broiler chickens, except 
that these hosts remain susceptible to infection but are protected against 
symptomatic disease (Current and Snyder, 1988; Miller et al., 1990). In farm 
livestock there is some evidence that animals will become less susceptible to 
disease the older they are (Harp et al., 1990; Kvac et al., 2014; Ortega-Mora and 
Wright, 1994) though one experimental study in calves demonstrated that it does 
not matter what age the calf is when it is first challenged with C. parvum the 
animal will shed oocysts and may have diarrhoea (Harp et al., 1990). However, if 
a calf has previous exposure to the parasite and is subsequently challenged then 
the animal will not shed oocysts (Harp et al., 1990). Similar studies in mice show 
that mice do not need to be exposed to the parasite to develop resistance at an 
older age (Harp et al., 1992; Harp et al., 1988), it has also been shown that the 
age at which the mouse becomes resistant to infection is also the age at which 
the intestinal flora is fully mature (Harp et al., 1992). It is not known if it is 
possible to develop immunity which is specific to a species or subtype of 
Cryptosporidium but which will not provide protection to infection with a 
different species or subtype. Most experimental trials have only tested the 
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development of immunity to a homologous challenge (Harp et al., 1990; Miller et 
al., 1990; Ortega-Mora and Wright, 1994). 
1.7.3.1 Host Immune Response 
Immunity to Cryptosporidium involves both the innate and adaptive immune 
response. Studies on this subject are few and the nature of the immune response 
is poorly understood. 
The innate immune response will provide an immediate defence against the 
parasite invading the epithelial cells by preventing attachment. It has been 
shown that mucin interferes with the sporozoite’s ability to attach to the cell 
wall (Barnes et al., 1998; Cevallos et al., 2000) and other immune cells such as 
natural killer (NK) cells will secrete cytokines which may have a direct effect on 
the parasite or signal a further immune response. 
Following invasion of the host epithelial cells cytokines are produced which 
signal NK cells into action. When stimulated by TNFα and IL-12, NK cells produce 
IFN-γ (and other cytokines but mainly IFN-γ), NK cells also produce TNFβ, which 
can directly damage target cells and cause cell lysis. TNFα activates APC 
(antigen presenting cells) such as dendritic cells and macrophages which are 
found in the villi of the intestinal mucosa. Activation of these leads to the 
secretion of further cytokines and interaction with CD4+ T cells, these cells 
differentiate into either Th1 or Th2 cells. Th1 cells produce IL-12, IFN-γ and 
TNFβ which enhance the cytotoxic response, Th2 cells produce other 
interleukins which stimulate the differentiation of B-cells into antibody 
producing cells (Figure 1-6). 
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Figure 1-6: Simplified diagram showing the most important steps and interactions in the 
acquired immune response against Cryptosporidium infection.  
Adapted from Cryptosporidium from molecules to disease.(Thompson et al., 2003) 
 
Much of the knowledge of immune responses to Cryptosporidium has been 
gained through infection trials in murine models. There are some studies 
investigating the immune responses to Cryptosporidium in humans but very few 
in livestock hosts. 
Experimental infections in mice have shown that Th1 cytokines, CD4+ T cells and 
IFN-γ are essential for elimination of Cryptosporidium infection (McDonald and 
Bancroft, 1994; McDonald et al., 1996). Mice lacking CD4+ T cells become 
seriously ill if infected compared with ‘normal’ mice, the same is assumed for 
humans as it is known that AIDS patients with low CD4+ T cell counts suffer from 
more severe disease which can be fatal (Hoepelman, 1996; Lopez-Velez et al., 
1995; Tali et al., 2011). 
Cytokines that play a key role in both innate and adaptive immunity include IFN-
γ. In mice it has been established that IFN-γ is a major player in controlling 
Cryptosporidium infection, not only in cell-mediated immunity but in early 
innate immune responses as well (Riggs, 2002; Theodos, 1998). Mice deficient in 
IFN-γ and other cytokines (IL-12 and IL-18) have increased susceptibility to 
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infection (Mead and You, 1998; Tessema et al., 2009). Similar results have been 
reported for HIV-negative patients with IFN-γ deficiency (Gomez Morales et al., 
1999) and in vitro studies have demonstrated that in human cells IFN-γ directly 
prevents the parasite from invading host cells (Pollok et al., 2001). 
1.7.4 Control of cryptosporidiosis 
Cryptosporidiosis is a difficult disease to control, as the oocysts are very 
environmentally stable and can survive for long periods of time in cool, moist 
conditions, infected animals shed huge numbers of infective oocysts (Fayer et 
al., 2010a) and infection can pass through a group of susceptible hosts very 
quickly. The oocysts are also resistant to many disinfectants (Chalmers and 
Giles, 2010), there are no vaccines available to prevent the disease, and 
treatment options are limited and often rely on rehydration therapy. 
1.7.5 Therapeutics 
At present there are very few products licensed in the UK for the treatment or 
prevention of cryptosporidiosis in livestock or humans, the few products which 
are available are not very effective and in most cases will only reduce the 
duration of shedding and have little or no effect on immunocompromised 
patients.  
1.7.5.1 Livestock 
The only licensed treatment for cryptosporidiosis in calves is halofuginone 
lactate which affects invading parasite stages of Cryptosporidium (Jarvie et al., 
2005). This drug is approved for use in both prevention and treatment of 
cryptosporidiosis in calves at a dose of 0.10 mg/kg of body weight per day for 
seven consecutive days. As a preventative measure the drug should be given 
within 48 h of birth and as a therapeutic, within 24 h of the onset of symptoms. 
Treatment with halofuginone lactate does not completely prevent or cure 
disease but it does reduce oocyst shedding and duration of diarrhoea (Jarvie et 
al., 2005; Lefay et al., 2001; Trotz-Williams et al., 2011). There is no licensed 
treatment for cryptosporidiosis in sheep, goats or pigs. 
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Several other chemotherapeutic agents have been tested for the treatment of 
cryptosporidiosis in livestock but none have resulted in a significant reduction in 
oocyst shedding; some antibiotics have shown efficacy against Cryptosporidium 
oocyst shedding, clinical disease and mortality in calves, lambs and goat kids but 
these are not registered for use in calves (Fayer and Ellis, 1993; Viu et al., 
2000). A few coccidiostats, such as decoquinate have been tested against 
Cryptosporidium with limited or no reduction in oocyst shedding (Moore et al., 
2003).  
1.7.5.2 Humans 
For human cases of cryptosporidiosis the only treatment available is 
nitazoxanide, which interferes with anaerobic metabolism of the parasite. Like 
halofuginone lactate in the treatment of cryptosporidiosis of livestock this drug 
cannot prevent or cure the disease but does reduce shedding of oocysts and 
severity of disease in immunocompetent patients (Rossignol et al., 2001). It has 
little effect on the severity of disease in immunocompromised patients (Amadi 
et al., 2002). 
1.7.6 Vaccines 
At present there are no vaccines available to prevent cryptosporidiosis in either 
farm livestock or humans. However, several attempts to develop such a vaccine 
have been made, some of which were partially successful under experimental 
conditions. Calves that were immunised with killed (gamma-irradiated or 
lyophilised) C. parvum oocysts showed a reduction in oocyst shedding and levels 
of diarrhoea compared to non-immunised calves (Harp and Goff, 1995; Jenkins 
et al., 2004). However, this vaccine was not effective when tested under field 
conditions (Harp and Goff, 1998).  
Infection with Cryptosporidium often occurs within the first week of life so 
attempting to immunise the calves themselves is probably ineffective as this will 
not mediate a significant immune response prior to infection (de Graaf et al., 
1999; Innes et al., 2011). Some attempts to immunise cows so that they produce 
antibodies against Cryptosporidium which can be passed to their calves in the 
colostrum have been made.  Calves receiving colostrum from cows vaccinated 
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with a recombinant C. parvum were protected against diarrhoea and also a 
reduction in oocyst shedding compared to the calves which did not receive 
colostrum from vaccinated cows (Perryman et al., 1999). 
1.7.7 Disinfectants 
The oocysts are highly resistant to commonly used disinfectants (Virkon® S 
(peroxygen compounds (DuPont) (Ares-Mazas et al., 1997), FAM® 30 (Iodophors 
(Evans Vanodine)), Sorgene® 5 (hydrogen peroxide (BASF)) at their 
recommended working concentrations, (reviewed by Casemore & Watkins (, 
1998)), making them difficult to eliminate in cattle areas on farms.Some less 
common or harder to obtain disinfectants (KenoTMCox (amine based (CID Lines)), 
(Ox-Virin & Ox-Agua (peroxygen compounds (Edificio OX)) have been shown to be 
effective against Cryptosporidium oocysts, at least in vitro (Castro-Hermida et 
al., 2006b; Naciri et al., 2011; Quilez et al., 2005). There are very few field 
trials testing these disinfectants but one such study demonstrated that even 
though these may be effective in vitro they are not effective enough to rely on 
for the effective elimination of Cryptosporidium oocysts on farms (Keidel and 
Daugschies, 2013). 
1.7.8 Farm management 
Most recommendations for controlling cryptosporidiosis rely on good 
management and hygiene practices as the oocysts are so difficult to eliminate it 
is better to try and reduce the environmental contamination in the first 
instance. Frequent mucking out of calving areas and calf houses combined with 
steam-cleaning and disinfection can help to reduce environmental build up 
(Castro-Hermida et al., 2002) as can thorough cleaning with hot water followed 
by drying (Harp and Goff, 1998) as the oocysts are susceptible to extremes of 
temperature and desiccation (Robertson et al., 1992). 
Other calf management practices such as housing can have an effect on infection 
rates but some of the results are conflicting. In one study it was shown that 
housing calves with their dams decreased the risk of C. parvum infection while 
calves removed from their dam and kept in individual pens were at higher risk of 
infection (Duranti et al., 2009). In contrast, other studies have shown that the 
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opposite is true (Quigley, III et al., 1994). It is also possible for infection to be 
passed between subsequent calves in a particular pen (O'Handley et al., 1999) if 
the pen is not thoroughly cleaned between calves. Calves housed outdoors are at 
less risk than those housed indoors regardless of the housing arrangements 
(Quigley, III et al., 1994). 
1.8 Summary 
In summary, cryptosporidiosis is a very serious cause of enteritis and disease in 
many vertebrate and invertebrate species. Detailed, longitudinal studies in farm 
livestock are few and since the development of new molecular tools the 
dynamics of parasite infection should be further investigated. There is a lack of 
diagnostic tools to enable the quick speciation of Cryptosporidium present in 
calf samples; it is also difficult to detect mixed infections meaning that zoonotic 
infections can be missed where the predominant species is a less-pathogenic 
one. In particular, the transmission of C. parvum from adult cattle to neonatal 
calves is much debated and the ability of animals to develop immunity to 
disease is not well understood. This PhD work hopes to answer, in part, some of 
these important questions.
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1.9 Aims 
The main aims of this PhD are:  
1. To develop new typing tools (multiplex PCR) to distinguish 
Cryptosporidium species commonly found in cattle samples  
 
2. To assess the shedding profile of Cryptosporidium species and genotypes 
found in calves on a study farm 
 
3. To assess the role of adult cattle in the transmission and persistence of 
Cryptosporidium parvum on a study farm 
 
4. To assess the host-pathogen interactions involved in animals given serial 
experimental challenges with distinct Cryptosporidium parvum isolates  
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Chapter 2: Materials and Methods 
The methods described here are general protocols used throughout this PhD in 
various studies. Animal and sample numbers are described in more detail in the 
relevant chapter as well as any adaptations or changes to the general protocol. 
2.1 Cattle Sample Collection 
2.1.1 Dairy Calves 
Faecal samples from dairy calves were collected directly from the rectum using 
a gloved finger and bag for collection; where possible the entire motion was 
collected. It was not always possible to collect a sample from each calf on each 
sampling day; therefore the number of samples collected per calf did vary. After 
collection the samples were transferred to the laboratory where a sub-sample 
was aliquoted into a bijoux tube and stored at -20°C. 
2.1.2 Adult Dairy Cattle 
Collection of faeces from adult dairy cattle was carried out by observing the cow 
until she defecated and picking the sample from the floor; the whole pat was 
collected where possible. The cows were housed in cubicle sheds before calving, 
in straw courts at calving and in slatted cubicle sheds after calving when they 
returned to the milking herd. After collection the samples were transferred to 
the laboratory where the entire motion was mixed and a sub-sample aliquoted 
into a 125 ml tub and stored at 4°C. 
2.2 Experimental Animals 
All experimental animals were used in accordance with Home Office regulations, 
with approval of the experimental design sought before the study commenced 
from the Moredun Research Institute’s ethics committee.  
2.2.1 Lambs  
Forty newborn (<24 h old) Texel and Texel cross male lambs were obtained from 
Firth Mains farm, Roslin. 
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2.2.1.1 Pre-amplification of Cryptosporidium isolates 
Four of the 40 lambs were obtained one month prior to the study start date. 
These lambs were separated into two groups of two and each group was 
inoculated with one of two different C. parvum isolates (see section 3.3.1). 
2.2.1.2 Study animals 
Animals used in the study were separated into six groups of six depending on 
experimental challenge (see section 3.3.2). 
2.2.2 Clinical Scoring  
Lambs were monitored a minimum of three times per day for the first six weeks 
and then a minimum of twice daily for the remainder of the study. Daily 
monitoring involved the recording of the volume of milk each lamb drank along 
with how well the animal drank, the demeanour of the animal and the 
appearance of the faeces produced (Table 2-1).
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Table 2-1: Scoring system used to score lambs daily 
 Demeanour Rising Demeanour Standing Feeding Faecal Consistency 
Score Description Description Description Description 
1 
Already on feet 
 
Happy to rise 
Fit and well 
Feeding vigorously 
 
Complete feed with interruptions (due to excitement) 
 
Complete feed with assistance (due to age) 
Solid Pellet (s) 
2 Reluctant to rise Listless Partial feed with assistance (due to age) Soft Pellet (s) 
3 Needs assistance to rise Unsteady on feet Complete feed with interruptions (due to illness) Soft Mass 
4 N/A Cannot remain standing Complete feed with assistance (due to illness) Scour 
5 N/A N/A Partial feed – no assistance Liquid 
6 N/A N/A Partial feed with assistance (due to illness) N/A 
7 N/A N/A Animal refuses to feed N/A 
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2.2.3 Blood Sampling 
Blood samples were taken weekly from each lamb by jugular vein puncture using 
a vacutainer needle (BD Vacutainer, USA). Blood samples were left overnight at 
4°C to clot then centrifuged at 2000 × g for 10 mins and the serum transferred 
to a 1.5 ml tube. Serum samples were stored at -20°C. 
2.2.4 Faecal Collection 
Total faecal output was collected from each lamb using a specially designed 
harness and bag system (see section 2.2.4.1) which the lamb wore continuously. 
This enabled the lambs to be penned in groups rather than separately but still 
allowed collection of samples from each lamb individually. This system also 
ensured that after inoculation the lambs were not exposed to any faecal matter 
and were not re-infected by oocysts shed in the faeces. Bags were taken off and 
replaced with a new one clearly marked with group/animal/sample when 
required. Samples were stored in the bags at 4°C until they were processed (see 
section 2.5.2). 
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2.2.4.1 Harness and bag design 
An adjustable body harness with attachment points for the collection bag was 
designed and made using 20 mm webbing and plastic buckles (Figure 2-1). 
Collection bags were made using resealable polythene bags with a pipe cleaner 
to keep the bag open, a hole for the tail and a length of India cotton tape to 
attach the bag to the harness. 
 
Figure 2-1: Lambs wearing harness and bags for collection of faeces. 
 
2.3 Cryptosporidium oocysts 
In the experimental study (Chapter 3) three different C. parvum isolates were 
used, these are described in more detail in section 3.3.3. 
2.3.1 Collection of faeces for oocyst purification 
Faecal samples were collected from calves on three different farms known to 
have a problem with Cryptosporidium (history of cryptosporidiosis diagnosed by 
a veterinarian and regular occurrence of scour in neonatal calves). Samples were 
collected using the method described in section 2.1.1 from 2-6 scouring calves 
on each farm. 
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2.3.2 Identification, quantification, extraction and purification of 
positive samples 
2.3.2.1 Identification and quantification 
Each faecal sample was weighed and the starting weight recorded. If the sample 
was not sufficiently liquid (easy to pipette through a 1000 µl pipette tip) then 
water was added and the sample re-weighed. Approximately 1 ml of the faecal 
suspension was added to a bijoux, weighed, and diluted 1:5 with dH2O. The 
sample was then vortexed vigorously and 100 µl added to 900 µl malachite green 
stain (0.16% malachite green, 1% SDS). Using a haemocytometer 10 µl of the 
stained faecal suspension was examined under the microscope for the presence 
of oocysts. The number of oocysts in each of the four, sixteen grid corner 
squares were counted (Figure 2-2) on both side of the haemocytometer and the 
average number of oocysts calculated. The detection limit of this counting 
method is 62500 oocysts per gram of faeces. 
 
Figure 2-2: Example of the grid pattern on a haemocytometer. 
The number of oocysts in each of the four sixteen grid squares (circled) 
 
Quantification of the oocysts in each sample was done as follows (mean) × 
(dilution factor) × (104) × (sample weight). 
Oocysts were extracted from positive samples with high oocyst numbers using 
the method described in section 2.3.2.2. 
39 
 
2.3.2.2 Extraction and purification of oocysts from positive samples 
Oocysts were extracted from faeces that were found to be positive for 
Cryptosporidium when tested as described in section 2.3.2.1 using a sucrose 
flotation method. Sixty millilitres of faecal suspension was added to a 250 ml 
centrifuge bottle with 90 ml 45% sucrose solution and mixed thoroughly before 
being centrifuged at 1000 × g for 20 mins. The meniscus was removed and 
diluted 1:5 with dH2O and centrifuged at 1000 × g for 20 mins. The supernatant 
was discarded and the pellet resuspended in 20 ml dH2O in a 30 ml universal 
tube, this was centrifuged for 5 mins at 500 × g, the supernatant discarded and 
the pellet resuspended in 20 ml dH2O. This step was repeated until the 
supernatant was clear (four washes on average). After the final wash the pellet 
was resuspended in 10 ml 10% sodium dodecyl sulphate (SDS) and left to stand at 
room temperature for 1 h. After 1 h the samples were centrifuged at 500 × g for 
5 mins, the supernatant discarded and the pellet resuspended in 10 ml dH2O the 
centrifugation and resuspension step were repeated. The samples were stood for 
10-15 mins to allow any debris to flocculate and the supernatant removed to a 
clean universal tube. If any debris still remained after this step 100 µl 2% 
sulphuric acid was added to aid flocculation. 
Once oocysts were extracted from the faeces they were counted using the 
method described in section 2.3.2.1 except 10 µl oocyst suspension was added to 
990 µl 0.16% malachite green, 10% SDS. 
2.3.3 Viability of oocysts and inoculum preparation 
In order to test if the oocysts extracted from the calf faeces were infective a 
excystation assay was performed. A certain percentage of oocysts must be viable 
for the challenge dose to be effective. 
2.3.3.1 Excystation assay 
Forty microlitres of oocyst suspension was transferred to a 0.5 ml mini 
microcentrifuge tube and centrifuged at 12,500 × g for 30 s to pellet the oocysts. 
The supernatant was discarded and 40 µl of 1x Hanks Buffered Saline Solution 
(HBSS) was added and the pellet resuspended, 50 µl 1x trypsin (prepared in HBSS 
at pH3) was added and the sample mixed and incubated at 37°C for 1 h. 
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Following incubation the sample was centrifuged at 500 × g for 30 s and the 
supernatant discarded, the pellet was resuspended in 90 µl 1 × HBSS and 10 µl 
2.2% sodium bicarbonate and 10 µl 1% sodium deoxycholate (in HBSS) added. The 
sample was mixed and incubated at 37°C for 40 mins. Following incubation the 
sample was centrifuged at 12,500 ×g for 30 s and the supernatant discarded. The 
pellet was resuspended in 50 µl 3% gluteraldehyde to fix the sample. To assess 
the viability of the oocysts 10 µl fixed sample was spotted onto a microscope 
slide a cover slip placed on top and examined under × 40 phase contrast 
magnification. The total numbers of oocysts, sporozoites and empty oocyst shells 
were counted until the combined total reached 250. The sporozoite per shell 
ratio was calculated as follows: 
 
                
           
                        
 
And the excystation percentage as follows: 
 
           
                         
                              
 
Each oocyst can contain a maximum of 4 sporozoites. A sporozoite per shell ratio 
of >2 and an excystation percentage of >85% are considered good indicators of 
viability. Figure 2-3 shows excysted oocysts and sporozoites. 
41 
 
 
Figure 2-3: Excysted oocysts. Empty oocyst shells (dark circles) and sporozoites (bright 
"commas") can be seen. 
 
2.3.3.2 Preparation of inoculum 
Cryptosporidium oocysts were surface sterilised using 2 ml 70% EtOH (ethanol) 
for 30 mins before being resuspended in phosphate buffered saline (PBS). 
Oocysts were then counted and the oocyst suspension diluted with PBS to give 
the desired infective dose. 
2.4 Sample Processing 
2.4.1 Adult Dairy Cattle 
A 50 g sub-sample of faeces was thoroughly mixed and added to a 1000 ml 
cylinder containing 600 ml water and 7 ml 2% sulphuric acid. The volume was 
then made up to 700 ml by the addition of water. The samples were mixed for 5 
mins on a magnetic stirrer and then left to settle for 5 mins. The heavy, fibrous 
material sank to the bottom of the cylinder while the oocysts were suspended in 
the liquid fraction. Using a 25 ml pipette tip the supernatant was removed and 
added to two 250 ml centrifuge bottles, the bottles were then centrifuged at 
1000 × g for 20 mins and the supernatant poured off. The thin layer of sediment 
at the bottom of the centrifuge bottle was resuspended in 7 ml dH2O and poured 
into a 15 ml tube; two 3.5ml washes were used to remove the whole layer. The 
15 ml tubes were centrifuged at 5000 ×g for 5 mins and the supernatant poured 
off. The pellet was then subjected to salt flotation to purify the oocysts further. 
Three grams of the pellet was added to 8 ml saturated salt solution and 
Sporozoites 
Empty Shells 
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thoroughly mixed by vortexing then 2 ml dH2O trickled on top of the salt solution 
before centrifugation at 1000 × g for 8 mins. Following centrifugation the water 
layer was gently swirled using a Pasteur pipette to create a vortex which draws 
the oocysts from the layer between the dH2O and salt into the dH2O, the layer 
was removed and added to 6 ml dH2O, the total volume was made up to 10 ml, 
mixed by inverting and centrifuged at 5000 × g for 5 mins. The supernatant was 
poured off and the pellet resuspended in TE buffer (10 mM Tris-HCl, 0.5 mM 
EDTA) for DNA extraction. 
2.4.2   Experimental Lambs 
Samples collected from the lambs used in the experimental challenge (Chapter 
3) were processed individually. The sample was weighed and the weight 
recorded, water was then added to the sample to make the faeces liquid enough 
to pipette. If the sample was already liquid then no additional water was added. 
The sample was then re-weighed and the new weight recorded. Using a food 
processor the sample was homogenised completely and a 2 ml sample aliquoted 
into a tube for storage for subsequent use. These aliquots were stored at -20°C. 
A small subsample ~850 µl was taken and used to quantify the oocysts present in 
the sample (see section 2.3.2.1). The remainder of the faecal material was 
discarded. 
2.5 DNA Extraction 
2.5.1 Adult Cattle Faecal Samples 
DNA was extracted using a Macherey-Nagel Tissue Kit (Macherey-Nagel, 
Germany) following the manufacturer’s instructions except 10 × freeze-thaw 
cycles in liquid nitrogen were added. Briefly, the resuspended pellet (see section 
2.4.1) was mixed vigorously using a vortex then centrifuged at 4,000 × g for 15 
mins. The supernatant was poured off and the pellet resuspended in 200 µl 
buffer T1, 10 × freeze-thaw cycles in liquid nitrogen were performed and 25 µl 
proteinase K (provided in the kit) added. The samples were then incubated at 
56°C overnight. Following incubation the samples were briefly mixed using a 
vortex and then 200 µl lysis buffer B3 was added and incubated at 70°C for 10 
mins, after incubation samples still containing insoluble particles were 
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centrifuged at 11,000 × g for 5 mins and the supernatant transferred to a new 
1.5 ml tube. The samples were mixed by vortexing and the binding conditions 
adjusted by adding 210 µl EtOH (100%). The whole sample was loaded into a spin 
column placed in a 2 ml collection tube, the samples were centrifuged at 11,000 
× g for 1 min, the flow through discarded and the spin column placed into a new 
2 ml collection tube. The silica membrane was washed twice, first using 500 µl 
wash buffer BW and centrifugation for 1 min at 11,000 × g and secondly using 
600 µl wash buffer B5 followed by centrifugation for 1 min at 11,000 × g. After 
the initial wash the spin column was placed in a new 2 ml collection tube and 
after the second wash the flow through was discarded and the samples 
centrifuged at 11,000 × g for 1 min to dry the silica membrane. The DNA was 
eluted in 100 µl dH2O and stored at -20°C. 
2.5.2 Calf and Lamb Faecal Samples 
DNA was extracted from calf and lamb faecal samples in much the same way as 
described for adult samples (section 2.5.1) except 200 µg (or 200 µl if liquid) of 
faecal material was added to TE buffer and no freeze-thaw cycles were 
performed as previous work in the laboratory had shown that free-thawing of 
faeces from calves or lambs did not improve the detection of Cryptosporidium. 
2.6 Polymerase Chain Reaction (PCR) 
2.6.1 Cryptosporidium Specific 18S rRNA PCR 
A previously described nested PCR protocol (Xiao et al., 1999) was used to 
amplify a ~840 bp fragment of the 18S rRNA gene. Each 25 µl reaction contained 
10 × PCR buffer (45 mM Tris-HCl pH 8.8, 11 mM (NH4)2SO4, 4.5 mM MgCl2, 4.4 µM 
EDTA, 113 µg ml-1 BSA, 1 mM each of the four deoxyribonucleotide 
triphosphates) (MacLeod et al., 1999), 0.5 units BioTaq (Bioline, UK), 10 µM of 
forward and reverse primers (Table 2-2) and 3 µl DNA in the primary round and 1 
µl primary PCR product in the secondary round. The total volume was made up 
to 25 µl with dH2O. In each PCR run one set of positive control DNA and negative 
controls consisting of dH2O were included. All PCR reactions were carried out in 
triplicate. 
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Table 2-2: Primer sequences and size of amplicon when used with primer pair for the 18S 
rRNA gene. 
Primer Sequence 5’-3’ 
Fragment Size  
(bp) 
AL1687(EF) 
AL1691(ER) 
TTCTAGAGCTAATACATGCG 
 
CCCATTTCTTCGAAACAGGA 
1370 
AL1598 (IF) 
AL3032 (IR) 
GGAAGGGTTGTATTTATTAGATAAAG 
 
AAGGAGTAAGGAACAACCTCCA 
840 
 
Cycling conditions were 3 mins at 94°C, followed by 35 cycles of 45 seconds at 
94°C, 45 seconds at 55°C and 1 min at 72°C. The final extension was 7 mins at 
72°C. Secondary amplification products (~3 µl) were visualised following 
electrophoresis on a 1.5% agarose gel stained with GelRedTM (Biotium, UK) on an 
AlphaImager 2000. 
2.6.2 Nested Species Specific Multiplex PCR (nssm-PCR) 
For the differentiation of Cryptosporidium species, the primary PCR products 
from the 18S rRNA nested PCR were amplified using a nested species specific 
multiplex PCR (nssm-PCR) (Chapter 4) which can distinguish the four most 
commonly detected bovine species of Cryptosporidium. The primary PCR 
products were diluted with 50 µl dH2O and 1 µl of the dilution used as template 
in the secondary round. Secondary PCR reactions contained 2.5 µl 10 × PCR 
buffer (section 2.6.1), 0.5 units BioTaq (Bioline, UK), 10 µM of each primer ( 
Table 2-3) and 1 µl template. Cycling conditions were 3 mins at 94°C, followed 
by 35 cycles of 45 seconds at 94°C, 45 seconds at 56°C and 1 min at 72°C. The 
final extension was 7 mins at 72°C. Secondary PCR products (~2 µl) were 
visualised following electrophoresis on a 1.5% agarose gel stained with GelRedTM 
(Biotium, UK) on an AlphaImager 2000. 
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Table 2-3: Primer sequences and size of amplicon for nssm-PCR. 
The C. ryanae specific primer contains a degenerate base which is shown in bold and underlined. (CaF: C. 
andersoni specific forward primer, C.rF: C. ryanae specific forward primer, C.phF: C. parvum specific forward 
primer, CbF: C. bovis specific forward primer. 
Primer Sequence 5’-3’ Fragment Size  (bp) 
AL1598 (IF) 
AL3032 (IR) 
GGAAGGGTTGTATTTATTAGATAAAG 
 
AAGGAGTAAGGAACAACCTCCA 
840 
CaF GCAAATTACCCAATCCTGAC 625 
CrF TGTTAATTTTTATATACAATRCTACGG 415 
CphF AGAGTGCTTAAAGCAGGCATA 241 
CbF CTTCTTATTCCTTCTAGAATAAAAATG 305 
 
2.6.3 gp60 Subtyping 
A nested PCR designed to amplify a 450 bp fragment of the gp60 gene (Brook et 
al., 2009) was used on a selection of C. parvum positive samples to identify the 
subtype. Each 25 µl reaction contained 10 × PCR buffer (section 2.6.1), 0.5 units 
BioTaq (Bioline, UK), 10 µM of forward and reverse primers (Table 2-4) and 3 µl 
DNA in the primary round and 1 µl primary PCR product in the secondary round. 
Cycling conditions were 3 mins at 94°C, followed by 35 cycles of 45 seconds at 
94°C, 45 seconds at 55°C and 1 min at 72°C. The final extension was 7 mins at 
72°C. Secondary PCR products (~2 µl) were visualised following electrophoresis 
on a 1.5% agarose gel stained with GelRedTM (Biotium, UK) on an AlphaImager 
2000. 
Table 2-4: Primer sequences and amplicon sizes for gp60 PCR 
Primer Sequence 5’-3’ Fragment Size  (bp) 
GP60 1F (EF) 
GP60 1R (ER) 
ATAGTCTCCGCTGTATC 
 
GAGATATATCTTGGTGCG 
480 
GP60 2F (IF) 
GP60 2R (IR) 
TCCGCTGTATTCTCAGCC  
 
CGAACCACATTACAAATGAAG 
~375 
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2.7 Sequencing 
2.7.1 Purification of PCR products 
PCR products which were sent for sequencing were purified using the Promega 
Wizard SV gel and PCR Clean-Up System (Promega, UK) following the 
manufacturer’s instructions. Briefly, an equal volume of membrane-binding 
solution was added to the PCR in a 1.5 ml tube before being added to the 
minicolumn assembly. The solution was incubated at room temperature for 1 
min then centrifuged at 16,000 × g for 1 min. The supernatant was discarded and 
the minicolumn reinserted into the collection tube. Seven hundred microlitres of 
membrane wash solution was added and the assembly centrifuged at 16,000 × g 
for 1 min. The supernatant was discarded and the wash step repeated with 500 
µl membrane wash solution and centrifugation at 16,000 × g for 5 mins. The 
supernatant was discarded and the minicolumn centrifuged for a further min to 
remove all residual ethanol. The minicolumn was inserted into a clean 1.5 ml 
tube and the DNA eluted in 50 µl dH2O. 
2.7.2 DNA quantification 
DNA concentration of purified PCR products was quantified using a NanoDrop 
ND1000 spectrophotometer (Labtech International Ltd, UK). 
2.7.3 Sequencing 
Sequencing of PCR products was carried out by GATC (GATC, Germany) using 
their “Light-run” service. Five microlitres of purified PCR product was sent at a 
concentration of between 20-80 ng/µl with 5 µl of the appropriate primer at a 
concentration of 5 pmol/µl. In some circumstances, instead of the light-run 
service, unpurified PCR products were sent to GATC for sequencing using their 
“Supremerun96” sequencing option which includes PCR purification. With this 
service 20 µl PCR product was sent with a separate 1.5 ml tube containing 50 µl 
of the appropriate primer at a concentration of 10 pmol/µl. 
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2.7.4 Sequence analysis 
Sequences were analysed using BioEdit Sequence Alignment Software 
(www.mbio.ncsu.edu/bioedit/bioedit.html) and Chromas Lite 
(www.technelysium.com). 
2.8 Statistical Analysis 
Statistical analyses were performed using Minitab17 (Version 17.1.0.0, Minitab 
Inc.) P≤0.05 was considered significant. Survival curves were produced using R 
statistical package. 
For association between binary outcome variables (Chapter 3) , such as the 
presence/absence of diarrhoea, chi squared tests were used for univariate 
analysis and logistic regression for multivariate analysis. Continuous outcomes, 
such as number of days on which diarrhoea occurred, were tested for association 
with the explanatory variables using ANOVA. For the outcome variable of first 
day of diarrhoea, data was right censored (i.e. no values were recorded if the 
lamb did not develop diarrhoea) and Kaplan–Meier survival curves were analysed.  
 
 
 
 
 
48 
 
Chapter 3: Can infection with one isolate of 
Cryptosporidium parvum protect against 
infection with another? 
3.1 Introduction 
An experimental challenge in neonatal lambs was carried out to determine if 
lambs are able to develop immunity to infection with C. parvum following a 
primary infection. We also investigated the effect of an increase in age on 
susceptibility to disease when older naïve lambs were challenged with C. 
parvum. 
There are very few studies which have investigated the effect of sequential 
infection with distinct strains of C. parvum on neonatal livestock. Two studies, 
one in sheep (Ortega-Mora and Wright, 1994) and one in cattle (Harp et al., 
1990) have studied the effect of age on infection with Cryptosporidium species 
(believed at the time to be C. parvum). In the study in sheep, they noted an 
age-related susceptibility to infection with younger animals (<4 weeks of age) 
shedding larger numbers of oocysts for a more prolonged period compared with 
those infected a few weeks later. Both of these studies showed that animals 
exposed to the parasite at a younger age do not have such severe disease when 
exposed a second time showing that the animals were able to develop immunity 
to a homologous challenge. Most of the studies done in animals investigating 
immune responses to infection were carried out over 10 years ago before the 
discovery of some of the different species of Cryptosporidium which are now 
known to infect farm livestock. At this time there was not the knowledge of 
different isolates of C. parvum that we have now. It is not known if infection 
with one isolate of C. parvum will provide protection against infection with 
another isolate. It is possible that if one isolate does provide protection against 
another that there is potential for development of control measures using a less 
virulent (if one is identified) isolate to protect against infection from severe 
disease caused by a more virulent subtype. This strategy has been used 
previously to protect against other protozoan parasites, for example, the 
vaccine Toxovax® (MSD, Animal Health) uses a less virulent strain (S48) of the 
Toxoplasma gondii parasite to provide protection to pregnant ewes from more 
virulent strains of T. gondii. 
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Similar studies have been carried out in other host species with different 
Cryptosporidium species. Kvac et al (2014) investigated the age-related 
susceptibility of pigs to C. scrofarum; previous work had indicated that while C. 
suis (the other pig adapted Cryptosporidium species) infected all age groups of 
pigs it appeared that C. scrofarum only infected older animals. In their study the 
authors infected groups of pigs ranging from 4 – 8 weeks of age with C. 
scrofarum oocysts and tested all faecal samples produced from each animal. The 
presence of Cryptosporidium oocysts was confirmed using aniline-carbol-methyl-
violet (ACMV) staining and 18S nested PCR.  
The results of the study showed that C. scrofarum was not detected in the 
faeces of 4 week old pigs while in pigs aged 5-8 weeks, oocyst shedding was 
detectable by both microscopy and PCR from 6-8 DPI. The authors suggested that 
the animals  became more susceptible to invading sporozoites at weaning when 
the gut was adapting to different food. 
Another study investigating Cryptosporidium infection in chickens demonstrated 
an age-related susceptibility to infection (Hatkin et al., 1993). Chicks infected 
with C. baileyi at 1 day of age showed severe clinical disease (diarrhoea, 
respiratory distress and lesions detected by necropsy) and 28.7% (n=33) of the 
infected birds died. Naïve birds infected at 7 days of age had less severe clinical 
disease with a longer prepatent period and naïve birds infected at 14 days of age 
showed only asymptomatic oocyst shedding.  
Some studies investigating other protozoan parasites have carried out similar 
trials and one such trial showed that, similarly to the age-related susceptibility 
of pigs to C. scrofarum, rabbits older than 19 days were susceptible to Eimeria 
intestinalis whereas younger rabbits (up to 16 days of age) were resistant to 
infection (Pakandl and Hlaskova, 2007).  
In piglets, coccidiosis caused by Isospora suis is responsible for up to 20% of 
cases of piglet diarrhoea (Lindsay et al., 1985). One study carried out by Koudela  
(1999) examined the effects of age and sequential infection with I. suis in 
piglets. 
50 
 
Naïve piglets infected at 3 days of age showed clinical signs of disease 
(diarrhoea) at 2-4 DPI which lasted until 11 DPI following the primary challenge. 
Piglets which were re-challenged showed less severe clinical signs (less 
diarrhoea) at 5 d post-secondary challenge, and the piglets which were infected 
for the first time at 19 days of age showed similar clinical signs to piglets which 
were re-challenged. The authors suggested that this demonstrated that age has 
more of an effect on development of resistance to I. suis than acquired 
immunity by previous exposure.  
The trial described in this chapter aims to answer the question of whether lambs 
are able to develop immunity following  infection with Cryptosporidium parvum 
and if this will protect them against a homologous or heterologous infection with 
C. parvum. The effects of increasing age on development of resistance to 
disease will also be explored. The possibility of differences in isolate 
pathogenicity/virulence will also be examined. 
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3.2 Aims 
1) Determine whether lambs develop immunity following a primary infection 
with C. parvum to a homologous or heterologous challenge 
2) Determine the effects of an increase in age on the resistance or 
susceptibility to infection by C. parvum 
3) Determine if there are differences in the severity of disease caused by 
distinct C. parvum isolates 
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3.3 Materials and Methods 
3.3.1 Animals 
Forty Texel and Texel cross male lambs were obtained from Firth Mains farm, 
Roslin at <24 h of age and were housed in groups and kept Cryptosporidium-free 
until challenge. 
3.3.2 Experimental Design 
A total of 40 lambs were used in the experiment and were separated into eight 
groups. Four lambs were used for pre-amplification of two different C. parvum 
isolates to produce oocysts for inoculation, these lambs were separated into two 
groups each containing two lambs (Table 3-1). 
Table 3-1: Pre-amplification of C. parvum isolates. 
Group C. parvum Isolate Challenge Number of Animals 
Group A BB 1 × 105 n=2 
Group B LH 1 × 105 n=2 
 
The remaining 36 lambs were used for the experimental trial and were 
separated into six groups each containing six lambs. Group I and II were age-
related susceptibility challenge groups (not challenged until week 6), Group III 
and VI were homologous challenge groups and Group IV and V were heterologous 
challenge groups (Figure 3-1). 
53 
 
 
Figure 3-1: Experimental design. 
Lambs were infected with two different C. parvum isolates at either 6 weeks of age only or at <1 week of age 
and re-infected with a homologous or heterologous challenge at 6 weeks of age. 
 
3.3.3 Cryptosporidium parvum isolates 
C. parvum isolates were obtained from calves from three dairy farms (Farm OV, 
Farm BB & Farm LH) in Scotland with known histories of cryptosporidiosis and 
assessed for suitability for use in the trial. Isolates from two farms (Farm BB &  
Farm LH) were chosen for use in the experimental trial. 
The isolates used in the experimental trial were obtained from naturally 
infected calves on two dairy farms; one in Midlothian (also the study farm used 
in the studies described in Chapter 5 & 6 (Farm LH), Scotland and the other in 
the Scottish Borders (Farm BB), Scotland. In general the farm management 
practices on both farms was very similar. Farm LH milked approximately 240 
dairy cows (Holstein Friesian and Norwegian Red) and farm BB milked 
approximately 500 dairy cows (Holstein Friesian). Both used artificial 
insemination (AI) to impregnate their cows, any cows which did not hold to AI 
were serviced naturally by the stock bull, on farm LH only heifers not holding to 
AI were serviced naturally. On both farms the only animals bought in was a new 
stock bull every 3-4 years.  
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For prevention of enteritis, in-calf cows and heifers were vaccinated with 
RotavecTM Corona vaccine (MSD Animal Health, UK) in accordance with the 
manufacturers recommendations. 
In-calf cows and heifers were removed from the main herd before calving and 
are housed in cubicle sheds with automatic scrapers. Approximately 1 week prior 
to calving the cows and heifers were moved to a straw bedding court, the pens 
were regularly bedded (~3 × per week) with fresh straw and are mucked out and 
steam cleaned annually. On farm LH once the cows calved the calf was kept with 
its dam for a minimum of 24 h and was assumed to have received adequate 
colostrum if the calf is seen to suckle. On farm BB the stockworker was alerted 
to all newborn calves within 1 h of birth and they ensured that each calf 
received an adequate volume of colostrum in the 2 h following birth. Farm BB 
had a frozen supply of colostrum with 2 litres ready at anytime to give to a calf 
if the dam did not have a sufficient supply or if the calf was born to a heifer. 
Only cows colostrum is used to feed newborn calves on farm BB as it is higher in 
antibodies (Morrill et al., 2012) than colostrum from heifers and the stockworker 
believes that this is beneficial to the calves. 
Following birth, calves on farm LH were kept in small groups (3-5 calves) for 5 
days and were bottle fed calf milk replacer before being moved to a bigger pen 
of ~20 calves. The calves were housed in a large straw bedded pen in a well 
ventilated barn and had free access to hay, water and pelleted calf feed. The 
calves were fed milk replacer through an automated system which dispenses a 
set volume of milk for each individual calf. The volume of milk is set by the 
stockworker. The calves were weaned at 3 months and were then moved to a 
larger indoor straw bedded pen of ~40 calves until they reach 6 months of age. 
At this point, depending on the time of year they were either turned out to 
pasture or moved to a cubicle shed until turn out. The straw courts were 
regularly bedded (~3 × per week) with fresh straw and were mucked out, steam 
cleaned and disinfected between calf batches. Each year when the calves were 
turned out the calf pens were thoroughly cleaned, disinfected and painted. 
Calves on Farm BB suffering from mild or asymptomatic infection whilst still 
shedding large numbers of oocysts Calves on farm BB were kept in individual calf 
pens for 2 days following birth and, depending on the condition of the calf and 
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the weather conditions the calves may have had a calf jacket (Cosy Calf, UK) put 
on. The calf wore the jacket until the temperature was warm enough to remove 
the jacket. Whilst in individual pens the calves were bottle fed milk replacer. 
The individual pens were mucked out and disinfected between calves. 
After 2 days the calves were removed from the individual pen and were housed 
in a straw bedded pen in a large well ventilated barn with approximately 15 
other calves of a similar age group (<1 month). The calves were fed milk 
replacer through an automated system which dispenses a set volume of milk for 
each individual calf. The volume of milk was set by the stockworker. They also 
had free access to hay, water and pelleted calf feed. Once the calves were old 
enough they were moved into an adjacent pen with other older calves until 
weaning at 3 months. At weaning calves were either turned out or moved to a 
shed until turn out, depending on the time of year. The straw pens were 
regularly bedded (~3 × per week) with fresh straw and were mucked out, steam 
cleaned and disinfected between calf batches. Each year when the calves were 
turned out the calf pens were thoroughly cleaned and disinfected. 
Faecal samples were collected directly from the rectum  from calves (n=2-6) on 
each farm as described in section 2.1.1.  
3.3.4 Analysis of Calf Faecal Samples 
Following sample collection the oocysts present in each sample were counted as 
described in section 2.3.2.1 and DNA extracted from the faeces following the 
protocol in section 2.5.2.  
3.3.4.1 Microsatellite PCR primers and conditions 
A nested PCR protocol was used to amplify regions of five previously described 
microsatellite markers (Morrison et al., 2008). Each 20 µl reaction contained 10 
× PCR buffer (45 mM Tris-HCl pH 8.8, 11 mM (NH4)2SO4, 4.5 mM MgCl2, 4.4 µM 
EDTA, 113 µg ml-1 BSA, 1 mM each of the four deoxyribonucleotide 
triphosphates), 0.5 units BioTaq (Bioline, UK), 10 µM of forward and reverse 
primers (Table 3-2) and 1 µl DNA in the primary round and 1 µl primary PCR 
product diluted 1:100 in the secondary round. In the secondary round 10 µM 
primers labelled with FAM or HEX were used (Table 3-2). The total volume was 
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made up to 20 µl with dH2O. In each PCR run one set of positive control DNA and 
negative controls consisting of dH2O were included.  
Table 3-2: Primers used for microsatellite analysis of Cryptosporidium isolates 
Primer Sequence 5’-3’ 
MM5 (EF) 
MM5 (ER) 
TCACAAGTTACCCCTTCTGATGCTG 
 
TCCACCTCCGGATTGGTTGTG 
MM5 (IF) 
MM5 (IR) 
CCTGGACTTGGATTTGGACTTACACC 
 
GGAGAAGATAAGCTAGCCGAATCT 
MM18 (EF) 
MM18 (ER) 
GTTCAGCTGATACGGGTTTGCAACA 
 
CATCACCATCTCCTCCGCCAGA 
MM18 (IF) 
MM18 (IR) 
CTTTCTGGAGGGTTTGTTCCTCC 
 
CTTCCTGATGATCCAGGCCAAGC 
MM19 (EF) 
MM19 (ER) 
TGGTTTTAGCTAAGGAAGCGATAG 
 
CTGCTGCTGCTGTTGCTTTA 
MM19 (IF) 
MM19 (IR) 
GATTCTGTCAACTTTGAATTCAG 
 
CCAACCCCGAATTCATTTCCAAC 
TP14 (EF) 
TP14 (ER 
GAGAAGGAGCAATGGGAGCA 
 
TCCTCCTTTTTGCCCTTGAA 
TP14 (IF) 
TP14 (IR) 
CTAACGTTCACAGCCAACAGTACC 
 
CAATAAAGACCATTATTACCACC 
MS1 (EF) 
MS1 (ER) 
AAGGGTGAGGATGAGCAGAA 
 
TTCTTAACTTTCCATTTTGAGTGA 
MS1 (IF) 
MS1 (IR) 
TTAGTCGACCTCTTCAACAGTTGG 
 
GGAACACCATCCAAGAACCAAAGGT 
 
Secondary amplification products were visualised following electrophoresis on a 
2% agarose gel stained with GelRedTM (Biotium, UK) on an AlphaImager 2000). 
3.3.4.2 Microsatellite Analysis and Allele Identification 
Labelled PCR products were subjected to fragment analysis using capillary 
electrophoresis (CE) via ABI 3730 (Applied Biosystems; University of Dundee), 
using size standard Genescan ROX500 (Applied Biosystems). A subset of samples 
was also re-sized using ROX400HD (Applied Biosystems). Trace files were then 
analysed using both Peak Scanner (Applied Biosystems) and STRand 
(www.vgl.ucdavis.edu/informatics/strand).  
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3.3.4.3 gp60 subtyping 
Subtyping of C. parvum positive samples was carried out by amplification and 
sequencing of the gp60 gene (see sections 2.6.3 and 2.7). The PCR products 
were visualised on a 1.5% agarose stained with GelRed (Biotium, UK). Reactions 
were originally carried out in duplicate and if amplification was not successful 
the reactions were repeated. A sample was considered positive if a band 
corresponding with ~375 bp was seen. Positive, negative and extraction controls 
were included for each set of reactions. A positive result was only accepted 
when all negative controls were negative and all positive controls were positive. 
gp60 positive samples were sequenced in the forward and reverse orientation by 
GATC Biotech (GATC, Germany) as described for “supremerun96” sequencing in 
section 2.7.3. The sequences were analysed using Chromas Lite (version 2.01 
Technelysium) and the subtypes named as according to (Sulaiman et al., 2005) 
3.3.5 Purification from faeces and preparation of inoculum 
Oocysts were purified from faecal samples from calves from two farms (Farm BB 
& Farm LH) by selecting the samples with the highest oocyst counts in the 
smallest volume of faeces as determined by malachite green staining and 
microscopy as described in section 2.3.2.1. Using sucrose flotation (section 
2.3.2.2) oocysts were purified from the Cryptosporidium positive faeces, the 
viability of the oocysts was tested by carrying out an excystation assay (section 
2.3.3.1) which mimics the gut conditions and stimulates the oocysts (if viable) to 
excyst. 
To prepare the oocysts for inoculation they were surface sterilised using 2 ml 
70% EtOH for 30 mins before being resuspended in PBS. Oocysts were then 
counted (section 2.3.2.1) and the oocyst suspension diluted with PBS to give the 
desired infective dose. 
3.3.5.1 Pre-amplification in lambs 
To produce sufficient oocysts to inoculate all lambs in the experimental trial two 
of the C. parvum isolates (BB & LH) were amplified by orally infecting four 
neonatal lambs (in two groups) with 1 × 105 C. parvum oocysts in 1 ml PBS. Each 
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group of lambs were housed in separate plastic-sided lamb crates within 
individual concrete stables for ~13 days and were fed and monitored three times 
per day. Clinical assessments were made at each feeding/monitoring point using 
the criteria described in section 2.2.2. Total faecal output was collected from 
each lamb as described in section 2.2.4 using a harness and bag system. Faecal 
samples containing sufficient numbers of oocysts were processed as described in 
section 2.3.2 and processed to produce inoculum for the experimental trial. 
3.3.6 Experimental Animals 
Lambs used in the experimental trial were assigned to one of six groups. Each 
group of lambs was housed in concrete sided isolation boxes bedded with straw, 
the lambs were fed on UHT-treated milk three times per day via bottle and teat 
in a specially designed lamb feeder (Figure 3-2) to ensure that each lamb could 
access only its own milk. This enabled the handler to accurately record the feed 
intake of each individual animal; it also made the task of feeding 36 lambs 
slightly easier.  
 
Figure 3-2: Lambs in specially designed feeder. 
Lambs were fed UHT-treated milk three times per day in a specially designed feeder which allowed each lamb 
to be fed individually. 
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Lambs were fed exclusively on UHT-treated milk for the first two weeks of life 
with ad libitum access to hay and water, after this they were fed UHT-treated 
milk three times per day with ad libitum access to hay, water and pelleted lamb 
creep feed. Once the lambs reached six weeks of age they were fed UHT-treated 
milk twice per day and had ad libitum access to hay, water and pelleted lamb 
creep feed. 
3.3.7 Collection of samples 
3.3.7.1 Faecal Collection 
Total faecal output was collected from each lamb using a specially designed 
harness and bag system (see section 2.2.4.1) which the lamb wore continuously 
(Figure 3-3). This enabled the lambs to be penned in groups rather than 
separately but still allowed collection of faeces from each lamb individually. 
This system also ensured that after inoculation the lambs were not exposed to 
any faecal matter and were not re-infected by oocysts shed in the faeces. Bags 
were taken off and replaced with a new one clearly marked with 
group/animal/sample when required. Samples were stored in the bags at 4°C 
until they were processed (see section 2.4.2). 
3.3.7.2 Blood Sampling 
Blood samples were taken weekly from each lamb by jugular venipuncture using 
a vacutainer needle (BD Vacutainer, USA). Blood samples were left overnight at 
4°C to clot then centrifuged at 2000 × g for 10 minutes and the serum 
transferred to a 1.5 ml tube. Serum samples were stored at -20°C. Serum 
samples will be used to monitor the level of specific Cryptosporidium antibodies 
in an ELISA. Due to time constraints it was not possible to develop an ELISA 
during the course of this PhD. 
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Figure 3-3: Lambs with the harness and bag system to collect faeces 
Lambs wore a harness and bag at all times to ensure that total faecal output was collected and the animals 
were kept away from oocysts which were shed in the faeces 
 
3.3.8 Clinical Assessment 
Lambs were monitored a minimum of three times per day for the first six weeks 
and then a minimum of twice daily for the remainder of the study. Daily 
monitoring involved the recording of the volume of milk each lamb drank along 
with how well the animal drank, the demeanour of the animal and the 
appearance of the faeces produced, see section 2.2.2 for more details. 
3.3.9 Sample Processing 
Samples collected from the lambs were processed individually. The sample was 
weighed and the weight recorded, water was then added to the sample to make 
the faeces liquid enough to pipette. If the sample was already liquid then no 
additional water was added. The sample was then re-weighed and the new 
weight recorded. Using a food processor the sample was homogenised 
completely and a 2 ml sample aliquoted into a tube for storage for use in DNA 
extraction. These aliquots were stored at -20°C. A small subsample ~850 µl was 
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taken and used to quantify the oocysts present in the sample (see section 
2.3.2.1). The remainder of the faecal material was discarded (Figure 3-4). 
 
 
Figure 3-4: Sample processing 
Entire faecal samples from each lamb were processed in the lab (A), the entire motion was homogenised in a 
food blender (B) and a sub-sample taken for counting of oocysts (C) 
 
3.3.9.1 Oocysts counts 
Oocysts present in the faeces were counted by staining the faecal suspension 
with 0.16% malachite green and examination under × 40 magnifications on a 
haemocytometer as described in section 2.3.2.1. A selection of samples from 
each lamb were counted; every sample produced by the lamb during the clinical 
stage of infection and 1-2 samples per week in the non-clinical stages were 
processed and counted.  
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3.3.10 Statistical Analysis 
All statistical analyses were performed using Minitab17 (Version 17.1.0.0, 
Minitab Inc.). Outcome and explanatory variables are shown in (Table 3-3: 
Outcome and explanatory variables). Survival curves were produced using R 
statistical package. 
Table 3-3: Outcome and explanatory variables 
Codes used for definitions of value ranges and analytical approaches used for outcome and explanatory 
variables 
 
Code Description Value Analysis 
O
u
tc
o
m
e
 V
a
ri
a
b
le
s
 
D1 
Diarrhoea occurring 
during the time period 
wk1 to wk4 
Yes/No 
Chi-Squared test for 
univariate and logistic 
regression for 
multivariate 
D2 
Diarrhoea occurring 
during the time period 
wk6 to wk8 
Yes/No 
Chi-Squared test for 
univariate and logistic 
regression for 
multivariate 
FD1 
First day of diarrhoea 
during time period wk1 to 
wk4 
1-28 
Survival curve - 
Kaplan-Meier 
estimate 
FD2 
First day of diarrhoea 
during time period wk6 to 
wk8 
42-56 
Survival curve - 
Kaplan-Meier 
estimate 
DD1 
Number of days on which 
diarrhoea occurred in the 
time period wk1 to wk4 
0-28 One-way ANOVA 
DD2 
Number of days on which 
diarrhoea occurred in the 
time period wk6 to wk8 
0-28 One-way ANOVA 
OC1 
Total oocyst count for 
time period wk1 to wk4 
0-1.8E9 
Logn transformed 
then One-way 
ANOVA 
OC2 
Total oocyst count for 
time period wk6 to wk8 
0-1.8E9 
Logn transformed 
then One-way 
ANOVA 
 
 
Code Description Value 
E
x
p
la
n
a
to
ry
 
V
a
ri
a
b
le
s
 
Age Age of primary infection D7, D42 
Isolate Isolate used for challenge BB, LH 
Dose Challenge dose Low, High 
Challenge Previous exposure or not Primary, Secondary 
Type 
Secondary challenge with same 
isolate or not 
Homologous, Heterologous 
Group Group to which lamb was assigned I - VI 
 Animal Unique ID within Group A-F 
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3.3.10.1 Clinical Disease 
The association between clinical disease (D1, D2, FD1, FD2, DD1 & DD2) for the 
dependant variables was analysed using chi-squared test, binary logistic 
regression and One-way ANOVA. The data for FD1 and FD2 was right-censored 
and survival curves were produced using R statistical package. The interval to 
morbidity (diarrhoea) was tested for each isolate using the “survdiff” function of 
R, using the G-rho family of Harrington and Fleming (1982). Weights on each 
morbidity are S(t)^rho, where S is the Kaplan-Meier estimate of survival, with 
rho = 0, this is the log-rank or Mantel-Haenszel test, and with rho = 1, it is 
equivalent to the Peto & Peto modification of the Gehan-Wilcoxon test. 
3.3.10.2 Oocyst Shedding 
Logn transformation was applied to all oocyst count data which resulted in 
approximately normal distributions, according to Anderson-Darling tests for 
normality, taken together with visual inspection of histograms of transformed 
data. One-way ANOVA with Tukey’s post-hoc test was used to explored the 
association with explanatory variables. 
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3.4 Results 
3.4.1 Cryptosporidium parvum isolates 
3.4.1.1 Microsatellite analysis to identify suitable isolates 
Microsatellite analysis of 6 markers including gp60 was carried out to ensure that 
the selected isolates were genetically distinct. The results of the analysis 
revealed that all three of the selected isolates were genetically distinct at at 
least one locus (Table 3-4). BB and LH could be distinguished at 3 markers (MM5, 
MM19 and gp60), BB and OV at 2 markers (MM5 and MM19). LH and OV could only 
be distinguished at 1 marker (gp60). 
Table 3-4: Alleles assigned to each isolate  
Red text indicates markers at which the isolates differed. 
Marker Isolate BB Isolate LH Isolate OV 
MM5 Allele 2 Allele 1 Allele 1 
MM18 Allele 1 Allele 1 Allele 1 
MM19 Allele 3 Allele 4 Allele 4 
TP14 Allele 2 Allele 2 Allele 2 
MS1 Allele 1 Allele 1 N/A 
gp60 IIaA15G2R1 IIaA19G2R1 IIaA15G2R1 
 
3.4.1.2 Faecal Consistency and Oocyst Shedding in Sampled Calves 
These isolates presented different clinical signs in terms of oocysts shed and 
presence of diarrhoea in naturally infected calves (from personal observation 
and previous experience of Cryptosporidium infected calves on these two farms) 
(Table 3-5). 
Table 3-5: Faecal consistancy and average oocysts counts associated with different C. 
parvum isolates in naturally infected calves 
Isolate Faecal Consistency 
Average Oocyst 
Count (per ml) 
Number of Samples 
Collected 
BB No diarrhoea 1.53 × 107 n=2 
LH Watery diarrhoea 1.72 × 106 n=6 
OV Slight diarrhoea 3.24 × 107 n=4 
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3.4.1.3 C. parvum isolates used in experimental trial 
Isolates BB and LH were chosen as the ideal isolates to take forward to the trial 
as they differed in clinical manifestation as well as being genetically distinct at 
three loci. These isolates also came from calves on closed herd farms which 
decreased the likelihood that the infections were mixed. Isolate OV was 
excluded from the trial at this stage.  
3.4.2 Production of inoculum 
In total eight samples were obtained and were processed and the oocysts 
counted. The total numbers of oocysts obtained from each farm are shown in 
(Table 3-6). Samples containing high numbers of oocysts in a small volume of 
faeces were chosen for further processing to obtain oocysts for production of 
inoculum. 
Table 3-6: Oocyst counts from faeces obtained from calves farms BB & LH 
Sample Type† Volume (ml) No. Oocysts 
Total No. 
Oocysts 
BB1* 
BB2 
3 
3 
194 
90 
1.84 × 109 
1.91 ×109 
3.75 × 109 
LH1 
LH2* 
LH3* 
LH4 
LH5 
LH6* 
3 
5 
5 
4 
3 
5 
108 
73 
65 
189 
294 
152 
1.35 × 107 
6.02 × 108 
6.91 × 107 
0 
1.10 × 108 
7.60 ×107 
8.71 × 108 
*these samples were processed by sucrose flotation to produce the inoculum for pre-amplification 
† See Table 2-1 
 
The oocysts obtained from LH2, LH3, LH6 were pooled as a single sample did not 
contain sufficient oocysts. Before producing inoculum the viability of the oocysts 
were purified by sucrose flotation (section 2.3.2.2) prior to an excystation assay 
which mimics the gut conditions and stimulates the oocysts to excyst, releasing 
sporozoites (section 2.3.3.1). A sporozoite:shell ratio of >2 and an excystation 
percentage of >85% is desirable (Katzer F, Pers Comm.) (Table 3-7).  
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Table 3-7: Sporozoite:Shell ratios and excystation percentages for each isolate 
Isolate Sporozoite:Shell ratio Excystation %age 
BB 2.8 97% 
LH 2.1 88% 
 
3.4.3 Pre-amplification of Cryptosporidium parvum isolates 
Four neonatal lambs were successfully inoculated with two different C. parvum 
isolates (n=2 lambs per group/isolate) by oral infection using a syringe and         
1 × 105 oocysts in PBS. All lambs showed clinical signs of disease (diarrhoea, 
inappetence) approximately three DPI (days post-infection) and oocyst shedding 
occurred in all animals (Figure 3-5).  
 
Figure 3-5: Shedding profile of lambs inoculated with BB (1A & 2A) and LH (1B & 2B) 
isolates.  
Day of inoculation is indicated by the black arrow. 
 
3.4.3.1 Sample Processing 
Positive samples containing the highest number of oocysts in the smallest volume 
of faeces were processed by sucrose flotation to separate the oocysts from the 
faecal matter. The sucrose flotation step was repeated for samples from Group B 
as the faeces, in this case, was slightly thicker than ideal.  
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In total, 6.73 × 109 oocyst in 430 g faeces from Group A (BB) and 1.01 × 1010 
oocysts in 596 g faeces from Group B (LH) were processed. From Group A, 2.36 × 
109 oocysts were recovered (35% recovery) and from Group B, 5.5 × 108 oocysts 
were recovered (5% recovery). 
A minimum of 4.2 × 107 oocysts of each isolate were required to inoculate all 36 
lambs in the trial. 
3.4.3.2 Excystation Assay 
Cleaned oocysts were subjected to an excystation assay prior to each inoculation 
(<1 week & 6 weeks) (section 2.3.3.1) to determine the excystation percentage 
and sporozoite:shell ratio (Table 3-8). 
Table 3-8: Sporozoite:Shell ratios and excystation percentages for inoculum used in 
experimental trial  
Challenge Isolate Sporozoite:Shell ratio Excystation %age 
<1 week 
BB 2.21 95% 
LH 2.94 92% 
6 weeks 
BB 2.04 74% 
LH 1.31 82% 
 
The excystation percentages and sporozoite:shell ratios were slightly lower than 
ideal (>2 sporozoite:shell ratio/>85% excystation) for the challenge at 6 weeks of 
age. 
3.4.4 Experimental Animals – clinical observations 
All lambs drank well even following infection, some animals showed mild signs of 
abdominal pain (lying down after feeding) one or two days after infection but 
they did not stop feeding. Feed intake between groups was similar (Error! 
Reference source not found.). 
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Figure 3-6: Average feed intake of each group. 
Lambs did not go off their feed following infection with C. parvum. 
 
3.4.4.1 Age-related Susceptibility to Disease 
To determine whether animals become less susceptible to disease as their age 
increases two groups (Group I and Group II) were infected with C. parvum at 6 
weeks of age and the disease outcome and oocyst shedding was compared with 
lambs which were infected at <1 week of age (Group III, Group IV, Group V  and 
Group VI). Lambs infected at 6 weeks of age were given with a higher dose (5 × 
106) than animals infected at <1 week of age (1 × 106) (Figure 3-1).. 
 Isolate BB 
Animals which were infected with BB for the first time at 6 weeks of age (Group 
I)  showed milder clinical disease (number of diarrhoeic samples and duration of 
diarrhoea) compared with animals infected with this isolate for the first time at 
<1 week of age (Group III & Group IV). Overall, following primary infection at 6 
weeks of age only one sample collected from one animal in Group I (BB wk6) was 
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scored as diarrhoeic compared with 12 samples from four animals in Group III 
and 32 samples from six animals in Group IV (BB wk1). (Figure 3-7). 
 Isolate LH 
Animals which were infected with isolate LH for the first time at 6 weeks of age 
(Group II)showed milder clinical disease compared with animals infected for the 
first time at <1 week of age (Group V & Group VI).Overall, following primary 
infection at 6 weeks of age five samples collected from one animal in Group II 
were scored as diarrhoeic. In contrast, 23 samples collected from six animals in 
Group V and 55 samples from six animals in Group VI were scored as diarrhoeic. 
(Figure 3-7). 
 
Figure 3-7: Number of days lambs produced a diarrhoeic sample following primary-infection 
at <1 week (Group III, IV, V & VI) and 6 weeks (Group I & II) of age.  
Lambs infected at 6 weeks of age produced fewer diarrhoeic samples than lambs infected at 6 weeks of age. 
Red bars show primary infection with BB isolate and blue bars show primary infection with LH isolate. (* 
indicates outliers, the horizontal line the median and the vertical line indicates that the median is zero). 
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Animals challenged at 6 weeks (Group I & II) had a shorter duration of diarrhoea 
than animals challenged at <1 week of age (Group III, IV, V & VI) and produced 
fewer diarrhoeic samples (P<0.001).  
3.4.4.2 Difference between isolates 
To compare the pathogenicity of the two isolates one age-related susceptibility, 
one homologous and one heterologous challenge per isolate was carried out. 
Results show that the isolate used in the primary infection at <1 week of age 
does not significantly affect the probability of diarrhoea during the first three 
weeks post-infection . There was no significant effect of isolate on diarrhoea 
following challenge at 6 weeks of age.  
Isolate had a significant effect on the interval to onset of diarrhoea (P < 0.05, 
Table 3-9a and Figure 3-8) such that isolate LH resulted in earlier onset 
diarrhoea following primary infection. There was no effect of isolate on days to 
diarrhoea after the second challenge (P= 0.434, Table 3-9b and Figure 3-8). 
BB Isolate 
 
LH Isolate 
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Figure 3-8: Time to onset of diarrhoea following primary challenge at <1 week (A) and 6 
weeks (B) of age. 
Lambs challenged with isolate LH at <1 week of age began scouring sooner than animals infected with isolate 
BB. There was no difference in time to onset of diarrhoea following challenge at 6 weeks of age. 
 
Table 3-9a: Log-rank test on Kaplan-Meier survival curves for onset of diarrhoea after 
challenge at <1 week of age. 
Isolate 1 N Observed(O) Expected(E) (O-E)^2/E (O-E)^2/V 
BB 18 13 18.5 1.61 4.91 
LH 18 17 11.5 2.58 4.91 
Chisq= 4.9  on 1 degrees of freedom, p= 0.0266  
 
Table 3-9b: Log-rank test on Kaplan-Meier survival curves for onset of diarrhoea after 
challenge at 6 weeks of age. 
Isolate 1 N Observed(O) Expected(E) (O-E)^2/E (O-E)^2/V 
BB 18 4 3.04 0.301 0.612 
LH 18 2 2.96 0.310 0.612 
Chisq= 0.6 on 1 degrees of freedom, p= 0.434  
A 
B 
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Figure 3-9: Number of days lambs infected with BB (red) or LH (blue) isolate produced a 
diarrhoeic sample in the 3 weeks post-primary infection at <1 week of age. 
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3.4.4.3 Previous exposure (homologous and heterologous challenge) 
To determine if previous exposure to C. parvum provides protection against a 
secondary challenge later in life two sequential challenges were carried out to 
test each isolate in a homologous and heterologous challenge.  
All animals which received a primary infection or secondary challenge at 6 week 
of age showed a reduction in clinical disease compared with animals which 
received a primary infection at <1 week of age. Previous exposure did not 
provide significant protection (P>0.99) against re-infection and the occurrence 
of clinical disease. The effect which age had on the occurrence of diarrhoea 
masked any effect that previous exposure may have had. There was no 
significant difference in the occurrence (P>0.99) or days of diarrhoea (p=0.378) 
between groups with previous exposure (Group III, IV, V & V) and groups which 
had no previous exposure (Group I & II) (Figure 3-10 and Table 3-10). 
 
Figure 3-10: Occurrences of diarrhoea following challenge at 6 weeks 
There was no difference in the occurrence or days of diarrhoea following challenge at 6 weeks in lambs 
receiving (purple boxes) or not receiving (orange boxes) a primary infection. (* indicates outliers, the horizontal 
line the median and the vertical line indicates that the median is zero). 
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There was no difference (P=0.571) in clinical disease caused by a homologous or 
heterologous challenge (Table 3-10), again, any effect of the type of challenge 
(homologous or heterologous) may be masked by the effect of age. 
Table 3-10: Multivariate logistic regression model for analysis of factors associated with 
occurrence of diarrhoea in wk1 – wk4 and wk6 – wk8. 
Outcome 
Variable 
Explanatory 
Variable 
1 0 
 Odds 
Ratio 
95% CI P-value 
D1 
 
Isolate       0.086 
 BB 13 5  1   
 LH 17 1  * 0.00 - *  
        
Group       0.0837 
 I 3 3  1   
 II 5 1  5.00 0.55 – 45.39  
 III 4 2  2.00 0.31 – 13.06  
 IV 6 0  0 0.00 - *  
 V 6 0  0 0.00 - *  
 VI 6 0  0 0.00 - *  
  
D2 
Isolate       1 
 BB 4 14  1   
 LH 2 16  1 0.17 – 5.77  
        
Group       0.0977 
 I 1 5  1   
 II 1 5  1 0.05 – 20.83  
 III 1 5  1 0.05 – 20.83  
 IV 1 5  1 0.05 – 20.83  
 V 2 4  2.5 0.16 – 38.60  
 VI 0 6  0 0.00 - *  
        
Type       0.571 
 * 2 10  1   
 Homologous 1 11  1.67 0.22 – 12.37  
 Heterologous 3 9  0.45 0.04 – 5.81  
        
Challenge       1 
 Primary 1 10  1   
 Secondary 4 20  1 0.16 – 6.42  
 
 
3.4.5 Experimental Animals – oocyst shedding 
Due to time constraints it was not possible to carry out oocyst counts for all 
groups, instead oocyst counts were carried out for four of the six groups. Oocyst 
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counts were carried out on samples from animals in Group I & II (age-related 
susceptibility to disease), Group III (homologous challenge with BB) and Group V 
(heterologous challenge). 
3.4.5.1 Group I  
Oocysts counts were carried out on 167 (52.35%) samples from six lambs in 
Group I. One sample from each lamb was counted each week for the first 6 
weeks to ensure that the animal remained Cryptosporidium-free for this period. 
Following primary challenge every sample produced by each lamb was processed 
and counted. The number of samples processed from each lamb is summarised in 
Table 3-11. 
Table 3-11: Samples collected and processed from each lamb in Group I 
Lamb Samples Collected 
Samples 
Processed and 
Counted 
Percentage (%) of 
Samples 
Processed 
A 59 30 50.84 
B 60 22 36.60 
C 46 26 52.38 
D 54 29 53.70 
E 57 32 56.14 
F 43 28 65.11 
 
None of the lambs showed any signs of Cryptosporidium infection in the first 6 
weeks of life and all samples tested were negative for oocysts. Following 
primary challenge at 6 weeks lambs started to shed oocysts at 1-2 DPI, shedding 
continued for 12-16 days before tailing off. Peaks in oocyst shedding occurred at 
2, 4, 8, 11 & 15 DPI in individual animals (Figure 3-11). Oocyst shedding between 
lambs differed significantly (P=0.037) with one lamb (C) shedding higher 
numbers of oocysts than other animals (Figure 3-12).  
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Figure 3-11: Oocyst counts from lambs in Group I 
Shedding profiles from lambs in Group I following primary challenge at 6 weeks of age with 5 × 10
6
 C. parvum oocysts isolate BB. Lambs began shedding oocysts very soon after 
inoculation with peaks in oocyst shedding at 2, 4, 8, 11 & 15 DPI in individual animals. Shedding began to tail off at 14 DPI. It was not possible to collect a sample from each animal on 
each day, days on which samples were collected are indicated by a data point. 
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Figure 3-12: Total number of oocysts shed by individual lambs in Group I (BB wk6) 
Oocyst shedding between individual animals within the same group varied with some animals shedding 
significantly more oocysts than others. (* indicates outliers). 
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3.4.6 Group II   
Oocysts counts were carried out on 150 (48.85%) samples from six lambs in 
Group II. At least one sample from each lamb was counted each week for the 
first 6 weeks to ensure that the animal remained Cryptosporidium-free for this 
period. Following primary challenge every sample produced by each lamb was 
processed and counted. The number of samples processed from each lamb is 
summarised in (Table 3-12). 
Table 3-12: Samples collected and processed from each lamb in Group II 
Lamb Samples Collected 
Samples 
Processed and 
Counted 
Percentage (%) of 
Samples 
Processed 
A 50 30 60.00 
B 63 28 44.44 
C 59 26 44.06 
D 39 21 53.84 
E 45 19 42.22 
F 51 26 50.98 
 
None of the lambs showed any signs of Cryptosporidium infection in the first 6 
weeks of life and all samples tested (n=52) were negative for oocysts. Following 
primary challenge at 6 weeks lambs started to shed oocysts at 1-2 DPI, shedding 
continued for 11 days before tailing off. Peaks in oocyst shedding occurred at 3, 
5, 8 & 10 DPI in individual animals (Figure 3-13). Oocyst shedding between lambs 
differed but the difference in shedding was not significant (Figure 3-14). 
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Figure 3-13: Oocyst counts from lambs in Group II 
Shedding profiles from lambs in Group II following primary challenge at 6 weeks of age with 5 × 10
6
 C. parvum oocysts isolate LH. Lambs began shedding oocysts very soon after 
inoculation with a peak in shedding at approximately 3 DPI. Shedding began to tail off at 11 DPI. It was not possible to collect a sample from each animal on each day, days on which 
samples were collected are indicated by a data point. 
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Figure 3-14: Total number of oocysts shed by individual lambs in Group II. 
Oocyst shedding between lambs in the same group varied but not significantly. (* indicates outliers). 
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3.4.7 Group III  
Oocysts counts were carried out on 335 (73.62%) samples from six lambs in 
Group III. Following primary infection (BB) every sample produced by each lamb 
was processed and counted for 3-4 weeks then 1-2 samples per week for two 
weeks and then every sample following secondary challenge (BB) for a further 19 
days. The number of samples processed from each lamb is summarised in Table 
3-13. 
Table 3-13: Samples collected and processed from each lamb in Group III 
Lamb Samples Collected 
Samples 
Processed and 
Counted 
Percentage (%) of 
Samples 
Processed 
A 65 51 78.46 
B 73 58 79.45 
C 83 67 80.72 
D 82 69 84.14 
E 74 60 81.08 
F 68 50 73.53 
 
None of the lambs showed any signs of Cryptosporidium infection in the days 
prior to primary challenge and all samples tested (n=26) were negative for 
Cryptosporidium oocysts. Following primary infection lambs began to shed 
oocysts at 14 DPI, shedding continued until 26-28 DPI when oocysts shedding 
tailed off for the majority of animals. Peaks in oocysts shedding occurred at 15, 
18, 21 and 23 DPI in five of the six animals. Within this group animal F 
consistently shed higher numbers of oocysts than the others with peaks in 
shedding occurring at Days 24 and 31 PI. By 27 DPI oocyst shedding had 
decreased to <2.5 × 107 in most of the animals (Figure 3-15 & Figure 3-16). 
Animals in this group were re-challenged with the same isolate (BB) at 39 days of 
age, the dose of the secondary challenge was higher than the primary infection 
(primary infection 1 × 106  and secondary challenge 5 × 106). 
Following secondary challenge animals began shedding oocysts at 2-4 DPI and 
continued to shed oocysts for 10–17 days. Peaks in shedding occurred at 5,7 and 
11 DPI in the majority of animals, again animal F shed higher numbers of oocysts 
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than the others and in this animal peaks in oocyst shedding occurred at 4, 6, 9, 
12, 14 and 17 DPI. 
All animals shed more oocysts following secondary challenge than following 
primary infection with the same isolate. In total the lambs in this group shed    
1.80 × 1010 oocysts, 4.97 × 109 following the primary infection and 1.31 × 1010 
following the secondary challenge. 
There was a significant difference (P<0.001) between the number of oocysts 
each lamb shed with some lambs, particularly animal F shedding higher numbers 
of oocysts than the others. This animal shed ~5.00 × 109 oocysts more than the 
other animals in this group following secondary challenge (Figure 3-17). 
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Figure 3-15: Oocyst counts from animals in Group III 
Shedding profiles from lambs in Group III following primary infection at  <1 week of age with 1 × 10
6
 C. parvum oocysts isolate BB and challenge at 6 weeks of age with 5 × 10
6
 C. 
parvum oocysts isolate BB. Shedding began to tail off at 14 DPI. It was not possible to collect a sample from each animal on each day, days on which samples were collected are 
indicated by a data point. 
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Figure 3-16: Oocyst counts from animals in Group III excluding animal F 
Shedding profiles from lambs in Group III following primary challenge at  <1 week of age with 1 × 10
6
 C. parvum oocysts isolate BB and re-challenge at 6 weeks of age with 5 × 10
6
 C. 
parvum oocysts isolate BB. It was not possible to collect a sample from each animal on each day, days on which samples were collected are indicated by a data point. Animal F has been 
excluded from this graph in order to see the shedding profile of the other 5 lambs more clearly. Animal F shed more oocysts than the other lambs in the study. 
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Figure 3-17: Total number of oocysts shed by individual lambs in Group III 
Oocyst shedding between individual animals within the same group varied with some animals shedding 
significantly more oocysts than others. (* indicates outliers). 
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3.4.8 Group V  
Oocysts counts were carried out on 275 (75.55%) samples from 6 lambs in Group 
V. Following primary infection (LH) every sample produced by each lamb was 
processed and counted for 3-4 weeks then 1-2 sample per week for two weeks 
and then every sample following secondary challenge (BB) for a further 15 days. 
The number of samples processed from each lamb is summarised in Table 3-14. 
Table 3-14: Samples collected and processed from each lamb in Group V 
Lamb Samples Collected 
Samples 
Processed and 
Counted 
Percentage (%) of 
Samples 
Processed 
A 64 43 67.19 
B 67 53 79.10 
C 67 48 71.64 
D 69 51 73.91 
E 51 38 74.51 
F 46 42 91.30 
 
None of the lambs showed any signs of Cryptosporidium infection in the days 
prior to primary challenge and all samples tested (n=26) were negative for 
Cryptosporidium oocysts. Following primary infection lambs began to shed 
oocysts at 11-18 DPI, shedding within animals in this group did not tail off as in 
other groups. In the majority of animals oocyst shedding continued at <1.00 × 
108 until they were re-challenged at 38 days of age. Peaks in oocysts shedding 
occurred at 16, 21 and 30 DPI in most of the lambs although oocysts shedding 
within animals in Group V was more sporadic than in other groups.  
Animals in this group were challenged with a different C. parvum isolate (BB) at 
38 days of age, the dose of the secondary challenge was higher than the primary 
infection (primary infection 1 × 106  and secondary challenge 5 × 106). 
Following secondary challenge animals continued shedding oocysts and all 
animals showed an increase in the number of oocysts shed compared with the 
previous challenge. Following secondary challenge oocyst shedding continued for 
10–15 days. Peaks in shedding occurred at 2,5 and 11 DPI in the majority of 
animals (Figure 3-18 & Figure 3-19) with animals E & F shedding significantly 
(P<0.001) higher numbers of oocysts than the others (Figure 3-20).  
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Figure 3-18: Oocyst counts from Group V 
Shedding profiles from lambs in Group V following primary challenge at  <1 week of age with 1 × 10
6
 C. parvum oocysts isolate LH and re-challenge at 6 weeks of age with 5 × 10
6
 C. 
parvum oocysts isolate BB. It was not possible to collect a sample from each animal on each day, days on which samples were collected are indicated by a data point. 
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Figure 3-19: Oocyst counts from Group V excluding animals E & F 
Shedding profiles from lambs in Group V following primary challenge at  <1 week of age with 1 × 10
6
 C. parvum oocysts isolate LH and re-challenge at 6 weeks of age with 5 × 10
6
 C. 
parvum oocysts isolate BB. It was not possible to collect a sample from each animal on each day, days on which samples were collected are indicated by a data point. Animals E & F 
have been excluded from this graph in order to see the shedding profile of the other 4 lambs more clearly. Animals E & F shed more oocysts than the other lambs in the study. 
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Figure 3-20: Total number of oocysts shed by individual lambs in Group V 
Oocyst shedding between animals in group V varied significantly with lambs E and F shedding more oocysts 
than the other lambs. (* indicates outliers). 
 
3.5 Effect of age and infective dose on shedding 
When comparing the patterns of oocyst shedding between the groups, animals 
which were infected at <1 week of age with a low dose (1 × 106) began shedding 
oocysts after approximately 14 DPI whereas animals which were infected for the 
first time at 6 weeks of age with a higher dose (5 × 106) began shedding after a 
much shorter period of 1-2 DPI. Animals re-challenged with a higher dose (5 × 
106) at 6 weeks of age (Group III & V) also began shedding oocysts sooner at 1-2 
DPI. There was no significant difference (P=0.457) in number of oocysts shed 
between animals infected at <1 week of age and animals infected at 6 weeks of 
age. 
3.5.1 Variation between isolates  
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5F5E5D5C5B5A
1600000000
1400000000
1200000000
1000000000
800000000
600000000
400000000
200000000
0
Animal
N
u
m
b
e
r 
o
f 
O
o
c
y
s
ts
90 
 
 
and secondary challenge (Group III & Group V) at 6 weeks of age infection with 
BB isolate was significantly associated with higher oocyst output (P<0.001). 
3.5.2 Previous Exposure 
Animals which had been previously exposed to C. parvum (Group III) & Group V) 
shed more oocysts following secondary challenge at 6 weeks of age than naïve 
animals (Group I & Group II) which received a primary infection at the same age 
(P=0.02)
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Figure 3-21 Average oocysts counts (Group I, II, III & V) following primary infection. 
Lambs receiving a high (5 × 10
6
) dose at primary infection shed more oocysts and had a shorter prepatent period than lambs receiving a low (1 × 10
6
) dose.
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3.6 Discussion 
Infection with Cryptosporidium is very common in young ruminant livestock (de 
Graaf et al., 1999). As reported, in this thesis (Chapter 5 & Chapter 6) and other 
work, animals may become infected with Cryptosporidium at a very early age 
(Ortega-Mora et al., 1999; Tzipori et al., 1983) indicating that they have been 
exposed to the parasite almost immediately at birth. As a result it is difficult to 
examine the development of resistance to disease in a field setting. In this 
experiment the susceptibility of lambs to disease caused by two distinct C. 
parvum isolates was tested by a primary infection at <1 week and a homologous 
or heterologous challenge at 6 weeks of age as well as testing the susceptibility 
of lambs kept in isolation from the parasite and then experimentally challenged 
at 6 weeks of age.  
Although the isolates used in this trial were originally derived from naturally 
infected calves it was decided to carry out the trial using lambs. From previous 
and ongoing work at the Moredun Research Institute it is known that lambs are 
susceptible to infection with C. parvum and exhibit similar clinical signs and 
patterns of oocyst shedding. Lambs are smaller and easier to handle than calves 
especially once they grow to 8 weeks of age. In addition, total faecal output 
from each individual animal was collected for the duration of the trial. Total 
faecal output from a calf infected with C. parvum could be as much as 3 kg per 
day compared to 600 g from a lamb (Bartley, Pers. Comm.). The results of this 
study suggest that lambs can be used as a model for disease outcome and 
shedding in calves as the clinical disease and shedding patterns of 
experimentally infected lambs, in general, were consistent with that of the 
naturally infected calves from whom the oocysts were originally derived. 
3.6.1 Age-related clinical disease and oocyst shedding 
The results of this study confirmed previous reports which demonstrated that 
livestock (calves and lambs) which were naïve to Cryptosporidium were still 
susceptible to the parasite at an older age (Harp et al., 1990; Ortega-Mora and 
Wright, 1994). In the present study the animals challenged at 6 weeks of age 
suffered from significantly less severe clinical disease than animals challenged at 
<1 week of age although they all still showed evidence of oocyst shedding. The 
93 
 
 
same is true of the lambs challenged in a previous study (Ortega-Mora and 
Wright, 1994). The lambs in that study were infected at 6 days and then re-
challenged (with the same isolate and dose (1 × 106)) at 4 weeks of age. In 
parallel, a further two groups of lambs were infected once at 4 and 8 weeks of 
age respectively. Lambs which were naïve to C. parvum at 4 weeks still showed 
clinical disease (diarrhoea) and shed oocysts whereas lambs with prior exposure 
(infected at 1 week of age) had no clinical disease or (detectable) oocyst 
shedding when re-challenged at 4 weeks of age. This demonstrates that lambs 
can develop specific immunity to infection with this particular C. parvum isolate 
if they have previous exposure to the same parasite. When naïve lambs were 
challenged at 8 weeks of age none of the lambs showed evidence of clinical 
disease though some lambs did shed oocysts although this was over a shorter 
duration and lower numbers of oocysts were shed. This indicates that sometime 
between 4 (naïve lambs still susceptible to disease) and 8 weeks (naïve lambs 
not susceptible to disease) of age lambs develop an age-related resistance to 
Cryptosporidium infection.  
In the present study we demonstrate that lambs become less susceptible to 
disease at around 6 weeks of age with a reduction in the percentage of animals 
showing clinical signs of disease to 17–33% from 50-100% depending on isolate 
despite an increase in challenge dose. This shows that as the animals increase in 
age they are becoming less susceptible to cryptosporidiosis with a reduction in 
disease severity at 6 weeks but no change in oocyst shedding. In a similar study 
in calves, Harp et al (1990) reported that when naïve calves were challenged 
with C. parvum at 1 or 3 months of age they remained fully susceptible to 
disease and all challenged animals showed clinical signs (diarrhoea) as well as 
oocyst shedding. Two of the animals which were initially challenged at 3 months 
were re-challenged at 6 months of age and neither showed any evidence of 
clinical disease or oocyst shedding. There were no calves which were naïve to 
Cryptosporidium challenged at this age so it is not known if the calves developed 
resistance to disease because of previous exposure or because of an age-related 
immune response. Based on this study it seems that, in calves, a previous 
challenge can protect against re-infection indicating that exposure of calves to 
C. parvum results in specific acquired immunity but the age at which they 
develop age-related immunity to disease is not known. However, as will be 
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reported later in this thesis, it is possible for calves with previous exposure to 
one isolate of C. parvum to become infected with, and shed oocysts of, another 
C. parvum isolate later in life (Chapter 5). 
It is possible that this age-related resistance to symptomatic disease in lambs (6-
8 weeks of age) and calves (>6 months) is related to changes within the animal 
gut. These changes usually occur at weaning or when the diet of the animal is 
changed. In the present study lambs were fed on UHT-treated milk 3 × per day 
for the first 2 weeks with ad libitum access to hay, pelleted lamb feed was made 
available from day 14 onwards. In the study by Ortega-Mora et al., (1994) lambs 
were fed on UHT-treated milk only for the first 20 days after which hay and lamb 
rations were made available. By day 45 of age the lambs had been weaned from 
milk completely. In the calf study (Harp et al., 1990) calves were fed a diet of 
milk replacer for 2.5 months with the addition of pelleted feed at 2 weeks of 
age and hay at 4 weeks of age. In addition, rumen fluid from five calves at 3.5 
months of age was tested and showed some degree of function but not at the 
level of a fully mature adult bovine. The maturity of the rumen in cattle and 
sheep is affected by the age of weaning and diet (Quigley, III et al., 1985) . This 
ties in with the development of age-related resistance to disease in both 
previous studies (resistant to disease at 6 months (calves) and 8 weeks (lambs)) 
and the current study (not resistant at 6 weeks but mild clinical disease only). It 
is not known if an animal with mature gut function which has no prior exposure 
to Cryptosporidium would be susceptible to disease. From other studies, carried 
out as part of this PhD we know that calves can still remain susceptible to 
infection and can shed oocysts at 6 months of age (Chapter 5 and Chapter 6). 
In mice age-related resistance to disease caused by Cryptosporidium has been 
well documented (Sherwood et al., 1982; Tarazona et al., 1997; Upton and 
Gillock, 1996) and it has been demonstrated that even when the mice have had 
no previous exposure to the parasite they were not susceptible to disease after 3 
weeks of age. This age-related resistance in mice coincides with the maturation 
of the intestinal gut flora (about 3 weeks in mice) (Harp et al., 1992). It has also 
been noted that pigs become more susceptible to infection with C. scrofarum at 
around 5-8 weeks of age (Kvac et al., 2014), the authors suggested that this may 
95 
 
 
be due to changes in the gut at weaning (~6 weeks of age) which may make the 
gut easier for the parasite to invade.  
3.6.2 Challenge dose, Clinical Disease and  oocyst shedding  
It appeared that when lambs received a higher infective dose (5 × 106) they 
began shedding oocysts sooner than when they received a lower infective dose 
(1 × 106). However, due to the age difference between the two dose groups it is 
not possible to attribute the shortened onset to oocyst shedding following 
infection at 6 weeks of age solely to the higher infective dose as age of the 
animal may also contribute to this effect. To clarify this a further study which 
focuses only on effect of age OR effect of infective dose on animals of the same 
age should be carried out. Lambs which received a secondary challenge at 6 
weeks of age shed significantly more oocysts than lambs receiving a primary 
infection at this age. It is possible that this is because the lambs receiving a 
secondary challenge are still shedding oocysts from the primary infection they 
received at <1 week of age. It is also a possibility that the early onset of oocyst 
shedding which was seen in lambs receiving a higher dose may simply be due to 
some ingested oocysts passing through the animal.  
Within each group in this study there were significant differences in individual 
lamb’s responses to infection in terms of oocysts shed and clinical disease with 
the variation between some animals being considerable. Thirty-one percent of 
samples collected from lamb F (Group V) over the whole study were diarrhoeic 
compared with just 5.2% of samples from lamb C (Group V) and in Group III lamb 
F shed 1.01 × 1010 oocysts in total compared with lamb A (Group III) which shed 
5.75 × 108 oocyts in total, a difference of 9.50 × 109.  
Differences, sometimes considerable, in oocyst shedding (number of oocysts 
shed, duration of shedding) as well as clinical manifestation between individuals 
within groups have been noted in other Cryptosporidium infection trials in 
humans (Baxby et al., 1985; Chappell et al., 1996; Teunis et al., 2002), calves 
(Moore et al., 2003) and mice (Petry et al., 1995). This may be due to the 
different immunocompetence status of individual animals; all lambs in this study 
received some colostrum, either from their dams or artificial colostrum. The 
quality of each individual ewes colostrum was not known, nor was the quantity 
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that the individual lamb took. It is known that in other livestock and in humans 
the severity of disease depends very much on the immune status of the 
individual. Immunocompromised patients (human and animal) will suffer from 
more severe and prolonged disease than immunocompetent individuals (Baxby et 
al., 1985; Current et al., 1983; DuPont et al., 1995; Harp et al., 1992; Harp et 
al., 1988; Hojlyng and Jensen, 1988; Shepherd et al., 1988; Snyder et al., 1978). 
We already know that the prepatent period is dependent on host species, 
Cryptosporidium species and infective dose (Tzipori et al., 1983). In this study 
we noted that following primary challenge at <1 week of age the animals in both 
Groups III & V did not begin shedding oocysts until 3-14 DPI (Group III (mean = 
7.2, mode = 4, median = 5.5) Group V (mean = 9.8, mode = 14, median = 10)) 
whereas, when these animals were re-challenged at 6 weeks of age, with a 
higher dose, they began shedding oocysts much sooner, almost immediately 
following the oral challenge. It is not possible to determine exact number of DPI 
following secondary challenge as most animals did not completely cease 
shedding oocysts before being re-challenged. Although, it appears that 1-3 DPI 
the animals began shedding much higher numbers of oocysts than previously. 
The difference in the prepatent period following higher or lower doses has also 
been noted in other studies. Zambriski et al., (2013) carried out an experimental 
challenge in calves using doses of 25, 50, 100, 500, 1 × 103, 1 × 104, 1 × 105, and 
1 × 106 C. parvum oocysts. They reported that calves receiving lower doses (25 
and 50 oocysts) shed later than calves receiving higher doses (100 - 1 × 105 and 
1 × 106) oocysts. Other studies report a mean prepatent period of 7.4 DPI in 
experimentally infected calves (challenged with 50, 100, 1000 and 10,000 C. 
parvum oocysts) with a longer prepatent period for animals receiving a lower 
dose and an increase in number of days of oocyst shedding in calves receiving a 
higher challenge dose and 16.3 DPI in naturally infected calves (Moore et al., 
2003; O'Handley et al., 1999).  
Not every sample produced from each animal was positive for oocysts indicating 
that oocyst production and excretion is not a constant process, similar results 
have been noted in experimental infections of human volunteers (Chappell et 
al., 1996). The observation in variation of oocysts shedding day to day could be 
as a result of the limitations of the detection method (62500 oocysts per gram of 
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faeces) used in this study. This suggests that for diagnostic purposes a single 
sample from a potentially infected individual, even if with clinical disease, may 
not be sufficient to detect oocysts and diagnose infection. To minimise the 
chances of missing potential positive samples total faecal output was collected 
and processed from all lambs in this study (during the clinical stage). In addition, 
the whole faecal sample was homogenised completely before a sub-sample was 
taken for analysis.  
As we can see from the results of this study the amplification rate of the 
parasite in a young naïve animal is phenomenal; an animal infected with 1 × 106 
oocysts is able to shed up to 2.73 × 109 potentially infectious oocysts in a two 
week period. In theory, this is enough to infect a further 2730 susceptible hosts 
with the same number of oocysts as the initial challenge. It is the amplification 
rate which leads to the rapid spread of disease within a herd or flock. From this 
we can see why, in a field setting, it is possible that older lambs, or even adults, 
may become subclinically infected with Cryptosporidium and maintain the 
parasite between lambing or calving periods.  
3.6.3  Cryptosporidium parvum isolates 
Despite the similarities in management on these farms the differences in disease 
between calves on the two farms is marked with calves on farm LH becoming 
very sick and calves on farm BB showing very little illness. If we take only the 
clinical manifestation of disease on the farms into consideration we may be able 
to conclude that the better early calf management (good quality colostrum 
within 2 h of birth, calf jackets) on farm BB means that the calves on this farm 
are better protected against disease in general and are better able to fight off 
infection. The results of the study described in this chapter indicate that these 
differences which were noted in naturally infected calves are mimicked the 
experimental infection trial in lambs. We found that isolate LH which caused 
more severe disease in naturally infected calves also was associated with an 
increased probability of diarrhoea and number of days of diarrhoea as well as a 
quicker onset to diarrhoea in the experimentally infected lambs and that isolate 
BB which seemed to cause an increase in oocyst output in naturally infected 
calves was shown to significantly affect the oocyst shedding of experimentally 
infected lambs. 
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Other studies have also reported variations in the severity of infection in humans 
and animals depending on the specific Cryptosporidium species and isolate 
(Cama et al., 2008; Cama et al., 2007). An experimental trial which involved 
infection of calves with four different C. parvum isolates (three derived from 
human patients and one calf derived) showed that there was a difference in 
disease severity between the isolates examined (Pozio et al., 1992). Although, 
with the added knowledge that we have now we cannot be sure that these 
isolates were a) truly C. parvum and not another species i.e. C. hominis (which 
is not infectious in calves (Morgan-Ryan et al., 2002)) and b) different isolates, 
in this study the oocysts were assumed to be different isolates of C. parvum 
based on morphology and clinical presentation in naturally infected hosts. 
Another study (Okhuysen et al., 1999) investigated the virulence of three C. 
parvum isolates in human volunteers (two calf derived and one horse derived) 
and found  differences in ID50, prepatent period and duration of oocyst shedding 
between the three isolates. These studies indicate that though host factors are 
very important and can be responsible for differences in individual response to 
infection with C. parvum it is also clear that there can be a difference in 
virulence and pathogenicity of particular isolates. 
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3.7 Conclusion 
In summary, it appears that from the work carried out in this study that when 
lambs are initially challenged with C. parvum at <1 week of age the resulting 
disease is more severe than when lambs are challenged at 6 weeks of age. The 
fact that lambs which are naïve to Cryptosporidium still show mild clinical 
disease when challenged at 6 weeks of age with a higher challenge dose 
demonstrates that lambs do not develop complete immunity to disease with 
increasing age. The results of this study also show that infection with C. parvum 
does not provide complete protection against a homologous or heterologous 
challenge later in life. These results do not confirm a previous study which 
showed that lambs challenged at <1 week of age will be resistant to a 
homologous challenge at 1 month of age (Ortega-Mora and Wright, 1994) though 
in the present study any protection provided by prior challenge is masked by the 
effect of age. The lambs in this study were also challenged with a higher dose at 
6 weeks of age whereas the lambs in the study by Ortega-Mora & Wright were 
given exactly the same challenge dose at 1 month of age. It is possible that had 
the lambs in this study received an identical challenge dose at 6 weeks of age to 
the one they received at <1 week of age the results may have been different. 
There may also be differences in the isolates used in these studies, the study by 
Ortega-Mora and Wright (1994) used the Moredun isolate (first isolated from a 
deer calf and then passaged in calves and lambs 4 × per year since 1987) and the 
present study used two different isolates (BB and LH) both isolated from calves 
and passaged once in neonatal lambs. 
We have also demonstrated in this study that it is possible for different C. 
parvum isolates to behave differently in the host. From the results of this study 
we can report that one isolate (BB) resulted in fewer diarrhoeic samples in 
infected animals than another isolate (LH) which caused more severe and 
prolonged diarrhoea in infected animals. We also demonstrated that clinical 
disease does not directly correlate with oocyst output; animals challenged with 
isolate BB shed greater numbers of oocysts whilst showing milder clinical signs 
compared with animals infected with isolate LH. In some cases the oocyst 
shedding was completely asymptomatic and these asymptomatic animals could, 
in a field setting, be shedding several million potentially infective oocysts into 
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the environment where susceptible human and animal hosts could then become 
infected.  
Further research in this area could be focused on determining the host factors 
which effect resistance to disease and why individuals experience different 
clinical manifestations of disease even when challenged with the same isolate 
and dose. In this study, there were differences in clinical disease and oocyst 
shedding between individuals from the same challenge groups. Some animals 
shed much larger numbers of oocysts than others in the same challenge group 
and some suffered from diarrhoea while others simply exhibited asymptomatic 
shedding. Differences in clinical symptoms have been reported in other studies 
(Jeckel and Williams, 2009; Lindsay et al., 1986; Santin, 2013; Vitovec et al., 
2006; Zambriski et al., 2013a) but the reason for these differences is unknown, 
it is likely that it is due to differences in the immune response of the infected 
individuals. Understanding more about how and when animals mount an immune 
response to infection with Cryptosporidium will help in the development of 
suitable control measures. 
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Chapter 4: Development of a molecular tool to 
differentiate between the most common species of 
Cryptosporidium in cattle 
4.1 Introduction 
For the work carried out for this thesis one of the first steps was to develop a 
quick, easy and reliable method for detection and speciation of Cryptosporidium 
species which may be found in cattle. This was to enable rapid identification of 
species present in faecal samples from calves and older cattle. 
The most common methods for detection of Cryptosporidium in farm livestock 
are microscopy (in veterinary diagnostic laboratories) or by molecular detection 
(research laboratories); of the two methods molecular detection followed by 
sequencing or RFLP is much more sensitive and provides additional information 
(such as species or genotype) than microscopy which can only indicate the 
presence of the parasite (Chalmers and Katzer, 2013). One of the most common 
genes targeted for PCR detection of Cryptosporidium is the 18S rRNA gene which 
is located on a multi-copy DNA element meaning that the PCR is more sensitive 
than those which target a single copy gene for example actin, COWP or hsp70. 
The 18S rRNA gene is also one of the most commonly used genes for species 
discrimination and there are many 18S rRNA reference sequences available on 
the National Centre for Biotechnology Information website 
(www.ncbi.nlm.nih.gov). When using this gene it is necessary to carry out 
sequencing or PCR-RFLP to identify species in Cryptosporidium positive samples. 
These methods can be expensive, time consuming and it is very difficult to 
detect mixed infections as often only the most predominant species in a sample 
is detected (Cama et al., 2006). 
 A multiplex PCR test would enable the rapid speciation of a subset of 
Cryptosporidium species and previous attempts have been made to develop such 
a test (Lindergard et al., 2003; Patel et al., 1999; Santin and Zarlenga, 2009); 
the most recent of which can detect the four most commonly found 
Cryptosporidium species in cattle (Santin and Zarlenga, 2009). This test 
amplifies different sized fragments of the actin gene for the different species 
(C. bovis and C. ryanae both generate identically sized fragments of 300 bp and 
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further PCR tests and sequencing would be required to distinguish these 
species). This defeats the purpose of designing such a test and it would still be 
very difficult if not impossible to detect mixed infections if both of these species 
were present.
103 
 
 
4.2 Aims 
1) Develop a multiplex PCR that enables the identification of the four most 
common Cryptosporidium species found in cattle in single and mixed 
infections as well as identify any non-cattle adapted species
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4.3 Materials and Methods 
4.3.1 Design of Cryptosporidium species specific primers 
Alignments of multiple (between 50 and 100 for each species) 18S rRNA gene 
sequences for Cryptosporidium species (C. parvum, C. bovis, C. ryanae, C. 
andersoni, C. ubiquitum, C. hominis, C. muris, C. xiaoi and C. suis) were made 
using the BioEdit Software Program (www.mbio.ncsu.edu/bioedit/bioedit.html) 
to identify representative sequences for each species. ClustalW 
(www.ebi.ac.uk/Tools/msa/clustalw2) alignments of the representative 
sequences were made and regions for species specific primers were identified 
which would produce amplicons of different sizes for each species when used 
with the 18S rRNA reverse primer (AL3032) (Xiao et al., 2000a). The location of 
the primers used are shown in Figure 4-1; the first set of primers (AL1598 and 
AL3032) are those described by Xiao et al., 2000a and amplify a 840 bp genus 
specific fragment, the second primer set (CaF and AL3032) amplify a 625 bp 
fragment from C. andersoni; the third set (CrF and AL3032) amplify a 415 bp 
fragment from C. ryanae; the forward primer in this set contains a degenerate 
base (R) where the C. ryanae sequence contains either an ‘A’ or a ‘G’ ; the 
fourth set (CphF and AL3032) amplify a 305 bp fragment from C. parvum, C. 
hominis and C. suis which can be later distinguished with an additional PCR if 
desired and the final set of primers (CbF and AL3032) amplify a 241 bp fragment 
from C. bovis. The primer sequences are shown in Table 4-1. 
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                       10         20         30         40         50              
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     GGAAGGGTTG TATTTATTAG ATAAAGAACC AATATAATT- -GGTGACTCA   
C. andersoni  .......... .......... .......... ...GAGC..- -.....T...   
C. bovis      .......... .......... .......... .G...TT..- -.........   
C. ryanae     .......... .......... .......... ...T.TT..T T.........   
C. hominis    .......... .......... .......... .........- -.........   
C. suis       ---------- ---------- ---------- ---------- ----------   
C. ubiquitum  ---------- ---------- ---------- ---------- ----------   
C. xiaoi      ---------- ----...... .......... .....TT..- -.........   
C. muris      .......... .......... .......... ...GAGC..- -.....T...   
 
                       60         70         80         90        100             
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     TAATAACTTT ACGGATCACA TTAA--ATGT GACATATCAT TCAAGTTTCT   
C. andersoni  .......... .......G.. .CTCTG...C .......... ..........   
C. bovis      .......... .......... ..----.... .......... ..........   
C. ryanae     .......... .......... C.----.... .......... ..........   
C. hominis    .......... .......... A.T.--.... .......... ..........   
C. suis       .......... .......... ..TTTA.... .......... ..........   
C. ubiquitum  ---------- ---------- ---------- ---------- ----------   
C. xiaoi      .......... .......... ..----.... .......... ..........   
C. muris      .......... .......G.. .CTCTG...C .......... ..........   
 
                      110        120        130        140        150         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     GACCTATCAG CTTTAGACGG TAGGGTATTG GCCTACCGTG GCAATGACGG   
C. andersoni  .......... .......... .......... .......... ..T.......   
C. bovis      .......... .......... .......... .......... ..T.......   
C. ryanae     .......... .......... .......... .......... ..T.......   
C. hominis    .......... .......... .......... .......... ..........   
C. suis       .......... .......... .......... .......... ..........   
C. ubiquitum  ---------- -......... .......... .......... ..........   
C. xiaoi      .......... .......... .......... .......... ..T.......   
C. muris      .......... .......... .......... .......... ..T.......   
 
                      160        170        180        190        200         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     GTAACGGGGA ATTAGGGTTC GATTCCGGAG AGGGAGCCTG AGAAACGGCT   
C. andersoni  .......... .......... .......... .......... ..........   
C. bovis      .......... .......... .......... .......... ..........   
C. ryanae     .......... .......... .......... .......... ..........   
C. hominis    .......... .......... .......... .......... ..........   
C. suis       .......... .......... .......... .......... ..........   
C. ubiquitum  .......... .......... .......... .......... ..........   
C. xiaoi      .......... .......... .......... .......... ..........   
C. muris      .......... .......... .......... .......... ..........   
 
                      210        220        230        240        250         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     ACCACATCTA AGGAAGGCAG CAGGCGCGCA AATTACCCAA TCCTAATACA   
C. andersoni  .......... .......... .......... .......... ....G.C...   
C. bovis      .......... .......... .......... .......... ..........   
C. ryanae     .......... .......... .......... .......... ..........   
C. hominis    .......... .......... .......... .......... ..........   
C. suis       .......... .......... .......... .......... ..........   
C. ubiquitum  .......... .......... .......... .......... ..........   
C. xiaoi      .......... .......... .......... .......... ..........   
C. muris      .......... .......... .......... .......... ....G.C...   
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                      260        270        280        290        300         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     GGGAGGTAGT GACAAGAAAT AACAATACAG GACTT-TT-T GGTTTTGTAA   
C. andersoni  .......... .......... .......... .G.C.-AA-C ...C......   
C. bovis      .......... .......... .......... A..C.-.A-C ..........   
C. ryanae     .......... .......... .......... AG.C.-.A-C ..........   
C. hominis    .......... .......... .......... .....-..-. ..........   
C. suis       .......... .......... .......... .....T..-. A.........   
C. ubiquitum  .......... .......... .......... .....TAAA. A.........   
C. xiaoi      .......... .......... .......... A..C.-.A-C ..........   
C. muris      .......... .......... .......... .G.C.-AA-C ...C......   
 
                      310        320        330        340        350         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     TTGGAATGAG TTAAGTATAA ACCCCTTTAC AAGTATCAAT TGGAGGGCAA   
C. andersoni  .......... .G........ .......... G......... ..........   
C. bovis      .......... .......... .......A.. .......... ..........   
C. ryanae     .......... .......... .......A.. .......... ..........   
C. hominis    .......... .......... .......... .......... ..........   
C. suis       .......... .......... ........C. .......... ..........   
C. ubiquitum  .......... .......... .......... .......... ..........   
C. xiaoi      .......... .......... .......A.. .......... ..........   
C. muris      .......... .G........ .......... G......... ..........   
 
                      360        370        380        390        400         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     GTCTGGTGCC AGCAGCCGCG GTAATTCCAG CTCCAATAGC GTATATTAAA   
C. andersoni  .......... .......... .......... .......... ..........   
C. bovis      .......... .......... .......... .......... ..........   
C. ryanae     .......... .......... .......... .......... ..........   
C. hominis    .......... .......... .......... .......... ..........   
C. suis       .......... .......... .......... .......... ..........   
C. ubiquitum  .......... .......... .......... .......... ..........   
C. xiaoi      .......... .......... .......... .......... ..........   
C. muris      .......... .......... .......... .......... ..........   
 
                      410        420        430        440        450         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     GTTGTTGCAG TTAAAAAGCT CGTAGTTGGA TTTCTGTTAA TAATTTATAT   
C. andersoni  .......... .......... .......... ........GT AT.A..T...   
C. bovis      .......... .......... .......AAT C........- --....T...   
C. ryanae     .......... .......... .......AAT .........- --....T...   
C. hominis    .......... .......... .......... .......... ..........   
C. suis       .......... .......... T......... .......... ..........   
C. ubiquitum  .......... .......... .......... .......... ..........   
C. xiaoi      .......... .......... .......AAT C........- --....T...   
C. muris      .......... .......... .......... ........GT AT.A.CT-..   
 
                      460        470        480        490        500         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     AAAATATTTT GA-TGAATAT TTAT-ATAAT ATTAACATAA TTCATATTAC   
C. andersoni  .--.....AC C--AAGG..A ....T...T. ..C.....CC ...C.....T   
C. bovis      .T-...A.A. C--ACG.... ....-..... .......... ..........   
C. ryanae     .T-.C.A.GC T--ACGG... ....-..... .......... ..........   
C. hominis    .......... ..-....... ....-..... .......... ..........   
C. suis       .T........ T----..... ....-..... .......... ..........   
C. ubiquitum  .T........ ATT--..... ....-...G. .......... ..........   
C. xiaoi      .T-.C.A.A. C--ACG.... ....-..... .......... ..........   
C. muris      .--.....AC T--AAGG... A...T...T. ..C.....CC ...C.....T   
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                      510        520        530        540        550         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     TATATATTTT ---AGTATAT GAAATTTTAC TTTGAGAAAA TTAGAGTGCT   
C. andersoni  AT.-CTAAA. ----A....G .......... .......... ..........   
C. bovis      .T.T..G--- -----..... ....C..... .......... ..........   
C. ryanae     .T.T..G--- -----..... ....C..... .......... ..........   
C. hominis    ...T.T.... TTT....... .......... .......... ..........   
C. suis       ....AT.... ATT....... .......... .......... ..........   
C. ubiquitum  ....--.... AT-....... .......... .......... ..........   
C. xiaoi      .T.T..G--- -----..... ....C..... .......... ..........   
C. muris      AT.TCTAAA. ----A....G ....C..... .......... ..........   
 
                      560        570        580        590        600         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     TAAAGCAGGC ATATGCCTTG AATACTCCAG CATGGAATAA TAT-TAAAGA   
C. andersoni  .......... .AC....... .......... .......... ..AG...G..   
C. bovis      .......... TAT....... .......... .......... ...-...G..   
C. ryanae     .......... TAT....... .......... .......... ...-...G..   
C. hominis    .......... .......... .......... .......... ...-......   
C. suis       .......... .......... .......... .......... ...-A.....   
C. ubiquitum  .......... ..TA...... .......... .......... ...-A.....   
C. xiaoi      .......... TAT....... .......... .......... ...-...G..   
C. muris      .......... .AC....... .......... .......... ..AG...G..   
 
                      610        620        630        640        650         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     TTTTTATCTT TCTTATTGGT TCTAAGATAA GAATAATGAT TAATAGGGAC   
C. andersoni  C....G.... .......... ....G..C.. A.G.....G. ..........   
C. bovis      .......TC. .......... ....GA.... A...G..... ..........   
C. ryanae     .......TC. .......... ....GA.... A......... ..........   
C. hominis    .......... .T........ .......... .......... ..........   
C. suis       .......... .T........ .......... A......... ..........   
C. ubiquitum  .......... .T........ .......... A......... ..........   
C. xiaoi      .......TC. .......... ....GA.... A...G..... .......A..   
C. muris      C....G.... .......... ....G..C.. A.G.....G. ..........   
 
                      660        670        680        690        700         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     AGTTGGGGGC ATTTGTATTT AACAGTCAGA GGTGAAATTC TTAGATTTGT   
C. andersoni  .......... ...C...... .....C.... .......... ..........   
C. bovis      .......... .......... .......... .......... ..........   
C. ryanae     .......... .......... .......... .......... ..........   
C. hominis    .......... .......... .......... .......... ..........   
C. suis       .......... .......... .......... .......... ..........   
C. ubiquitum  .......... .......... .......... .......... ..........   
C. xiaoi      .......... .......... .......... .......... ..........   
C. muris      .......... ...C...... .....C.... .......... ..........   
 
                      710        720        730        740        750         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     TAAAGACAAA CTAATGCGAA AGCATTTGCC AAGGATGTTT TCATTAATCA   
C. andersoni  .......G.. ...C...... .......... .......... ..........   
C. bovis      .......... ...C...... .......... .......... ..........   
C. ryanae     .......... ...C...... .......... .......... ..........   
C. hominis    .......... .......... .......... .......... ..........   
C. suis       .......... ...G...... .......... .......... ..........   
C. ubiquitum  .......... ...G...... .......... .......... ..........   
C. xiaoi      .......... ...C...... .......... .......... ..........   
C. muris      .......G.. ...C...... .......... .......... ..........   
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                      760        770        780        790        800         
              ....|....| ....|....| ....|....| ....|....| ....|....|  
C. parvum     AGAACGAAAG TTAGGGGATC GAAGACGATC AGATACCGTC GTAGTCTTAA   
C. andersoni  .......... .......... .......... .......... ..........   
C. bovis      .......... .......... .......... .......... ..........   
C. ryanae     .......... .......... .......... .......... ..........   
C. hominis    .......... .......... .......... .......... ..........   
C. suis       .......... .......... .......... .......... ......----   
C. ubiquitum  .......... .......... .......... .........- ----------   
C. xiaoi      .......... .......... .......... .......... ..........   
C. muris      .......... .......... .......... .......... ..........   
 
                      810        820        830        840               
              ....|....| ....|....| ....|....| ....|....| ....| 
C. parvum     CCATAAACTA TGCCAACTAG AGATTGGAGG TTGTTCCTTA CTCCT  
C. andersoni  .......... ....G..... .......... .......... .....  
C. bovis      .......... .......... .......... .......... .....  
C. ryanae     .......... .......... .......... .......... .....  
C. hominis    .......... .......... .......... .......... .....  
C. suis       ---------- ---------- ---------- ---------- -----  
C. ubiquitum  ---------- ---------- ---------- ---------- -----  
C. xiaoi      .......... .......... .......... .......... ...--  
C. muris      .......... ....G..... .......... .......... .....  
 
Figure 4-1: Positions of species specific primers on the 18S rRNA gene plus the location of 
the 18S rRNA internal primers.  
The primers designed amplify a 625bp fragment for C. andersoni, 415bp fragment for C. ryanae, 305bp 
fragment for C. parvum,  C. hominis and C. suis and a 241bp fragment for C. bovis. Accession numbers for 
each species were: C. andersoni (FJ463187), C. ryanae (JN400880), C. parvum (AF164102), C. bovis 
(HQ179572), C. hominis (DQ286403), C. suis (AB694726), C. xiaoi (GU014553.1), C. muris (AF381167.1) 
and C. ubiquitum (KC608029.1). 
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Table 4-1: Primer sequences and size of amplicon produced with each primer pair 
Primer Sequence 5’-3’ 
Fragment 
Size  (bp) 
Species 
Detected 
AL1687 (EF) 
AL1691 (ER) 
TTCTAGAGCTAATACATGCG 
CCCATTTCTTCGAAACAGGA 
1370 
Genus 
Specific  
AL1598 (IF) 
AL3032 (IR) 
GAAGGGTTGTATTTATTAGATAAAG 
AAGGAGTAAGGAACAACCTCCA 
840 
Genus 
Specific 
CaF 
AL3032 (IR) 
GCAAATTACCCAATCCTGAC 
AAGGAGTAAGGAACAACCTCCA 
625 C. andersoni 
CrF 
AL3032 (IR) 
TGTTAATTTTTATATACAATR*CTACGG 
AAGGAGTAAGGAACAACCTCCA 
415 C. ryanae 
CphF 
AL3032 (IR) 
AGAGTGCTTAAAGCAGGCATA 
AAGGAGTAAGGAACAACCTCCA 
305 C. parvum 
CbF 
AL3032 (IR) 
CTTCTTATTCCTTCTAGAATAAAAATG 
AAGGAGTAAGGAACAACCTCCA 
241 C. bovis 
*The degenerate base in the C. ryanae primer is shown in bold and underlined 
 
4.3.2 Faecal Sample Collection and DNA extraction 
Faecal samples (n=498) were collected from 308 adult cattle and 190 calves from 
21 beef farms in Aberdeenshire and Caithness, Northeast Scotland in Spring 2011 
as part of another study. The faecal samples were collected by the farmers and 
sent to the Moredun Research Institute by their vet practices. 
DNA was extracted from the calf faeces processing with a QIAamp DNA Stool 
Minikit (Qiagen) according to the manufacturer’s instructions except that 10 × 
freeze-thaw cycles in liquid nitrogen were carried out after adding 200 µg 
sample to lysis buffer (provided in the kit). 
Adult faeces were subjected to a sedimentation step prior to DNA extraction. 
Briefly, 3 g of faeces was added to a 50 ml tube (A) and resuspended in 25 ml 
dH2O before vortexing vigorously. The solution was left to settle for 5 mins and 
the supernatant removed and added to a second tube (B). The pellet in tube A 
was resuspended with 25 ml dH2O and the settlement step repeated, the 
supernatant was removed from tube A and added to tube B. The tube containing 
the supernatant was centrifuged at 1000 x g for 5 mins and the supernatant 
discarded, 200 µg of the resultant pellet was added to lysis buffer and subjected 
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to 10 × freeze-thaw cycles in liquid nitrogen followed by processing by QIAamp 
DNA Stool Minikit (Qiagen) according to the manufacturer’s instructions. 
All 498 samples were tested for the presence of Cryptosporidium parasite DNA 
using the 18S genus specific PCR, 4.13% (n=13) of the samples from adult cattle 
and 60.5% (n=115) of the samples from calves tested positive for 
Cryptosporidium. These samples were used to test the nested species specific 
multiplex – Polymerase Chain Reaction (nssm-PCR). 
4.3.2.1 Testing of individual species specific primers 
First round reactions were carried out as described in section 2.6.1 using DNA 
from known positive samples for each of the four species. Secondary reactions 
were carried out to test each individual species specific forward primer with the 
reverse 18S rRNA primer (AL3032). First round PCR products were diluted with  
50 µl dH2O and 1 µl of the dilution used as a template in a reaction containing  
2.5 µl 10× PCR buffer (45 mM Tris-HCL pH 8.8, 11 mM (NH4)2SO4, 4.5 mM MgCl2, 
4.4 µM EDTA, 113 µg ml-1 BSA, 1 mM of each of the four deoxyribonucleotide 
triphosphates) (MacLeod et al., 1999), 0.5 units BioTaq (Bioline, UK) and 10 µM 
forward and reverse primers. The final volume of each reaction was made up to 
25 µl using dH2O. 
Cycling conditions were 3 min at 94°C, followed by 35 cycles of 45 s at 94°C, 45 
s on a temperature gradient of 49 - 59°C and 1 min at 72°C. The final extension 
was 7 min at 72°C. Second round PCR products were visualised following 
electrophoresis on a 1.5% agarose gel stained with GelRedTM (Biotium, UK) on an 
AlphaImager 2200. 
4.3.2.2 Field Samples 
Primers were tested on a panel of DNA samples which included: known positive 
samples for C. parvum, C. andersoni, C. bovis and C. ryanae from naturally 
infected cattle (n=128). Results from the nssm-PCR were compared with 
sequence data for some of these samples.  
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4.3.2.3 Optimisation of PCR cycling conditions 
The first round of the nssm-PCR was carried out in a 25 µl reaction as described 
in section 4.3.2.1 using 10 µM of each primer and 3 µl of template DNA in single 
and multiple species combinations. The first round products were diluted with 
50 µl dH2O and 1 µl of the dilution used as template in the 2nd round. Second 
round reactions were carried out in a 25 µl reaction as described in section 
4.3.2.1. Primers were tested on a temperature gradient to determine the 
optimum annealing temperature. Cycling conditions were 3 minutes at 94°C, 
followed by 35 cycles of 45 s at 94°C, 45 s on a temperature gradient of 49 - 
59°C and 1 minute at 72°C. The final extension was 7 minutes at 72°C. Second 
round PCR products were visualised following electrophoresis on a 1.5% agarose 
gel stained with GelRedTM (Biotium, UK) on an AlphaImager 2200.  
4.3.3 Sequence Analysis 
To confirm the results of the nssm-PCR when testing field samples, sequence 
analysis of the 18S rRNA amplicon was carried out. Sequencing of PCR products 
was carried out by GATC (GATC, Germany) using their “Light-run” service. Five 
microlitres of purified PCR product was sent at a concentration of between 20-
80 ng/µl with 5 µl of the appropriate primer at a concentration of 5 pmol/µl. In 
some circumstances, instead of the light-run service, unpurified PCR products 
were sent to GATC for sequencing using their “Supremerun96” sequencing option 
which includes PCR purification. With this service 20 µl PCR product was sent 
with a separate 1.5 ml tube containing 50 µl of the appropriate primer at a 
concentration of 10 pmol/µl. Sequences were analysed using BioEdit Sequence 
Alignment Software (www.mbio.ncsu.edu/bioedit/bioedit.html) and Chromas 
Lite (www.technelysium.com). 
 
 
 
 
112 
 
 
4.4 Results 
4.4.1 Primer Design 
The primer designed for C. parvum will also amplify C. hominis and C. suis, the 
C. andersoni primer will also amplify C. muris and the C. bovis primer will 
amplify C. xiaoi as the 18S region of these species are very similar. 
Cryptosporidium suis and C. hominis have only been found very rarely in cattle 
(Fayer et al., 2006; Smith et al., 2005) and C. muris and C. xiaoi have not yet  
been identified in cattle. 
4.4.2 Individual Species PCR 
Amplicons of the expected size for each species were obtained when tested in a 
single species PCR with the species specific forward primer and the 18S rRNA 
reverse primer. 
4.4.3 Optimisation of PCR cycling conditions 
An annealing temperature of 56°C was selected as the optimum temperature for 
all primers in the mix. 
4.4.4 Nested Species Specific Multiplex PCR 
Amplicons of the expected size for each of the four species (C. andersoni, C. 
ryanae, C. parvum and C. bovis – individually and mixed combinations) were 
obtained using the nssm-PCR assay (Figure 4-2) from a variety of cattle samples. 
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Figure 4-2: Detection of species specific amplicons on a 2% agarose gel stained with 
GelRedTM (Biotium, UK). 
Lane 1, 100bp marker XIV (Roche); lane 2, 18S rRNA genus specific amplicon (840 bp); lane 3, C. andersoni 
(625 bp); lane 4, C. ryanae (415 bp); lane 5, C. parvum (305 bp); lane 6, C. bovis (241 bp); lane 7, C. 
andersoni and C. bovis; lane 8, C. andersoni, C. ryanae and C. bovis; lane 9, C. ryanae and C. parvum; lane 
10, nssm-PCR molecular marker; lane 11, 100bp marker XIV (Roche). Amplicons in lanes 2-6 were produced 
using cloned DNA and lanes 7-9 were from naturally infected cattle.  
 
From the 128 samples from naturally infected cattle (1 day – adult) from farms 
in Aberdeenshire and Caithness the expected amplicons for all four cattle 
species (C. parvum (n=92), C. andersoni (n=1), C. ryanae (only in mixed 
infections) and C. bovis (n=13)) were observed as were various combinations of 
mixed infections (Figure 4-2). Occasionally an additional non-specific band 
appeared with the amplicon for C. parvum but of a different size to the species 
specific bands. The results of the nssm-PCR were compared with sequence data 
for the 18S rRNA gene of these samples. In all cases the single species of 
Cryptosporidium identified by nssm-PCR matched the species identified by 
sequencing. In addition, the nssm-PCR identified mixed infections in 14 of the 
samples examined. The mixed infections included; C. bovis, C. parvum and C. 
ryanae (n=1), C. ryanae and C. bovis (n=5), C. parvum and C. bovis (n=1), C. 
parvum and C. ryanae (n=1) and C. andersoni and C. ryanae (n=6). These mixed 
infections were not identified by sequencing. Eight of the samples failed to 
amplify using the nssm-PCR and three produced unreadable trace files when 
sequenced (Table 4-2). 
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Table 4-2: Comparison of results of nssm-PCR with sequencing of 18S rRNA gene. 
Sample Type 18S Sequence Result 18S Multiplex Result 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) failed sequencing C. bovis 
Calf (7-14 days) C. bovis did not amplify 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum did not amplify 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
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Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. bovis C. bovis, C. parvum + C. ryanae 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. bovis C. ryanae + C. bovis 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. bovis C. ryanae + C. bovis 
Calf (7-14 days) C. parvum C. ryanae + C. bovis 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. bovis C. bovis + C. ryanae 
Calf (7-14 days) C. bovis C. bovis + C. parvum 
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Calf (7-14 days) C. suis-like C. parvum + C. ryanae 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) failed sequencing did not amplify 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. bovis C. bovis + C. ryanae 
Calf (7-14 days) C. bovis C. bovis 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) failed sequencing C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
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Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Calf (7-14 days) C. parvum C. parvum 
Adult C. parvum C. parvum 
Adult C. andersoni C. andersoni 
Adult C. parvum did not amplify 
Adult C. parvum  did not amplify 
Adult C. suis-like did not amplify 
Adult C. andersoni did not amplify 
Adult C. andersoni C. andersoni + C. ryanae 
Adult C. andersoni C. andersoni + C. ryanae 
Adult C. andersoni C. andersoni + C. ryanae 
Adult C. andersoni C. andersoni + C. ryanae 
Adult C. andersoni C. andersoni + C. ryanae 
Adult C. andersoni did not amplify 
Adult C. andersoni C. andersoni + C. ryanae 
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4.5 Discussion 
In this chapter the development of a multiplex PCR test which allows the 
discrimination of four of the most commonly detected Cryptosporidium species 
of cattle (some of which are or may pose a risk to human health) is described. 
The test allows the differentiation of these species by generating distinct 
amplicons of the 18S rRNA gene: C. andersoni (625 bp), C. ryanae (415 bp), C. 
parvum (305 bp) and C. bovis (241 bp) in addition to a Cryptosporidium genus 
specific amplicon (840 bp). Currently the most popular method of species 
identification in Cryptosporidium positive samples is gene sequencing of the 18S 
rRNA gene. This method is very sensitive and can detect a large range of 
Cryptosporidium species and genotypes but is limited when mixed infections 
occur as it has been shown that in a mixed sample either the dominant 
Cryptosporidium species is preferentially amplified by PCR meaning that only 
one species will be identifiable by sequencing or the sequence is unreadable 
(Cama et al., 2006; Santin et al., 2004; Silverlas et al., 2010). The multiplex PCR 
described here allows the detection of mixed infections of up to four different 
common cattle species of Cryptosporidium and is an excellent method for 
detecting underlying infections of zoonotic C. parvum in calves which may have 
higher burdens of the less-pathogenic Cryptosporidium species.  
In addition to the easy and quick visual differentiation of the four common 
cattle species other species of Cryptosporidium may be identified by sequencing 
of the 18S rRNA gene when a fragment responding to the Cryptosporidium genus 
specific amplicon (840 bp) is amplified with no species specific amplicons. At 
present, using this method, it is not possible to distinguish between C. parvum, 
C. hominis  and C. suis however, as C. hominis and C. suis have rarely been 
detected in cattle (Park et al., 2006; Smith et al., 2005) there is, at this stage, 
no real need to distinguish between these two species. If necessary these 
species could be differentiated using a further PCR or by sequence analysis. 
The advantages of the PCR protocol described here over other methods used for 
species discrimination (PCR-RFLP, sequencing) are: (1) the ability to detect 
mixed infections which may be missed by other methods; (2) the ability to 
identify other Cryptosporidium species by further sequencing when none of the 
cattle adapted species are detected; (3) the ability to test large numbers of 
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samples quickly and easily, and; (4) the ability to detect subclinical infections of 
the zoonotic species C. parvum in animals shedding high numbers of non-
zoonotic species. 
As well as being used extensively throughout this PhD thesis this molecular tool 
has also been used to identify the species of Cryptosporidium  present in faeces 
from adult cattle and their calves as part of a whole catchment study in the 
North East of Scotland (Wells et al., 2015). 
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Chapter 5: Cryptosporidium species and 
subtypes found in calves from birth to one year  
5.1 Introduction 
Cryptosporidium parvum is one of the most important causes of neonatal 
enteritis in calves not only in the UK but worldwide (Mosier and Oberst, 2000). It 
is known that cattle are commonly infected with four distinct species of 
Cryptosporidium and that infection with these species tends to follow an age-
related distribution with C. parvum being predominantly found in pre-weaned 
calves, C. bovis and C. ryanae in older calves (<2 months) and C. andersoni in 
adult cattle (Fayer et al., 2006; Santin et al., 2004). There are some exceptions 
to this with C. bovis and C. ryanae being found in pre-weaned calves in some 
countries (France and Sweden) (Rieux et al., 2013; Silverlas et al., 2010) 
although these species have not been associated with clinical disease (Fayer et 
al., 2008; Fayer et al., 2005).  
Recent advances in typing and subtyping methodologies has allowed more 
detailed studies into the dynamics of C. parvum infection in cattle and humans. 
The most common subtyping method is sequencing of the 60-kDa glycoprotein 
(gp60) gene, so far, at least 14 subtype families for C. parvum  have been 
identified (IIa-IIo (there is no IIj)) (Wang et al., 2014a). Some of the subtype 
families appear to be exclusively anthroponotic (IIc and IIe) (Cama et al., 2008; 
Hijjawi et al., 2010; Sulaiman et al., 2005) and others are major zoonotic 
subtypes (IIa and IId) (Alves et al., 2001; Alves et al., 2003). The remaining 
subtype families have been found less commonly in animals and humans 
throughout the world. It has been demonstrated previously that most farms have 
one predominant gp60 subtype within their calves which persists over time 
(Brook et al., 2009).  
At present there is limited knowledge of the species and subtypes of 
Cryptosporidium found in cattle on Scottish farms. Particularly little is known 
about the shedding profiles (age and duration) of the different species found in 
cattle. Until more is understood about the species and subtypes which calves 
shed at different times throughout their lives it is difficult to develop effective 
strategies to control the parasite. Knowing when an animal is likely to pick up 
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the infection, and when they will be infective to others is hugely important as 
this will allow targeted control measures to help reduce the impact of 
cryptosporidiosis in young animals. This part of the thesis aims to address some 
of these questions by carrying out a detailed longitudinal study in calves.  
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5.2 Aims 
1) Identify the species of Cryptosporidium that are shed by calves over the 
initial six weeks of life and then again at set points over one year 
2) Determine the lengths of the intervals over which each of these species 
are shed 
3) Determine how the prevalence of each species changes over time  
4) Identify any periods during which the numbers of shed oocysts are 
significantly higher than average for the entire shedding period  
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5.3 Materials and Methods 
5.3.1 Sample Collection 
Faecal samples were collected from 25 calves on a dairy farm in Midlothian from 
the day of birth until six weeks of age, three times per week (Monday, 
Wednesday and Friday) as described in section 2.1.1. The calves were kept 
under the normal working conditions of this farm with regards to housing (kept 
in groups of ~20 in straw bedded pens), feeding (fed milk replacer with ad 
libitum access to pelleted calf feed, hay and water) and veterinary treatment. 
During this time none of the calves were treated specifically for scour or 
Cryptosporidium. The calves were kept with their mothers for one or two days 
then moved to a small group (5-8 calves) for one week then moved to a larger 
indoor straw bedded pen with approximately 20 calves in each pen for the 
remaining five weeks. After this time the calves were moved, and groups mixed, 
to a different, indoor straw bedded pen. Samples were collected from the same 
calves again at three, six, nine and twelve months of age where possible. The 
total number of samples collected was 426. The samples were mixed thoroughly 
and aliquoted into bijoux tubes and stored at -20°C for further processing.   
5.3.2 Sample processing and DNA extraction 
Faecal samples from calves up to, and including, 9 months were processed as 
described in section 2.5.2 and samples from calves aged 12 months as described 
in sections 2.4.1 and 2.5.1 to obtain DNA for PCR amplification. 
5.3.3 PCR amplification of the 18S rRNA gene 
All DNA samples were amplified using the 18S PCR described in section 2.6.1 and 
visualised on a 1.5% agarose gel stained with GelRed (Biotium, UK). All reactions 
were carried out in triplicate and a sample was considered positive if a band 
corresponding with ~840 bp was seen in 1/3 triplicates. Several controls, both 
negative (no template and extraction controls) and positive (C. andersoni, C. 
parvum, C. bovis and C. ryanae DNA) were run with each set of reactions. A 
positive result was only accepted when all negative controls were negative and 
positive controls were positive.  
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5.3.4 Species identification by nssm-PCR (nested species 
specific multiplex-PCR) 
For the differentiation of Cryptosporidium species an nssm-PCR was carried out 
using the first round PCR product from the 18S PCR (see section 2.6.1) as a 
template. The PCR products were visualised on a 1.5% agarose gel stained with 
GelRed (Biotium, UK). All reactions were carried out in triplicate and a sample 
was considered positive if a band corresponding with 840 bp and any 
combination of 625 bp, 415 bp, 305 bp or 241 bp was seen in at least 1/3 lanes. 
Positive controls (obtained from cloned DNA from oocysts collected from 
naturally infected cattle as part of another study) for each Cryptosporidium 
species tested for were included as well as extraction controls and no template 
controls. A positive result was only accepted when all negative controls were 
negative and all positive controls were positive. 
5.3.5 PCR amplification and sequencing of the gp60 gene for C. 
parvum subtyping 
Subtyping of C. parvum positive samples was carried out by amplification and 
sequencing of the gp60 gene (see sections 2.6.3 and 2.7). The PCR products 
were visualised on a 1.5% agarose stained with GelRed (Biotium, UK). Reactions 
were originally carried out in duplicate and if amplification was not successful 
the reactions were repeated. A sample was considered positive if a band 
corresponding with ~375 bp was seen. Positive, negative and extraction controls 
were included for each set of reactions. A positive result was only accepted 
when all negative controls were negative and all positive controls were positive. 
gp60 positive samples were sequenced in the forward and reverse orientation by 
GATC Biotech (GATC, Germany) as described for “supremerun96” sequencing in 
section 2.7.3. The sequences were analysed using Chromas Lite (version 2.01 
Technelysium) and the subtypes named as according to (Sulaiman et al., 2005). 
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5.4 Results 
5.4.1 Prevalence of Cryptosporidium in calves from birth to 
twelve months 
In total 426 faecal samples were collected from calves on the study farm (Table 
5-1). 
Table 5-1: Number of samples collected at each time point 
Week 
1 
Week 
2 
Week 
3 
Week 
4 
Week 
5 
Week 
6 
3 
Months 
6 
Months 
9 
Months 
12 
Months 
64 62 63 56 57 57 17 16 17 17 
 
All 426 samples were tested for the presence of Cryptosporidium parasite DNA 
using the 18S genus specific PCR and the overall percentage of positive samples 
for the whole study was 59.7% (n=255). In the first six weeks of life each calf 
tested positive for Cryptosporidium on at least six occasions, giving a period 
prevalence of 100% and the overall percentage of samples positive in calves <6 
weeks was 64% (n=232). The earliest observation of oocyst shedding occurred at 
2 d, which was observed in three calves. In several of the calves the first 
observation of oocyst shedding occurred at day 4 (4 animals) or day 6 (4 
animals). Peak shedding of Cryptosporidium oocysts occurred in week 3 with 
100% of the calves tested shedding oocysts. Oocyst shedding tailed off towards 
the end of week 6. Samples from the calves at 3, 6, 9 and 12 months showed a 
prevalence of 24%, 63%, 41% and 18.65% respectively (Figure 5-1). Five of the 
animals did not test positive for Cryptosporidium at any point after the initial 6 
week period and no animals tested positive at all age groups though two tested 
positive at <6 weeks, 3, 6 and 9 months.   
 The percentage of positive samples collected from each calf ranged from 38.9% 
to 87.5% (Figure 5-2).
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Figure 5-1: Shedding profile of Cryptosporidium oocysts in calves from birth to 12 months. 
Percentage of positive samples from calves in the first six weeks of life and at 3, 6, 9 and 12 months of age. The percentage of positive samples at each sampling point (i, ii, iii) is 
indicated by a red bar.
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Figure 5-2: Positive and negative samples collected from each calf. 
Samples collected from each calf at each time point. A positive sample is denoted by a red “P” while a negative sample is denoted by a blue “N”, “0” indicates that a sample was not 
collected from that calf at on that day. The percentage of positive samples at each time point are shown at the bottom of each column while percentage of positive samples from each 
individual is shown in the right-hand column.
Calf ID 3 M 6 M 9 M 12 M % Positive
2384 N N P P P P P P P N P 0 0 P N 0 N N P 0 P N 61.1
2385 N P P P P N 0 P P P P 0 0 P P 0 P N N N N N 61.1
2386 0 N P P P N P N P N P P 0 P P 0 N 0 0 0 0 64.3
2387 0 N P P P N 0 P P P P P 0 P P 0 N 0 0 0 0 76.9
2388 0 P P P P P P N P P P P 0 P N 0 N N P P N N 68.4
2389 N N P N N P 0 P 0 P P 0 N N 0 P 0 0 0 0 0 50.0
2390 N N P N P 0 P P N P P 0 N N 0 0 N N N P N N 38.9
2393 N P N P P 0 P P P P 0 0 N 0 N N P N N P P N 55.6
2394 N N P N P 0 0 P P P 0 0 P 0 P N P N 0 0 0 61.5
2395 N N N P 0 P P P P P 0 N N 0 N P P N 0 0 0 53.3
2396 N N N P P P P P P P 0 N N 0 N N P N 0 0 0 50.0
2397 0 P P P P P P P P 0 0 N 0 P 0 P P P N P P 0 87.5
2398 N N P P 0 P P P P 0 P N 0 0 N 0 P N P P P N 64.7
2399 0 0 N P P P P 0 N 0 N P 0 P N P N N 0 0 0 53.8
2402 P P P P P P P 0 N N 0 N N N N N N 0 N N P N 42.1
2403 P P P P P P P 0 P N 0 0 N P N 0 N N P P P N 66.7
2404 0 P N P P 0 0 0 P 0 P P P 0 N N N P N P N N 56.3
2405 0 N N P P P P 0 P P P P P P N P N N N P N N 60.0
2407 0 N P P P P 0 P N 0 P P P P P P P N N P N N 68.4
2409 0 P 0 0 P 0 P P P P N N N N N N N N 0 0 0 0 42.9
2411 0 P P P P 0 P P P N P N P P N N P N N N N N 55.0
2412 P N P P 0 P P P N P N P P P 0 P P 0 N P P N 73.7
2413 0 P P P 0 P P P P P P N N N N N N 0 N N N N 47.4
2415 N N P P 0 P P P P N P P N N N 0 N 0 N N N P 47.4
2417 0 N P P 0 P P P N P N P P N P P P 0 N N N P 63.2
% Positive 23.1 41.7 75.0 87.5 94.7 84.2 100.0 90.0 75.0 70.0 77.8 55.6 41.2 63.2 28.6 50.0 45.8 11.8 23.5 62.5 41.2 12.5
Calf Age (Months)Calf Age (Weeks)
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
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5.4.2 Speciation of Cryptosporidium-positive samples by nssm-
PCR 
All Cryptosporidium-positive samples were speciated using a nssm-PCR (Chapter 
4). Three  species were identified (C. parvum, C. bovis and C. ryanae) in 228, 21 
and 12 samples respectively. In four samples the species present could not be 
determined. Fourteen mixed infections were identified: these were C. parvum 
and C. bovis (n=7) and C. bovis and C. ryanae (n=7). In this study C. parvum was 
the predominant species detected in calves <6 weeks old with seven calves 
showing evidence of mixed infections. Mixed infections of C. parvum and C. 
bovis were detected between three and five weeks and C. parvum and C. ryanae 
were seen only in week 6. The species shed over the initial six week period and 
at the other age groups are shown in Figure 5-3.
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Figure 5-3: Prevalence of Cryptosporidium species in each age group of cattle. 
Percentage of each species of Cryptosporidium at each time point.
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To confirm the results of the nssm-PCR a selection of samples were sent for 
sequencing by GATC (see section 2.7) and all sequenced samples matched the 
result of the nssm-PCR. 
5.4.3 Subtyping of C. parvum by gp60 PCR  
To determine the gp60 subtypes C. parvum positive samples were subjected to a 
nested PCR to amplify a fragment of the gp60 gene. Two hundred and eight of 
these were positive, a sub-set of which, selected from 5 calves which shed C. 
parvum throughout the initial 6 weeks and at 6 months as well as others which 
were only C. parvum positive in the first 6 weeks, were sequenced (n=30). Two 
different gp60 subtypes were identified. In all of the samples from the calves <6 
weeks the genotype identified was IIaA19G2R1 and in the samples from the same 
calves at 6 months the genotype identified was IIaA15G2R1 (Table 5-2). 
Table 5-2: gp60 genotypes detected in calves at different ages. 
Calf ID < 1 Weeks 2-3 Weeks 6 Weeks 6 Months 
2384  IIaA19G2R1   
2385  IIaA19G2R1 IIaA19G2R1  
2388 IIaA19G2R1 IIaA19G2R1 IIaA19G2R1 IIAa15G2R1 
2393 IIaA19G2R1 IIaA19G2R1  IIAa15G2R1 
2395 IIaA19G2R1 IIaA19G2R1   
2397  IIaA19G2R1  IIaA15G2R1 
2398 IIaA19G2R1 IIaA19G2R1   
2404 IIaA19G2R1 IIaA19G2R1 IIaA19G2R1 IIaA15G2R1 
2405 IIaA19G2R1 IIaA19G2R1 IIaA19G2R1 IIaA15G2R1 
2407 IIaA19G2R1 IIaA19G2R1 IIaA19G2R1  
2417 IIaA19G2R1 IIaA19G2R1 IIaA19G2R1  
 
 
 
 
 
 
131 
 
 
5.5 Discussion 
Although many prevalence studies (longitudinal and point-prevalence) 
investigating Cryptosporidium in cattle have been carried out worldwide this 
study is the most in-depth study carried out in the UK and provides detailed 
information on the species and subtypes of Cryptosporidium shed in a group of 
calves over a 12 month period. The findings of this study are comparable with 
those found by others investigating species of Cryptosporidium in calves of a 
similar age; Santin et al. (2004) found that C. parvum was the predominant 
species detected in calves <2 months with C. bovis and C. ryanae being detected 
in some samples from week 3 onwards, in another study C. parvum was the only 
species detected in calves <4 weeks with C. bovis being detected in two samples 
at week 4 and one at week 5. Cryptosporidium ryanae was not detected until 
week 10 (Santin et al., 2008). A more recent study from France (Rieux et al., 
2013) also showed that C. parvum was the most prevalent species of 
Cryptosporidium in young calves (7-17 days old) with C. bovis first being 
detected at around week 2 and C. ryanae from week 3.  
In the present study, when the same calves were examined at 3 months, only 
two species were detected and there were no mixed infections with 50% of the 
positive samples being identified as C. bovis and 50% as C. ryanae. These species 
are the most commonly detected in calves of this age group in other studies 
including longitudinal and point prevalence studies (Follet et al., 2011; 
Langkjaer et al., 2007; Ng et al., 2011; Santin et al., 2008; Santin et al., 2004; 
Silverlas et al., 2010). Few studies have examined calves older than three 
months and most show that the most commonly detected species in this age 
group (~6 months) are C. bovis and C. ryanae (Follet et al., 2011; Langkjaer et 
al., 2007; Santin et al., 2008; Santin et al., 2004; Silverlas et al., 2010) and 
occasionally C. andersoni (Santin et al., 2004), C. ubiquitum (Follet et al., 2011) 
or C. suis-like (Langkjaer et al., 2007). In the group of calves studied here we 
report a more unusual distribution of Cryptosporidium species for the age of 
cattle, at three months the calves shed only C. bovis and C. ryanae which is as 
expected however, in the same calves at 6 months old 70% of the positive 
samples were identified as C. parvum (by both nssm-PCR and sequencing of a 
fragment of the 18S rRNA gene), 20% as C. bovis and 10% as a mixed infection of 
C. bovis and C. ryanae.  This is very unusual as C. parvum in 6 month old cattle 
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has only been reported a handful of times, and usually as a small percentage of 
positive samples.  
In one study, which examined faeces from older calves C. parvum was detected 
in 5% of calves between the age of 31 days and 6 months (n=368) but it is not 
stated at exactly which age the calves were shedding C. parvum (Follet et al., 
2011) and in another study from the USA (Santin et al., 2008) C. parvum was 
found in one calf at 6 months. In the present study, when the same calves were 
sampled at 9 months of age, no C. parvum positive samples were detected. 
Forty-three percent of the positive samples were identified as C. bovis, 14% C. 
ryanae and 29% as a mixed infection of C. bovis and C. ryanae. Again this ties in 
with other studies done on this age group of cattle (Langkjaer et al., 2007; 
Santin et al., 2008; Santin et al., 2004). 
The first detection of Cryptosporidium positive samples occurred at day two of 
age in three calves with the majority of calves producing a positive sample 
between day four and six of life. This early detection indicates that calves pick 
up the parasite very soon after birth and while it might seem unlikely that calves 
can become infected and be shedding oocysts in such a short period of time the 
prepatent period of Cryptosporidium in calves is known to be 2-7 days (Tzipori 
et al., 1983). The first born calves started to shed oocysts at 5-7 days while later 
born calves began shedding between 2-4 days. This may be an indication that as 
calving progresses there is a build-up of environmental contamination which 
means later born calves receive a higher infective dose and therefore begin to 
shed oocysts sooner. It is known that the prepatent period for Cryptosporidium 
is also dependant on infective dose (Tzipori et al., 1983). 
The previously reported age distribution of Cryptosporidium species in cattle has 
been confirmed again in this study with the majority of calves under 6 weeks of 
age being infected with C. parvum. However, in this study we also report the 
occurrence of C. bovis and C. ryanae in this age group, which is less common. 
We also show evidence of mixed infections within this age group and others (6, 9 
and 12 months). It has been previously shown that even when using sensitive 
molecular methods to detect Cryptosporidium species in faecal samples, mixed 
infections can be missed because the predominant species is preferentially 
amplified (Cama et al., 2006). The detection method used in this study (nssm-
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PCR) is much more effective at detecting mixed infections than standard 18S 
PCR, this accounts for the increased detection of mixed infections in these 
calves compared to similar studies. This is of particular use in terms of public 
health, when a low level of infection with the zoonotic species C. parvum is 
missed because of a predominant infection with a less pathogenic species such 
as C. bovis or C. ryanae.  
Recent advances in molecular techniques have enabled further characterisation 
of some Cryptosporidium species, this can help provide further information and 
aid in the understanding of parasite transmission and pathogenicity. In the 
present study subtyping of C. parvum delivered some interesting and unusual 
findings. It has been demonstrated previously that most farms tend to have to 
have only a single gp60 subtype present (Broglia et al., 2008; Brook et al., 2009) 
(Santin et al., 2008) particularly where there is little movement of cattle. On 
the study farm replacement heifers are reared on the farm and the only animal 
bought in is a bull every couple of years. In contrast, on farms where there is 
greater cattle movement (buying in stock) more than one subtype may be found 
(Brook et al., 2009; Follet et al., 2011; Silverlas and Blanco-Penedo, 2013). On 
the farm in this study it appears that there are two distinct populations (one in 
the young calves and one in the older calves) despite the fact that very few 
animals are bought in. The subtype identified from the 6 month old calves is the 
most commonly detected gp60 subtype in cattle and humans worldwide and has 
been found in cattle in many different countries including; Belgium (Geurden et 
al., 2007), Great Britain (Brook et al., 2009; Thompson et al., 2007), Germany 
(Broglia et al., 2008), Italy (Duranti et al., 2009), The Netherlands (Wielinga et 
al., 2008), Portugal (Alves et al., 2006; Alves et al., 2003), Romania (Imre et al., 
2011) and Spain (Quilez et al., 2008b). This subtype is extremely common and 
one review article reports that 55.3% of C. parvum subtypes in cattle were 
identified as IIAa15G2R1 (Imre and Darabus, 2011). In contrast, the subtype 
identified in the samples from the <6 week old calves (IIaA19G2R1) is much less 
common than IIAa15G2R1 in calves (Couto et al., 2013; Wielinga et al., 2008; 
Xiao et al., 2007) and humans (Gait et al., 2008; Hadfield et al., 2011). 
However, it is has been present on this particular farm for many years and is 
known to be zoonotic (Gait et al., 2008).   
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The management of cattle on this farm is very good: calves are kept in straw 
bedded pen in groups of ~20 from birth until they reach 3 months then the 
groups are mixed and moved to a new straw bedded shed (group sizes of ~40). 
Once the calves are older (5/6 months) they are moved again and all calves in 
the same age range are housed in a concrete floored pen with cubicles or turned 
out depending on the time of year. This could explain the different subtypes 
being found in different areas of the farm as different age groups of cattle are 
never mixed or housed in the same pens. It is also possible that there are two 
subtypes circulating in the calves but that one (IIaA19G2R1) is more pathogenic 
than the other (IIaA15G2R1) and that infection with this subtype overwhelms the 
gut and the second subtype is not seen until later in life. It has been 
demonstrated that in humans clinical disease and shedding of oocysts varies 
depending of species and subtype of Cryptosporidium (Cama et al., 2008) and 
the same may be true in cattle.  
Although some longitudinal studies have been carried out in cattle, most have 
focused on pre-weaned animals or have been point prevalence studies only 
looking at a group of animals at one particular time point, this study has 
investigated the prevalence of Cryptosporidium species in a group of animals 
over a longer period with more frequent sample collections (3/week initially) 
providing more detailed information on how the prevalence of Cryptosporidium 
in a group of calves changes as the animals get older. Of the few studies which 
have looked at older calves many report that as the calves’ age increases the 
prevalence of Cryptosporidium decreases (Follet et al., 2011; Rieux et al., 2013; 
Santin et al., 2008; Silverlas et al., 2010). This study reports that prevalence of 
Cryptosporidium decreases after 6 weeks with peak shedding at 3 weeks with a 
secondary peak in prevalence at 6 months. This pattern has been observed in 
two other studies, one in the USA and the other in The Netherlands (Huetink et 
al., 2001; Santin et al., 2004), the secondary peaks in shedding observed in the 
other studies were lower than reported here (~25% and 3.3% respectively), this is 
possibly due to the increased sensitivity of the techniques used in this study 
compared with previous studies. 
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5.6 Conclusion 
It has been shown from this work that young calves become infected with, and 
begin shedding, Cryptosporidium very soon (minimum 2 days) after birth and 
that shedding of oocysts (with and without clinical disease) occurs for at least 6 
weeks. It has also been demonstrated that calves can be infected with multiple 
species of Cryptosporidium simultaneously in the first 6 weeks of life. It was 
previously assumed that older post-weaned calves and adult cattle were not a 
significant risk for zoonotic transmission of C. parvum as most studies indicated 
that once calves were older they were not usually infected with this species. 
This study shows that even if calves are infected with C. parvum before weaning 
they can become infected with this species again, although a different subtype, 
when they are older. This is an important factor when considering the zoonotic 
implications, it also demonstrates the importance of molecular characterisation 
and speciation of all Cryptosporidium positive samples. Many older studies 
report “C. parvum-like” oocysts, since there are no morphological differences 
between C. parvum, C. bovis and C. ryanae this molecular characterisation is 
very important to make sure that the species is correctly and accurately 
assigned. 
Further subtyping which was carried out in this study showed evidence that 
multiple subtypes of C. parvum may be present on a single farm and that these 
different subtypes may have different clinical manifestations, this is important 
from both an animal and public health perspective. 
Finally, the techniques used in this study demonstrate the need to use the most 
sensitive methods available to detect oocysts and assign species particularly in 
the case of older animals where a predominant infection with a non-pathogenic 
species may be hiding a lesser infection with a pathogenic species such as C. 
parvum.  
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Chapter 6: Transmission of Cryptosporidium 
from dam to calf 
6.1 Introduction 
Many different routes have been proposed for the transmission of C. parvum to 
calves (Figure 6-1) and one suggestion is that adult cattle may be the source of 
infection for neonatal calves. Calves tend to become infected with 
Cryptosporidium shortly after birth, within 24-72 h (Ramirez et al., 2004; Xiao 
and Herd, 1994) therefore a  likely source for infection would be their dams as 
the calves are in close contact with them immediately after birth. A few studies 
have been carried out to test this hypothesis where the presence of 
Cryptosporidium in the adult faecal samples was detected using microscopy or 
ELISA (to detect Cryptosporidium antigens in faecal supernatant using an anti-
Cryptosporidium antibody) and from this it was assumed that the 
Cryptosporidium in the adult animals were the source of infection for the 
neonatal animals. However, the methods used in these studies were unable to 
identify the species of Cryptosporidium only that there were oocysts present. 
Now that it is known that there are many different species of Cryptosporidium 
and that cattle may be infected with four main species, the question of the 
source of C. parvum infection for neonatal animals needs to be clarified. 
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Figure 6-1: Possible routes for transmission of Cryptosporidium to calves. 
Many different routes for transmission of Cryptosporidium to young neonatal livestock have been suggested, 
the most common of these are transmission from dam to calf at or shortly after birth, from the environment 
(cattle shed or contaminated pasture), direct contact with contaminated faeces of another host or from 
contaminated drinking water supplies. 
 
In adult cattle excretion of oocysts tends to be low and intermittent and there 
are studies to demonstrate this (Table 6-4). One reason for this may be that the 
methods used are not sensitive enough to detect oocysts in adult cattle faeces. 
Studies on sheep suggested that dams were the likely source of infection to their 
young due to a periparturient rise in oocyst excretion (Ortega-Mora et al., 1999; 
Xiao et al., 1994) leading to the suggestion that the same may be true of cattle. 
However this evidence was based on the assumption that the oocysts shed were 
C. parvum and at this time many of the other species which we now know infect 
farm livestock had not been identified. More recent studies show no evidence for 
a periparturient rise in oocyst shedding in cattle (Atwill and Pereira, 2003; 
Sturdee et al., 2003) and dams as a source of infection for calves were suggested 
to be of minor importance (De Waele et al., 2012) except for the transmission of 
C. bovis in older calves (Kvac et al., 2011). Another study (Faubert and Litvinsky, 
2000) showed that a periparturient rise in oocyst shedding in cattle does occur 
and that cows are a likely source of infection for their calves.   
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A more probable source of infection for young calves is environmental 
contamination (from other calves or hosts); Cryptosporidium oocysts are highly 
resistant to heat, cold, disinfectants and are very difficult to eliminate 
(Robertson et al., 1992). It is thought that differences in calf management 
practices such as housing can have an effect on infection rates but some of the 
results are conflicting. In one study of 2024 calves from 248 farms over a two 
year period, it was shown that housing calves with their dams decreased the risk 
of C. parvum infection while calves removed from their dam and kept in 
individual pens were at higher risk of infection (Duranti et al., 2009) hinting that 
dam to calf transmission is less important than calf to calf or via environmental 
transmission. In contrast, other studies have shown that the opposite is true 
(Quigley, III et al., 1994; Quigley, III et al., 1995) or that calf housing (individual 
or group penning), has no effect on Cryptosporidium infection (Castro-Hermida 
et al., 2002) though calves housed on straw rather than concrete were at higher 
risk of infection regardless of whether or not they were housed individually or in 
a group. It is also possible for infection to be passed between calves in a 
particular pen (O'Handley et al., 1999).  
One reason for the apparent low level or lack of shedding of Cryptosporidium 
oocysts by adult animals (cattle and sheep) may be due to the lack of sensitivity 
of the methods used in processing the faecal samples. Faecal samples from adult 
animals, particularly cattle are much larger in volume than those from calves 
and contain more fibrous material meaning that detection of oocysts is much 
harder. In many studies when negative samples have been detected it is possible 
that these samples are actually positive but have been missed by the techniques 
used. In the first part of this study several techniques were assessed to 
determine the most effective method of processing adult cattle faeces. 
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6.2  Aims 
1. Develop a more sensitive method for oocyst concentration and extraction 
from adult cattle faeces 
2. Assess the shedding  profile of different Cryptosporidium species found in 
dams throughout gestation and after calving 
3. Determine the Cryptosporidium species found in the calves born to cows 
in the study  
4. Determine the subtypes of C. parvum in the same dams and calves 
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6.3 Materials and Methods 
6.3.1 Optimisation of oocyst concentration and DNA extraction 
from adult cattle faeces 
6.3.1.1 Spiking Experiment 
A Cryptosporidium negative faecal sample (as determined by 10 × DNA 
extractions and PCR) was obtained from a one year old Charolais bull from the 
University of Glasgow, School of Veterinary Medicine. The animal was born at 
the veterinary school and had never had access to grazing and had limited access 
to other cattle and livestock. To test each oocyst concentration method (direct 
DNA extraction, acid flocculation (AF), salt flotation (SF) and combined acid 
flocculation and salt flotation) 0, 5, 10, 100 and 1000 C. parvum oocysts 
(obtained from experimentally infected calves) per gram were added to each 
sample as shown in Table 6-1.  
Table 6-1: Methods tested for optimisation of oocyst concentration before DNA extraction 
from cattle faeces. 
Number of oocysts spiked per gram of faeces and volume of faeces used for each method.  
 Method 
No. of oocysts 
per gram 
 Acid 
Flocculation 
 Salt 
Flotation 
 Acid Flocculation and 
Salt Flotation 
 No Prior 
Concentration 
0 50 g 3 g 50 g 250 mg 
5 50 g 3 g 50 g 250 mg 
10 50 g 3 g 50 g 250 mg 
100 50 g 3 g 50 g 250 mg 
1000 50 g 3 g 50 g 250 mg 
 
6.3.1.2 Field Samples 
Using faecal samples (n=205) collected from adult dairy cattle as part of this 
study, AF followed by DNA extraction was compared with AF/SF followed by DNA 
extraction. 
6.3.1.3 Acid Flocculation 
The faecal sample was well mixed and 50 g added to a 1 L cylinder with 600 ml 
water and 7 ml 2% sulphuric acid. The sample was put on a magnetic stirrer and 
thoroughly mixed for 5 mins then left to settle for approximately 5 mins or until 
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a clear line was visible between the sediment and supernatant, after which the 
supernatant was removed by pipette, collected in two 250 ml bottles and 
centrifuged for 20 mins at 1000 x g. The supernatant was discarded and 6 ml H20 
was added to the pellet, mixed and put into a 15 ml tube, which was centrifuged 
for 5 minutes at 3000 x g. The supernatant was discarded and the pellet retained 
for further processing by either DNA extraction (6.3.1.5) or salt flotation 
(6.3.1.4). 
6.3.1.4 Salt Flotation 
A 3 g faecal sample or pellet from acid flocculation was added to 8 ml saturated 
salt solution and thoroughly mixed by vortexing and 2 ml dH2O trickled on top of 
the salt solution before centrifugation at 1000 x g for 8 mins. Following 
centrifugation the water layer was gently swirled using a Pasteur pipette to 
create a vortex which draws the oocysts from the layer between the dH2O and 
salt into the dH2O, the layer was removed and added to 6 ml dH2O, the total 
volume was made up to 10 ml, mixed by inverting and centrifuged at 5000 x g 
for 5 mins. The supernatant was poured off and discarded and the pellet 
retained for DNA extraction (Ryley et al., 1976). 
6.3.1.5 DNA Extraction 
DNA was extracted as described in section 2.5.1. 
6.3.1.6 PCR amplification of the 18S rRNA gene 
DNA samples were amplified using the 18S PCR described in section 2.6.1 and 
visualised on a 1.5% agarose gel stained with GelRed (Biotium, UK). All reactions 
were carried out in triplicate and a sample was considered positive if a band 
corresponding with ~840 bp was seen. Several controls, both negative (no 
template) and positive (Cryptosporidium DNA) were run with each set of 
reactions. A positive result was only accepted when all negative controls were 
negative and positive controls were positive.  
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6.3.2 Sample Collection 
6.3.2.1 Adults 
The study farm used for this study was the same farm which was used for the 
study described in Chapter 5. Faecal samples were collected from 29 in-calf 
adult dairy cattle (heifers and cows) three times per week for up to ten weeks 
pre-calving, in total 205 samples were collected. The cows were kept under the 
normal working conditions of this farm and as such were housed in cubicle sheds 
before calving, in straw courts at calving and in slatted cubicle sheds after 
calving when they returned to the milking herd. Cows were observed in the 
cattle shed until they defecated and then the entire motion was collected in a 
plastic bag. Due to the method of collection it was not always possible to collect 
a sample from each cow at each sampling point. After collection the samples 
were transferred to the laboratory where the entire motion was mixed and a 
sub-sample aliquoted into a 125 ml tub and stored at 4°C. 
6.3.2.2 Calves 
Samples from calves (n=30) born to these cows were collected from the day of 
birth until 6-9 weeks of age three times per week (Monday, Wednesday and 
Friday). The samples were collected from the rectum of calves using a gloved 
finger and bag for collection, where possible the entire motion was collected. It 
was not always possible to collect a sample from each calf on each sampling 
day; therefore the number of samples collected per calf did vary. The calves 
were kept under the normal working conditions of this farm with regards to 
housing, feeding and veterinary treatment. The calves were kept with their 
mothers for one/two days then moved to a small group (5-8 calves) for one week 
then moved to a larger indoor straw bedded pen with approximately 20 calves in 
each pen for the remaining five weeks. After this time the calves were moved, 
and groups mixed, to a different, indoor straw bedded pen. Samples were 
collected from the same calves again at six months of age where possible. The 
total number of samples collected was 380. The samples were mixed thoroughly 
and aliquoted into bijoux tubes and stored at -20°C for further processing 
143 
 
 
6.3.3 Sample processing and DNA isolation 
6.3.3.1 Adults 
Samples were processed to concentrate Cryptosporidium oocysts from a 50 g 
starting sample by acid flocculation and salt flotation as described in section 
2.4.1. DNA was isolated as described in section 2.5.1. 
6.3.3.2 Calves 
Faecal samples from calves were processed and DNA isolated as described in 
section 2.5.2. 
6.3.4 Species identification by nssm-PCR (nested species 
specific multiplex-PCR) 
For the differentiation of Cryptosporidium species an nssm-PCR was carried out 
using the first round PCR product from the 18S PCR (see section 2.6.1) as a 
template. The PCR products were visualised on a 1.5% agarose gel stained with 
GelRed (Biotium, UK). All reactions were carried out in triplicate and a sample 
was considered positive if a band corresponding with 840 bp and any 
combination of 625 bp, 415 bp, 305 bp or 241 bp was seen. Positive controls for 
each Cryptosporidium species tested for were included as well as extraction 
controls and no template controls. A positive result was only accepted when all 
negative controls were negative and all positive controls were positive. 
6.3.5 C. parvum subtyping 
Sequencing of C. parvum positive samples was carried out by amplification and 
sequencing of the gp60 gene (see sections 2.6.3 and 2.7). The PCR products 
were visualised on a 1.5% agarose gel stained with GelRed (Biotium, UK). 
Reactions were originally carried out in duplicate and if amplification was not 
successful the reactions were repeated. A sample was considered positive if a 
band corresponding with ~375 bp was seen. Positive, negative and extraction 
controls were included for each set of reactions. A positive result was only 
accepted when all negative controls were negative and all positive controls were 
positive. 
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gp60 positive samples were sequenced in the forward and reverse orientation by 
GATC Biotech (GATC, Germany) as described for “supremerun96” sequencing in 
section 2.7.3. The sequences were analysed using Chromas Lite (version 2.01 
Technelysium) and the subtypes named as according to (Sulaiman et al., 2005). 
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6.4 Results 
6.4.1 Optimisation of oocyst concentration and DNA extraction 
from adult cattle faeces 
6.4.1.1 Spiking Experiment 
The results of the spiking experiment comparing the four methods of oocyst 
extraction from adult cattle faeces are given in Table 6-2 and Figure 6-2. Acid 
flocculation alone failed to concentrate oocysts; SF alone was sensitive to 100 
oocysts/g; the combined AF/SF method to 5 oocysts/g and direct DNA extraction 
was sensitive to 100 oocysts/g of faeces. The PCR reactions were carried out in 
triplicate. 
Table 6-2: Detection limits of each of the four concentration methods. 
 Method 
No. of oocysts 
per gram 
Acid 
Flocculation 
Salt 
Flotation 
Acid Flocculation and 
Salt Flotation 
No Prior 
Concentration 
0 - - - - 
5 - - ++ - 
10 - - +++ - 
100 - ++ +++ + 
1000 - +++ +++ +++ 
- = negative, + = positive in 1 of 3 reactions, ++ = positive in 2 of 3, +++ = positive in 3 of 3 PCR reactions 
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Figure 6-2: Spiking experiment to compare AF, SF, AF/SF and no concentration methods of 
oocyst detection from adult cattle faeces.  
Top image: lane 1= DNA Molecular Weight Marker XIV 100 base pair ladder (Roche); lanes 2-13= direct 
method: 2-4=5 oocysts/g; 5-7=10 oocysts/g; 8-10=10
2
 oocysts/g; 11-13=10
3
 oocysts/g. Lanes 14-25=salt 
flotation only: 14-16=5 oocysts/g; 17-19=10 oocysts/g; 20-22=10
2
 oocysts/g; 23-25=10
3
 oocysts/g.  Lanes 26-
27= positive controls. 
Bottom image: lane 1= marker (Roche 100bp); lanes 2-13= acid flocculation only: 2-4=5 oocysts/g; 5-7=10 
oocysts/g; 8-10=10
2
 oocysts/g; 11-13=10
3
 oocysts/g. Lanes 14-25=acid flocculation and salt flotation: 14-16=5 
oocysts/g; 17-19=10 oocysts/g; 20-22=10
2
 oocysts/g; 23-25=10
3
 oocysts/g.  Lanes 26-27= negative controls. 
 
6.4.1.2 Evaluation of AF and AF/SF 
Two hundred and five faecal samples were tested for the presence of 
Cryptosporidium DNA by either AF followed by DNA extraction or AF/SF followed 
by DNA extraction. Of the 205, 11 tested positive using the acid flocculation 
method only and 57 tested positive using the AF/SF. 
6.4.2 Prevalence of Cryptosporidium 
6.4.2.1 Adult Cattle 
In total 205 faecal samples from 29 adult dairy cattle (cows and heifers) were 
collected. On average seven samples from each animal were collected over the 
pre-calving period (range 3-13, median 7, mode 7). Due to the nature of 
5/g     10/g    10²/g  10³/g
Acid flocculation
5/g   10/g    10²/g   10³/g   -ve
AF and SF
Bp
1000 
500
500
Salt flotation only
5/g   10/g    10²/g  10³/g
1    2   3   4   5   6   7    8   9  10  11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  26  27
1000
+ve
Direct method
5/g   10/g    10²/g    10³/g
Cryptosporidium
genus specific band
C. parvum band
1    2   3   4   5   6   7    8   9  10  11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  26  27
Cryptosporidium
genus specific band
C. parvum band
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collection it was not possible to collect a sample from each animal every day, it 
was hoped that a minimum of one sample per cow per week would be obtained. 
The majority of samples were collected during the four week period 
immediately prior to calving (Figure 6-3).
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Figure 6-3: Samples collected from each cow pre and post calving.  
Faecal samples collected over the study period from 29 adult dairy cattle (cows and heifers).  A blue “X” denotes a sample collected on that day while “0” shows that no sample was 
collected from that cow on that particular day. The total number of samples collected at each collection point are shown at the bottom of the figure and total number of samples collected 
from each cow are shown in the right-hand column.
I.D Calving Samples Per Cow
254 0 0 0 0 X 0 X 0 0 X X 4
220 0 0 X 0 0 0 X 0 X X X 0 X 0 0 0 0 X 0 0 0 X 8
136 0 0 0 0 X 0 0 X X X X 0 0 X 0 X 7
278 0 0 0 0 0 0 0 0 X X 0 X 0 0 0 0 3
350 0 0 0 0 0 0 0 X X 0 X 0 0 X 0 0 4
26 0 0 0 0 0 0 X 0 X X X X X 0 0 0 0 X 7
354 0 0 0 0 X 0 0 0 0 X X 0 0 0 0 X 0 4
52 0 0 0 0 0 0 0 X 0 0 X 0 0 0 X 0 0 0 0 0 0 0 X 4
15 0 0 X 0 0 0 X 0 X X X 0 0 0 0 0 0 0 X 6
256 0 0 0 0 0 0 0 X X X 0 0 0 0 X 0 0 X X 6
243 0 0 0 0 0 0 X X 0 X X X X 0 0 X 0 0 0 7
96 0 0 0 0 0 0 0 X X 0 X 0 0 0 X 0 0 X 0 5
178 0 0 X 0 X 0 0 0 X 0 X 0 X X 0 X 0 0 X 8
51 0 0 X 0 X 0 0 X 0 X X 0 0 X X 0 0 0 0 7
64 0 0 0 0 0 0 0 X X X X 0 X X 0 0 0 0 X 7
20 0 0 0 0 0 0 0 0 X X 0 0 0 X 0 X 0 X 0 0 X X 7
130 0 0 0 0 0 0 0 0 X 0 X 0 X X X X 0 X 0 0 0 X X 9
105 0 0 0 0 0 0 0 X X 0 0 0 X 0 X X 0 X 0 0 0 6
108 0 0 0 0 0 0 X X X 0 X 0 X 0 X 0 X X X 0 0 0 X X 11
62 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 0 0 X 0 X 0 X 0 4
176 0 0 0 0 0 0 X 0 0 0 0 X 0 0 0 0 0 X 0 0 0 X 0 X 5
138 0 0 0 0 0 0 0 0 0 0 0 X X 0 0 X 0 X 0 0 0 0 0 0 X X 6
50 0 0 0 0 X 0 0 X 0 X 0 0 X 0 0 X X X X X 0 X X 0 X X 13
54 0 0 0 0 0 0 0 0 X X 0 X X X X 0 0 0 X 0 0 0 0 0 0 X 8
357 0 0 0 0 0 0 X 0 0 X 0 0 0 X 0 0 0 0 X X 0 0 X X X X 0 X 10
149 0 0 0 0 X 0 0 X 0 X X X 0 0 X 0 0 X X 0 0 0 X 0 0 0 X X 11
57 0 0 0 X 0 0 X 0 0 0 0 0 0 X 0 0 0 0 0 0 X 0 X X 0 X 0 0 7
82 0 X 0 0 0 0 X X 0 0 0 0 X 0 0 0 X X X 0 0 0 X X X X 0 0 11
233 X 0 0 0 0 X 0 0 0 0 0 X 0 0 0 0 X X X 0 X 0 0 0 X 0 X 0 X 10
Total 1 1 0 1 1 1 2 3 1 1 2 7 4 5 6 7 13 12 11 14 16 14 17 11 13 5 10 6 13 4 1 0 1 1 205
Week 1 Week 1 Week 2
Post-CalvingPre-Calving
Week 9 Week 8 Week 7 Week 6 Week 5 Week 4 Week 3 Week 2
149 
 
 
All samples were tested for the presence of Cryptosporidium DNA by 18S nssm-
PCR after oocyst concentration by acid flocculation and salt flotation. Overall 
27.9% (n=57) of samples from adult cows tested positive for Cryptosporidium. 
Four cows did not test positive for Cryptosporidium at any point throughout the 
study, the remaining 25 cows tested positive on at least one occasion and two 
cows that tested negative for Cryptosporidium pre-calving tested positive post-
calving. The percentage of Cryptosporidium positive samples remained fairly 
stable throughout the study period (Figure 6-4) at ~30%. There were more 
fluctuations when looking at each individual time point when the percentage of 
positive samples ranged from 0-100%.
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Figure 6-4: Positive samples detected in adult cows pre- and post-calving.  
Percentage of positive samples detected in cows in the weeks pre- and post-calving. The percentage of positive samples at each sampling point (i, ii, iii) is indicated by a red bar. Weeks 
8 and 9 pre-calving and week 2 post-calving have been omitted from this graph as only two samples were collected in each of these week. “C” indicates the day of calving, it was not 
possible to collect a sample from every cow on the day it calved.
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6.4.2.2 Calves 
In total 380 samples were collected, 364 from the initial collection period then 
16 from the same calves at 6 months of age. On average 13 samples were 
collected from each calf (range 5-20, median 13, mode 14). Due to the nature of 
collection it was not possible to collect a sample from each animal every day, 
(Figure 6-5).
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Figure 6-5: Number of samples collected from each calf. 
Faecal samples collected over the study period from 30 dairy calves from birth.  A blue “X” denotes a sample collected on that day while “0” shows that no sample was collected from that 
calf at that particular collection point. The total number of samples collected at each collection point are shown at the bottom of the figure and total number of samples collected from 
each calf are shown in the right-hand column
Calf ID 6 Months Total
2596 0 0 X 0 X 0 X 0 X 0 X X X 0 X 0 0 X 0 X 0 X 0 X 0 X X 0 14
2604 0 0 0 X X 0 0 0 X X 0 X X X X 0 0 0 X X X 0 X X 0 0 0 0 13
2605 0 X 0 X X X X X X X 0 X X X X 0 X 0 X X X 0 X X X X 0 0 20
2606 0 0 X X X 0 X X X 0 X X 0 0 0 X 0 X X X 0 X X X X X 0 X 18
2607 0 0 X X X X X X X 0 X X X X 0 X 0 0 X X 0 0 X X X 0 0 0 17
2608 0 X X X X X X X 0 X X 0 X 0 0 0 X X 0 0 X 0 0 X X 0 X 16
2609 0 0 0 X X X X X 0 X X X X 0 0 0 X X 0 0 X 0 X X 0 0 X 15
2610 X 0 X X 0 X X 0 X X X X 0 0 0 0 0 X 0 0 X X X 0 X 14
2611 0 0 0 X X 0 X X 0 X X 0 X 0 X 0 X X 0 0 X X X X X 0 15
2612 0 0 X 0 X X 0 X 0 X X 0 X 0 0 0 X X 0 0 X 0 0 X 0 X 12
2613 0 0 X X 0 X X 0 X X X X 0 X 0 X X X 0 X 0 0 0 0 0 13
2614 0 0 X X X X 0 X X X 0 0 X 0 X X X 0 X X X 0 X X 16
2615 0 0 X X X X 0 X 0 X 0 0 X 0 X X X 0 X 0 X X 0 X 14
2616 0 0 X 0 X X X X X X X 0 X 0 X 0 X 0 X 0 0 X 0 X 14
2617 0 0 X X X X X X X X X 0 X 0 X X X 0 0 0 X X X X 17
2618 0 0 0 X X X X X X X X 0 X 0 X 0 X 0 X X X 0 0 X 15
2619 0 0 0 X X X X X X X X 0 X 0 0 X X 0 0 0 X 0 0 X 13
2620 0 0 0 0 X X X X X X X 0 X 0 0 0 X 0 X 0 0 X 0 X 12
2621 0 0 X X X X X X 0 X 0 X X X 0 X 0 0 0 0 0 11
2622 0 0 X 0 X X X X 0 0 0 X X 0 0 X X X X X 0 12
2623 0 X 0 X X X X X 0 X 0 X X X 0 X 0 X X X 0 14
2624 0 0 0 X X X X 0 0 0 0 X X 0 0 0 X X X 0 9
2625 0 0 0 X X X X 0 X 0 X X 0 0 0 X X X 0 X 11
2626 0 0 X X X X 0 X 0 X 0 X 0 X 0 X X 0 X 11
2627 0 0 X 0 0 X 0 X X X 0 X X X X 0 X 10
2628 0 0 X 0 0 0 X X X 0 0 X X X 0 0 7
2629 0 0 0 X 0 X X X 0 X X X X X 0 9
2630 0 0 0 0 X X X 0 0 0 X 0 X 0 5
2631 0 0 X 0 X 0 X X X X 0 0 0 0 X 7
2633 0 0 X 0 X 0 X X X X 0 0 0 0 0 6
Total 1 3 18 20 25 23 24 23 18 22 17 17 23 10 10 12 17 12 12 10 12 8 9 9 5 3 1 16 380
Week 7 Week 8 Week 9Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
Calf Age
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All 380 samples were tested for the presence of Cryptosporidium parasite DNA 
using the 18S genus specific PCR and overall percentage of positive samples over 
the whole study was 51.0% (n=194). In the first nine weeks of life each calf 
tested positive for Cryptosporidium on at least 2 occasions, giving a period 
prevalence of 100% and the overall percentage of samples positive in calves <9 
weeks was 51.9% (n=189).  The earliest evidence of oocyst shedding occurred in 
one calf one day after birth, the majority of calves began shedding oocysts at 
day 4 (7 calves) or day 5 (6 calves) after birth. Peak shedding of 
Cryptosporidium oocysts occurred in week two with 95% of calves tested 
shedding oocysts (Figure 6-6). The percentage of positive samples per calf 
ranged from 22.2% to 80.0% although the calf with 80.0% positive samples did 
have fewer samples collected overall (Figure 6-7).
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Figure 6-6: Shedding profile of Cryptosporidium oocysts in calves <9 weeks. 
Percentage of positive samples detected in calves in the first nine weeks of life. The percentage of positive samples at each sampling point (i, ii, iii) is indicated by a red bar. Peak 
shedding of oocysts occurred in week 2 of life and tailed off towards the end of week 8/9.
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Figure 6-7: Positive and negative samples collected from each calf. 
Samples collected from each calf at each time point. A positive sample is denoted by a red “P” while a negative sample is denoted by a blue “N”, “0” indicates that a sample was not 
collected from that calf on that day. The percentage of positive samples at each time point are shown at the bottom of each column while percentage of positive samples from each 
individual is shown in the right-hand column.
Calf ID 6 Months % Positive
2596 0 0 N 0 P 0 N 0 N 0 P N P 0 N 0 0 P 0 N 0 N 0 N 0 N N 0 28.6
2604 0 0 0 P P 0 0 0 P N 0 P P N N 0 0 0 N N N 0 N N 0 0 N 0 35.7
2605 0 N 0 P P P P N N N 0 N P N P 0 P 0 N P N 0 N N N N N 0 38.1
2606 0 0 P P P 0 P P N 0 P P 0 0 0 P 0 N P N 0 N N N N N N 50.0
2607 0 0 N P P P N P N 0 N P N N 0 N 0 0 P N 0 0 P N N 0 0 41.2
2608 0 N P P P P P N 0 P P 0 P 0 0 0 N N 0 0 P 0 0 N N N 56.3
2609 0 0 0 P P P P P 0 P P P N 0 0 0 N P 0 0 N 0 P N 0 P 73.3
2610 N 0 P P 0 N P 0 P N N P 0 0 0 0 0 N 0 0 P N N 0 N 42.9
2611 0 0 0 P P 0 P P 0 N P 0 P 0 N 0 N P 0 0 N N N N N 0 46.7
2612 0 0 P 0 N P 0 P 0 N P 0 P 0 0 0 N N 0 0 N 0 0 N 0 P 50.0
2613 0 0 P P 0 P P 0 P P P N 0 P 0 N P N 0 N 0 0 0 0 0 69.2
2614 0 0 P P P P 0 N P N 0 0 N 0 N P N 0 N P N 0 N N 43.8
2615 0 0 P P P P 0 P 0 N 0 0 N 0 N N N 0 N 0 N N 0 N 35.7
2616 0 0 N 0 P P P N P N P 0 P 0 N 0 N 0 N 0 0 N 0 N 42.9
2617 0 0 P P P P P N P N P 0 P 0 N N N 0 0 0 N N N N 47.1
2618 0 0 0 P P N P P P P N 0 N 0 N 0 N 0 P N N 0 0 P 53.3
2619 0 0 0 P P P P P P P P 0 P 0 0 N N 0 0 0 N 0 0 N 69.2
2620 0 0 0 0 P P P P P P P 0 N 0 0 0 N 0 P 0 0 N 0 P 75.0
2621 0 0 P P P N P P 0 P 0 N N N 0 N 0 0 0 0 0 54.5
2622 0 0 N 0 P P P P 0 0 0 N N 0 0 P P N N N 0 50.0
2623 0 P 0 P P P P P 0 N 0 N P N 0 N 0 N N N 0 50.0
2624 0 0 0 P P P P 0 0 0 0 P N 0 0 0 P N P 0 77.8
2625 0 0 0 P N P P 0 P 0 N P 0 0 0 N P P 0 N 63.6
2626 0 0 N P P P 0 P 0 N 0 N 0 N 0 N P 0 P 54.5
2627 0 0 P 0 0 P 0 P P N 0 P N N N 0 N 50.0
2628 0 0 N 0 0 0 P P N 0 0 P N N 0 0 42.9
2629 0 0 0 N 0 P P N 0 N N N N N 0 22.2
2630 0 0 0 0 P P P 0 0 0 P 0 N 0 80.0
2631 0 0 P 0 P 0 P N N P 0 0 0 0 N 57.1
2633 0 0 P 0 P 0 P N N P 0 0 0 0 0 66.7
% Positive 0.0 33.3 66.7 95.0 92.0 87.0 91.7 65.2 61.1 40.9 70.6 52.9 43.5 10.0 10.0 25.0 35.3 33.3 41.7 20.0 16.7 0.0 22.2 0.0 0.0 0.0 0.0 31.3
Week 7 Week 8 Week 9
Calf Age
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
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6.4.3 Speciation of Cryptosporidium positive samples by nssm-
PCR 
All Cryptosporidium positive samples were speciated using a nssm-PCR described 
in section 2.6.2. 
6.4.3.1 Adults 
Of the 57 Cryptosporidium positive samples from the adult cattle, 91.2% (n=52) 
of the samples were identified as C. parvum, 3.5% (n=2) as a mixed infection of 
C. parvum and C. ryanae, 1.75% (n=1) as a mixed infection of C. ryanae and C. 
bovis, 1.75% (n=1) as a mixed infection of C. parvum and C. andersoni and 1.75% 
(n=1) as a mixed infection of C. parvum, C. ryanae and C. bovis (Figure 6-8). 
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Figure 6-8: Species detected in individual cows.  
Percentage of different species detected in positive samples from each individual cow. C. parvum was the most frequently detected species in these samples. Four of the cows produced 
no Cryptosporidium positive samples. 
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To confirm the results of the nssm-PCR a selection of samples (n=19) were sent 
for sequencing by GATC (see section 2.7), 12 of these failed sequencing 
(unreadable trace files) the remaining 7 matched the result of the nssm-PCR. 
6.4.3.2 Calves 
All Cryptosporidium positive samples were speciated using the nssm-PCR 
described in section 2.6.2. All positive samples from calves <9 weeks were C. 
parvum positive. Of the five positive samples from the calves at 6 months old, 
20% (n=1) were C. parvum positive and 80% (n=4) were mixed infections of C. 
parvum and C. bovis. 
6.4.4 Subtyping of C. parvum by gp60 PCR 
To determine the gp60 subtypes of the C. parvum positive samples collected 
from both adult cattle and calves a subset of samples were amplified using the 
gp60 nested PCR described in section 2.6.3 and sequenced as described in 
section 2.7. 
6.4.4.1 Adults 
A small selection (n=32) of C. parvum positive samples were subjected to a 
nested PCR to amplify a fragment of the gp60 gene. Fifteen of these failed to 
amplify in the PCR. The remaining seventeen were positive and were sequenced 
successfully. Four different gp60 subtypes were identified; these were IIaA15G2 
(n=2), IIaA15G2R1 (n=11), IIaA18G2R1 (n=3) and IIaA19G2R1 (n=1). 
6.4.4.2 Calves 
A larger selection of C. parvum positive samples (n=106) from calves were 
further analysed using the gp60 nested PCR, 12 of these failed to amplify. Of the 
89 which were amplified successfully, 83 of these were sent for sequencing. 
Eighty of these returned good trace sequences and two subtypes were identified 
IIaA19G2R1 (n=75) in the samples from animals <9 weeks of age and IIaA15G2R1 
(n=5) in samples from the same animals at 6 months of age (Table 6-3). 
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Table 6-3: gp60 subtypes detected in calves at different ages. 
Calf ID < 1 Weeks 2-4 Weeks 5-8 Weeks 6 Months 
2604 IIaA19G2R1 IIaA19G2R1   
2609  IIaA19G2R1 IIaA19G2R1 IIAa15G2R1 
2612 IIaA19G2R1   IIAa15G2R1 
2613 IIaA19G2R1 IIaA19G2R1 IIaA19G2R1  
2617 IIaA19G2R1 IIaA19G2R1 IIaA19G2R1  
2619  IIaA19G2R1  IIaA15G2R1 
2620  IIaA19G2R1  IIaA15G2R1 
2626  IIaA19G2R1  IIaA15G2R1 
2633 IIaA19G2R1 IIaA19G2R1   
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6.5 Discussion 
6.5.1 Adults 
In adult cattle the reported prevalence of Cryptosporidium varies markedly 
between studies (0-71%) (Table 6-4), the most likely reason for this variation is 
the differing sensitivities of the techniques used to sample and test the faeces. 
The new and improved techniques developed in this study enabled detection of 
lower numbers of Cryptosporidium oocysts in faeces collected from adult cattle 
than other methods. Using these techniques it was possible to detect as few as 5 
oocysts per gram of faeces which is more sensitive than other methods such as 
acid fast staining (1000 opg), fluorescent staining (66 opg), although not as 
sensitive as the gold-standard qPCR which can detect as little as 40 fg of DNA 
(one oocyst) (Hadfield et al., 2011). The increased sensitivity with this method is 
probably due to a combination of the larger starting sample (50 g) combined 
with the two methods of concentrating the oocysts. The acid flocculation step 
removes the majority of fibrous material from the faeces and when followed 
with salt flotation there is very little debris left in the final pellet. This reduces 
the amount of inhibitors present in the pellet for DNA extraction and PCR. In this 
study the samples from the adult cattle were tested by both acid flocculation 
followed by DNA extraction, and acid flocculation and salt flotation followed by 
DNA extraction. Using the acid flocculation 5.4% (n=11) samples tested positive 
compared with 26.8% (n=55) when using both acid flocculation and salt flotation. 
This indicates that the initial acid flocculation concentration step is not enough 
to increase the chances of detecting oocysts.
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Table 6-4: Summary of studies carried out investigating Cryptosporidium in adult cattle. 
Table shows the studies carried out to determine prevalence and species of Cryptosporidium in adult cattle. The number of animals and samples, methods and results are summarised. 
Author(s) Year 
Number 
of 
Animals 
Number of 
Samples 
Methods Used 
%age 
Positive 
Species 
(Villacorta et al.) 1991 131 131 Microscopy (Heine’s Technique) 1.4% C. parvum (n=2) 
(Castro-Hermida 
et al.) 
2006 63 63 Microscopy (Heine’s Technique) 8% No Speciation 
(Gow and 
Waldner) 
2006 560 560 Sucrose flotation, Microscopy (DFA) 1% No Speciation 
(Singh et al.) 2006 67 67 Sucrose flotation, Microscopy (mZN) 13.4% No Speciation 
(Lorenzo Lorenzo 
et al.) 
1993 131 131 Microscopy (Heine’s Technique) 71.8%  
C. muris* (n=2) 
C. parvum (n=92) 
(Scott et al.) 1995 553 553 
Two smears of each sample, Microscopy (mZN and 
FITC to confirm) 
50x 5g samples - sucrose flotation, Microscopy (mZN) 
62.4% C. parvum (n=345) 
(Quilez et al.) 1996 225 225 Formalin-ethyl acetate sedimentation, Microscopy (mZN) 17.8%  C. parvum (n=40) 
(Bukhari and 
Smith)  
1996 109  109 Water-ether sedimentation, Microscopy (FITC, DAPI) 23.0%  
C. parvum (n=21) 
C. muris* (n=4) 
(Esteban and 
Anderson) 
1995 
Not 
Reported 
1746 Microscopy (mZN) 8.0% C. muris* 
(Esteban & 
Anderson) 
1996 1240
†
 1240 Microscopy (mZN) 0.6-2.6% C. muris* 
(Atwill et al.) 1998 154 384 
Direct fluorescent antibody (DFA) and acid-fast (AF) 
assays 
0.0% N/A 
(Kaneta and 
Nakai) 
1998 512  512 
Sucrose flotation, Microscopy (modified Kinyoun acid 
fast staining), Mouse Bioassay 
4.7%  C. muris* (n=24) 
(Atwill et al.) 1999 484 484 Immunofluorescent Microscopy 0.6%  C. parvum 
(Ares-Mazas) 1999 41 41 Immunofluorescent Microscopy 0.0%  N/A 
(Faubert and 
Litvinsky) 
2000 148 
Not 
Reported 
500g samples, Sucrose flotation, Microscopy (ZN) 
Not 
Reported 
Not Reported 
(Fayer et al.) 2000 184 184 
10g faecal sample, Filtered, Caesium Chloride Flotation, 
Fluorescence Microscopy 
22.3% 
C. parvum (n=38) 
C. andersoni (n=3) 
(Wade et al.) 2000 998 998 
1g Faecal Samples, Sucrose Flotation, Microscopy 
(bright field and phase contrast) 
1.5% C. muris* (n=15) 
(Enemark et al.) 
 
2002 117  117 
Smears, Microscopy (mZN, FITC), one sample was 
speciated by PCR-RFLP, Mouse Bioassay 
40.2% 
C. parvum (n=12) 
C. andersoni (n=27) 
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C. parvum & C. andersoni (n=8) 
(Atwill and 
Pereira) 
2003 43  86 2g faecal sample, Microscopy (IMS–DFA)  0.0% N/A 
(Kvac and 
Vitovec)  
2003 96  96 
Sucrose Flotation, Microscopy (light), PCR (18S), 
Sequencing 
43.8%  C. andersoni (n=42) 
(Sturdee et al.) 2003 736 736 
Modified Formal-Ether Sedimentation, Microscopy 
(FITC, mZN) 
3.5% C. parvum (n=26) 
(McAllister et al.) 2005 669 669 
2-3g faeces, Filtered through sponge, Sucrose Flotation, 
Microscopy (FITC) 
29.0% 
C. parvum 
C. muris* 
(Fayer et al.) 2006 571 571 
15g Faecal Sample, Filtered, Caesium Chloride 
Flotation, PCR (18S), Sequencing 
11.9% 
C. suis (n=1) 
C. parvum (n=4) 
Deer-like genotype
‡
 (n=10) 
C. bovis (n=24) 
C. andersoni (n=29) 
(Fayer et al., 2007) 2007 514  514 
15g Faecal Sample, Filtered, Caesium Chloride 
Flotation, PCR (18S), Sequencing 
5.7% 
C. parvum (n=2) 
C. bovis (n=9) 
C. andersoni (n=20) 
(Santin et al., 
2008) 
2008 30 360 
15g Faecal Sample, Filtered, Caesium Chloride 
Flotation, Microscopy (IFA), PCR (18S), Sequencing 
2.2%  
Deer-like genotype
‡
 (n=3) 
C. andersoni (n=2) 
(Ralston et al., 
2010) 
2010 567  567 
1-5g Faecal Sample, Filtered, Sucrose Flotation, 
Microscopy (FITC), PCR (18S), Sequencing 
3.5%  C. andersoni (n=20) 
(Wang et al.) 2011 295 295 
20g Faecal Sample, Sucrose Flotation, Microscopy 
(bright field), PCR (18S), Sequencing 
1.0%  C. andersoni (n=3) 
(De Waele et al.) 2012 42 126 2g Faecal Sample, Filtered, Centrifuged, qPCR,  33.3% 
C. parvum (n=6) 
C. bovis (n=2) 
C. andersoni (n=2) 
(Silverlas and 
Blanco-Penedo) 
2013 259 259 
1g Faecal Sample, Sodium Chloride flotation, 
Microscopy (Fluorescence), PCR (18S & GP60) 
3.5% C. parvum (n=9)
§
 
(Smith et al.) 2014 2669  2669 
10g Faecal Sample, Microscopy (IFAT), PCR (RFLP, 
GP60), Sequencing 
1.9%  C. andersoni (n=36) 
* Now recognised as C. andersoni 
† From 5 different herds – no indication is given of the number of cows from each herd 
‡ Now recognised as C. ryanae  
§ 
Reported in paper as C. parvum-like but the single sample which was sequenced was identified as C. bovis 
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It has been reported that the most common species of Cryptosporidium to be 
detected in adult cattle is C. andersoni (Fayer et al., 2010a; Feng et al., 2007; 
Santin et al., 2008; Xiao, 2010). This species is only rarely detected in pre-
weaned animals (Amer et al., 2010a; Kvac et al., 2011; Wang et al., 2011b) 
indicating that adult cattle are not a risk for infection for neonatal calves or that 
C. andersoni is not infective to neonatal calves. Some studies have reported a 
higher prevalence of C. andersoni in young calves, between 11.1-92.9% in calves 
<35 weeks old on a farm in Bohemia, Czech Republic (Kvac and Vitovec, 2003) 
and in China C. andersoni was found to be the most prevalent species in calves 
aged 3-11 months (8.70% of samples were C. andersoni positive and 2.6% C. 
bovis) (Wang et al., 2011a). Some studies investigating the risk factors 
associated with cryptosporidiosis in young calves found that calves kept for <72 h 
with their mothers increased the risk that the calf would suffer from 
cryptosporidiosis (Quigley, III et al., 1994). Other studies reported the opposite 
and show that being kept with their dams decreased the likelihood that calves 
would suffer from cryptosporidiosis (Duranti et al., 2009; Kvac et al., 2006). 
Most of these risk factor studies did not speciate or subtype the parasites 
detected in the dams, if, in fact, they even tested the adults for the presence 
Cryptosporidium. Although the present study was not looking at risk factors it 
did determine the species and subtypes of Cryptosporidium being shed by adult 
cattle and their offspring. We found that the predominant species of 
Cryptosporidium shed by adult cattle on this farm was C. parvum. This is 
unusual though C. parvum has been previously reported in adult cattle (Table 
6-4). In this study 98.2% (n=56) of the positive samples (n=57) were identified as 
C. parvum, either as a single species or in conjunction with other species. This is 
a more unusual result when compared with other studies investigating species in 
adults as most studies show either a low percentage of samples (<20%) from 
adult cattle are C. parvum (Atwill et al., 1999a; De Waele et al., 2012; Enemark 
et al., 2002; Fayer et al., 2007; Fayer et al., 2006; Quilez et al., 1996; Silverlas 
and Blanco-Penedo, 2013; Sturdee et al., 2003; Villacorta et al., 1991) or that 
only a small number of adult cattle (<20%) are positive for any species of 
Cryptosporidium (Atwill et al., 1999a; Atwill and Pereira, 2003; Bukhari and 
Smith, 1996; Esteban and Anderson, 1995; Kaneta and Nakai, 1998; Quilez et al., 
1996; Ralston et al., 2010; Santin et al., 2008; Silverlas and Blanco-Penedo, 
2013; Smith et al., 2014; Sturdee et al., 2003; Wang et al., 2011a). Very few 
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studies show a higher percentage of positive samples from adult cattle (Enemark 
et al., 2002; Kvac and Vitovec, 2003; Lorenzo Lorenzo et al., 1993; Scott et al., 
1995). The results from the present study sit somewhere in the middle at ~30% 
positive samples. This study was a longitudinal study and it should be noted that 
if a point prevalence study had been carried out on the same cattle then the 
percentage of positive samples would have ranged from 19.0% to 66.7% 
depending on the sampling day. This highlights the underestimation in parasite 
burden when looking at a single time point.  
In this study 86.2% (n=25) of the cows were positive for Cryptosporidium at some 
point throughout the sampling period, again if this had been a point prevalence 
study a huge underestimation in the percentage of positive animals (0-50%) may 
have been made. In adult cattle, unlike calves, the prevalence of 
Cryptosporidium seems to vary hugely making it difficult or impossible to apply 
findings from one study to another. Even within one country or region the results 
from each study differ. The variation in results may be due to different 
sensitivities of the techniques used and highlights the need for standardised 
methodologies for detection of Cryptosporidium in adult cattle faeces. 
From the results of this study when just taking into account the species of 
Cryptosporidium detected in both the adults and the calves the conclusion may 
be reached that adult cattle were in fact the source of infection for calves. The 
majority of positive samples (98.2% (n=56)) from adults were either C. parvum or 
C. parvum mixed infections as were all positive samples from calves <9 weeks. In 
previous studies this is the conclusion that many have made, several of these 
studies were carried out before we had the knowledge and ability to determine 
subtypes of these parasites or even before some common species of cattle 
adapted Cryptosporidium had been characterised (Faubert and Litvinsky, 2000; 
Scott et al., 1995). In this study a single subtype (IIaA19G2R1) was detected in 
all tested calf samples (n=75) from calves <9 weeks old and four different 
subtypes (IIaA15G2, IIaA15G2R1, IIaA18G2R1, IIaA19G2R1) were identified in the 
adults. The most common subtype in the adult cattle was IIaA15G2R1 which was 
identified in 11 samples from nine cows, this is also the subtype which has been 
identified in six month old calves in this, and a previous study on the same farm 
(Chapter 5). This subtype is the most common gp60 subtype identified worldwide 
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in both animal and human hosts (Broglia et al., 2008; Imre and Darabus, 2011). 
The other subtypes were identified in fewer samples, IIaA15G2 in two samples 
from two cows, IIaA18G2R1 in three samples from three cows and finally 
IIaA19G2R1 in a single sample from one cow which was also the most common 
subtype in calves <9 weeks of age. 
One explanation for the single subtype in the young calves is that the one cow 
which shed IIaA19G2R1 calved early on in the calving season (Figure 6-9). This 
meant that this subtype was one of the first in the calving shed and could have 
been picked up by naïve calves. Once a calf is infected with Cryptosporidium it 
amplifies rapidly in the gut (Borowski et al., 2010) and the infected calf can 
then shed many infective oocysts into the environment where other calves can 
pick them up and become infected themselves (Nydam et al., 2001). The 
amplification rate and shedding of huge numbers of oocysts increases the 
likelihood that other calves will become infected with this subtype rather than 
another. It is also possible that some calves were infected with more than one 
subtype but that the calf gut preferentially amplifies one subtype over another 
or that the techniques used in this study were not sensitive enough to detect 
another subtype which may be present at a lower level. This is a recognised 
issue with Sanger sequencing and some researchers are now moving towards a 
Next Generation Sequencing (NGS) or Multi-Locus Genotyping (MLG) approach. 
One study which used NGS to study intra-host genetic diversity of C. parvum 
identified 10 different gp60 alleles in samples which Sanger sequencing had 
identified only one (Grinberg et al., 2013). In the present study samples from 
five cows were tested twice and three of these cows were shedding different 
gp60 subtypes at each sample point, the remaining two cows shed the same 
subtype each time. This demonstrates that testing animals once does not give a 
true and clear picture and also that cattle (and other hosts) are likely to be 
infected with, or shedding, multiple Cryptosporidium species and subtypes at 
any one time. 
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Figure 6-9: Diagrammatic representation of cows calving dates and C. parvum subtypes they shed. 
Each individual cow is represented by a cow figure and each gp60 subtype detected is represented by a colour. This diagram represents the subtypes identified in the cows throughout 
the study, the sample collected at calving may not have been tested. 
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6.5.2 Calves 
6.5.2.1 Comparison with previous calf study 
This study was carried out on the same study farm as the study described in 
Chapter 5. Overall the study design was similar in that a group of calves were 
sampled and tested for Cryptosporidium on a regular basis from birth. The first 
study (Chapter 5) was carried out between December 2011 and January 2012 and 
this study approximately a year later from November 2012 until February 2013. 
The percentage of positive samples in each age group of calves was lower in the 
second study (Figure 6-10). Generally shedding followed a similar pattern, but 
with a slightly earlier peak in shedding at week 2 in the second study before 
tailing off towards the end of week 5. In this study where animals were followed 
for longer, until 9 weeks of life compared with 6 weeks of life in the first study, 
there was a secondary peak in positive samples at week 7 (not shown). In both 
studies the same animals were sampled at 6 months of age, a similar pattern 
occurs here with the percentage of positive samples in the second study being 
lower than the percentage in the first study. The overall percentage of positive 
samples was lower in study two (mean 37.6%) compared to study one (mean 
62.9%).  
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Figure 6-10: Comparison between studies. 
Throughout the whole study the prevalence of Cryptosporidium was lower in study two compared with study 
one. The blue bars represent the percentage of positive samples each collection day from calves in study 1 
and the orange bars represent the percentage of positive samples collected from calves in study two on each 
collection day. 
 
Only C. parvum was detected in calves in this study whereas C. bovis, C. ryanae 
and mixed infections of C. parvum and C. bovis and C. ryanae and C. bovis were 
seen in study one from week three onwards. It is likely that other species or 
mixed infections were present in study two but that they were missed by both 
the nssm-PCR and sequencing analysis. As stated previously one failing of PCR 
amplification when mixed species are present is that the predominant species is 
often preferentially amplified. Although the nssm-PCR is very effective for 
detecting mixed infections it is possible that any mixed infections were below 
the level of detection for this method.  
In both studies similar results were found when animals were aged 6 months. In 
the first study C. parvum, C. bovis and one mixed infection of C. bovis and C. 
ryanae were detected and in the second study C. parvum and C. parvum and C. 
bovis mixed infections. It is fairly unusual to detect C. parvum in older calves 
but in both studies on this farm C. parvum has been the predominant species 
detected in calves of this age group. Seventy percent (n=7) of the positive 
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samples for 6 month old calves were C. parvum in study one and all positive 
samples were C. parvum positive in study two (80% (n=4) mixed with C. bovis). 
In both studies a number of samples were subtyped at the gp60 locus (n=30, 
study one and n=106, study two) and findings from both studies were similar. All 
samples tested from calves <9 weeks of age were IIaA19G2R1 and all samples 
tested from calves 6 months of age were IIaA15G2R1. These results confirm that, 
on this farm, there are at least two distinct C. parvum populations which infect 
cattle at different times throughout their lives. It is not known if these different 
subtypes are present in the different age groups as a result of: a local 
geographical distribution of subtypes on the farm; if something changes in the 
animal gut to enable the secondary subtype to establish; if the secondary 
subtype is always present in the animal but at low levels (which the detection 
methods used here cannot detect) or whether the secondary subtype is, in fact, 
another species all together. Many of the Cryptosporidium species are very 
similar and only vary genetically by one or two base-pairs at a single locus. Some 
examples of this would be the two very closely related (genetically 98.50 – 
99.70% at certain loci) species which infect humans; C. parvum, C. hominis but 
which differ in their epidemiology (Morgan and Thompson, 1999; Morgan-Ryan et 
al., 2002; Sulaiman et al., 2000). In livestock the species C. bovis and C. xiaoi 
are genetically very similar but one is predominantly found in cattle (C. bovis) 
while the other infects sheep (C. xiaoi) (Fayer and Santin, 2009; Fayer et al., 
2005).  
 
 
 
 
 
170 
 
 
6.6 Conclusion 
This study shows that contrary to popular belief adult cattle are a potential 
source of Cryptosporidium infection in calves. Calves are in close contact with 
faeces from their mother directly at birth. It is very likely that the infection in 
calves on this farm came from this source as calves show signs of infection and 
shed oocysts very soon after birth (as few as one day following birth). Further 
subtyping which was carried out on faecal samples from both calves and dams 
showed evidence that multiple subtypes of C. parvum may be present on a single 
farm and that these different subtypes may have different clinical 
manifestations, this is important from both an animal and public health 
perspective. Although only one adult cow was shown to shed the C. parvum 
subtype which commonly infected calves it is possible that the neonatal calf gut 
preferentially amplified one subtype over another and therefore the oocysts 
shed are predominantly the dominant subtype. 
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Chapter 7: General Discussion 
The protozoan parasite Cryptosporidium is a common cause of diarrhoea in both 
human and animal hosts. In livestock hosts the disease caused by 
Cryptosporidium has been associated with reduced weight gain in infected 
animals (Ralston et al., 2010; Sweeny et al., 2011b) as well as mortality 
(Blanchard, 2012; Featherstone et al., 2010; Pritchard et al., 2008). There are 
many different species and genotypes of the parasite (~27 species and >60 
genotypes currently recognised) which infect different host species (Chalmers 
and Katzer, 2013; Fayer, 2010). Some of the species and genotypes are believed 
to be host specific while others can infect several host species (Fayer, 2010; 
Ryan et al., 2014). In farm livestock (sheep and cattle) one of the most common 
causes of neonatal enteritis is C. parvum (de Graaf et al., 1999; Mosier and 
Oberst, 2000), this species of Cryptosporidium is also zoonotic and is responsible 
for ~50% of human cases of cryptosporidiosis in the UK (Chalmers et al., 2009a). 
Unlike several other pathogens associated with neonatal enteritis in sheep and 
cattle there is no available vaccine to prevent disease caused by C. parvum and 
treatment options are extremely limited and generally rely on rehydration 
therapy.  
As previously discussed (Chapter 1), cattle may be infected with four different 
species of Cryptosporidium (C. andersoni, C. ryanae, C. bovis and C. parvum), 
infection with these species tends to follow an age-related distribution with 
young calves being infected with C. parvum, older calves with C. bovis and C. 
ryanae and adult cattle with C. andersoni (Fayer et al., 2007; Fayer et al., 2006; 
Santin et al., 2008; Santin et al., 2004). To date C. bovis and C. ryanae have not 
been associated with clinical disease (Fayer et al., 2008; Fayer et al., 2005) and 
C. andersoni has been associated with mild clinical disease (reduction in milk 
yield and weight-loss) (Kvac and Vitovec, 2003; Ralston et al., 2010). 
Morphologically these species look very similar, C. andersoni is slightly larger 
and more ovoid than the other three species (Fayer, 2010) which can make 
diagnosis and species identification difficult when relying on microscopy alone. 
More advanced methods for species identification generally involve sequence 
analysis of gene fragments or PCR-RFLP (as discussed in Chapter 1) these 
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methods can be costly and time consuming and it is also difficult or impossible 
to identify mixed infections. 
The development of immunity to Cryptosporidium is poorly understood, it is 
known that humans and animal hosts can be infected with Cryptosporidium more 
than once demonstrating that the immune response to infection is not 
particularly strong or long lasting (Okhuysen et al., 1998). Many of the studies 
into development of immunity and immune responses to Cryptosporidium 
infection have been carried out in murine models. This has given a basic 
understanding into the possible factors which might play a role in the immune 
response. However the immune responses in an inbred model may not always be 
applicable to outbred populations such as humans and livestock hosts. We know 
that in certain livestock species it appears that as the animals increase in age 
they become less susceptible to disease (Harp et al., 1990; Kvac et al., 2014; 
Ortega-Mora and Wright, 1994), it is also known that prior infection can reduce 
the signs of clinical disease but asymptomatic infection (oocyst shedding) can 
still occur (Current and Snyder, 1988; Harp et al., 1990; Miller et al., 1990; 
Ortega-Mora and Wright, 1994). This demonstrates that previous exposure does 
not provide compete immunity to Cryptosporidium but that some level of 
protection does occur. It is not known if this partial protection can provide 
protection to infection with another Cryptosporidium species or isolate or if the 
protection is species specific.  
The main aims of this PhD were to: assess the development of host resistance to 
C. parvum in experimentally infected lambs; develop a new typing tool to 
enable easy differentiation of the Cryptosporidium species commonly found in 
cattle; to determine which species and genotypes of Cryptosporidium calves 
became infected with in the first year of life and finally, to assess the role that 
adult cattle play in the transmission of Cryptosporidium (specifically C. 
parvum). 
These aims were all achieved with a variety of studies including experimental 
infections, longitudinal studies and molecular tool design. 
A novel technique (Chapter 4) for detection and differentiation of 
Cryptosporidium species commonly found in cattle (C. andersoni, C. ryanae, C. 
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parvum and C. bovis) was developed as part of this PhD. This enabled in-depth 
detailed longitudinal on farm studies to be carried out to investigate the 
transmission and persistence of Cryptosporidium in young calves and adult 
cattle. The nssm-PCR technique was used extensively throughout this PhD to 
identify the species of Cryptosporidium being shed in the faeces of naturally 
infected cattle. 
The longitudinal study described in Chapter 5 (Cryptosporidium species and 
genotypes found in calves from birth to one year) and the longitudinal study 
described in Chapter 6 (Transmission of Cryptosporidium from dam to calf) 
confirmed that young calves (<9 weeks) are most commonly infected with C. 
parvum which supports the results of many other studies carried out worldwide 
(Abu et al., 2013; Amer et al., 2010b; Broglia et al., 2008; Diaz et al., 2010; 
Follet et al., 2011; Geurden et al., 2007; Huetink et al., 2001; Kvac et al., 2006; 
Lefay et al., 2000; Rieux et al., 2013; Santin et al., 2004; Silverlas and Blanco-
Penedo, 2013; Thompson et al., 2007). The results of Chapter 5 also showed that 
neonatal calves become infected with Cryptosporidium at a very young age, 
almost immediately at birth, with some calves shedding oocysts at only 2 days of 
age. This suggested that adult cattle may be the source of infection for newborn 
calves and lead to the study described in Chapter 6. 
The results of both longitudinal studies (Chapters 5 & 6) showed that all calves 
<9 weeks old on the study farm became infected with C. parvum within 2 weeks 
of life. Infection with C. parvum caused severe diarrhoea, inappetence and 
lethargy in several of the affected animals, others suffered from mild disease 
only and some animals showed only asymptomatic shedding of oocysts. Shedding 
of C. parvum oocysts occurred for at least 7 weeks PI with peaks in oocysts 
shedding at 2-3 weeks of age and again at 7 weeks of age (Chapter 5). Clinical 
signs tended to occur in animals <4 weeks of age and by 6/7 weeks of age many 
of the infected animals showed no signs of clinical infection though they were 
still shedding oocysts. In both studies any calves which were still present on the 
farm at 6 months of age were sampled and their faeces tested again. The results 
showed that the majority of calves in Chapter 5 (62%) and 32% of calves in 
Chapter 6 were positive for Cryptosporidium and that the most common species 
detected was C. parvum. As discussed previously, this is unusual as it is 
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generally expected that after initial exposure to the parasite, at a young age, 
cattle will develop immunity to infection. None of the 6 month old calves were 
showing any clinical disease at the time of sampling. Subtyping results revealed 
that the subtype of C. parvum identified in the young calves in both studies was 
IIaA19G2R1 which is an uncommon subtype identified in cattle only a small 
number of times previously (Couto et al., 2013; Ng et al., 2012; Wielinga et al., 
2008; Xiao et al., 2007) while the subtype identified in faeces from 6 month old 
calves was the “common” subtype IIaA15G2R1 (Broglia et al., 2008; Imre and 
Darabus, 2011). Perhaps it is possible for cattle to develop immunity to one 
subtype of C. parvum following infection but this immunity may not necessarily 
protect against further infections with a different subtype. This possibility was 
tested in the experimental trial described in Chapter 3. 
Following the results of Chapter 5 where it was shown that calves can become 
infected with Cryptosporidium almost immediately at birth the second 
longitudinal study (Chapter 6) focused on the possible transmission of C. parvum 
from dam to calf. Previous studies investigating Cryptosporidium infection in 
adult cattle reported that adult cattle were not believed to be a potential 
source from which young calves became infected (Atwill and Pereira, 2003; De 
Waele et al., 2012; Sturdee et al., 2003) although there are two studies which 
disputed these results (Faubert and Litvinsky, 2000; Kvac et al., 2011). These 
studies found that adult cattle either shed a species other than C. parvum or 
that they shed such low numbers of oocysts that the authors believed that they 
were not a significant risk. It is likely that the apparent low levels of 
Cryptosporidium found in adult cattle in previous studies (Table 6-4) could be 
due to the limitations of the detection methods applied or the number of 
samples taken. It is known that oocyst shedding and production is not a 
continuous process and that by taking only a single sample from any individual 
the overall percentage positivity is underestimated. In previous studies 
microscopy (with a variety of different staining techniques) was a commonly 
used method to detect Cryptosporidium oocysts. Microscopy is generally a much 
less sensitive method for the detection of oocysts compared with PCR or qPCR 
(Chalmers et al., 2011). Only a few of the studies (n=9) used either PCR or qPCR 
to detect Cryptosporidium in adult cattle faeces and many of the studies did not 
use any prior concentration step before examining the faeces. Faeces from adult 
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cattle are very different to faeces from young milk fed animals. Faeces from 
adult animals contain a large amount of fibrous materials and the volume 
produced is also much greater (~43.1 kg faeces per cow per day) (Weiss, 2015) 
and so the oocysts may be harder to detect without a concentration step. In the 
study described in this PhD (Chapter 6) an optimised technique was developed 
for the concentration and extraction of oocysts from adult cattle faeces which 
involved an acid flocculation and salt flotation steps (Wells et al., 2015 (to be 
submitted)).  
 In this study (Chapter 6) a group of in-calf cattle were sampled 3 × per week 
from 10 weeks pre-calving until calving (increasing the number of samples 
collected from each cow) and then the calves born to these cows were sampled 
3 × per week for 6-10 weeks. We found that over 80% of the adult cattle involved 
in this study were shedding Cryptosporidium oocysts in their faeces, the 
majority of positive samples (98.2% (n=56)) were identified as C. parvum using 
the nssm-PCR described in Chapter 4. This finding is unusual as most studies 
investigating Cryptosporidium in adult cattle find only low numbers of positive 
samples, or animals and the species most commonly detected is C. andersoni not 
C. parvum. This is likely to be due to the additional concentration step 
employed during this study. 
Subtyping results of C. parvum positive samples from adult cattle showed 
evidence of four different C. parvum gp60 subtypes within this farm. One of the 
subtypes was IIaA19G2R1 which was the only subtype identified in young (<9 
week old) calves and another (IIaA15G2R1) which was the only subtype found in 
older (6 months) calves, these and a further two subtypes (IIaA15G2 and 
IIaA18G2R1) were also detected in adult cattle on this farm. This age-related 
distribution of C. parvum subtypes in calves on this farm is very interesting; 
similar results were found in two separate studies in subsequent years on this 
farm indicating that this age-related distribution of C. parvum subtypes occurs 
frequently on this farm. From other work carried out on this particular farm it is 
known that the IIaA19G2R1 C. parvum subtype has been present and stable since 
at least 2008 (Gait et al., 2008). None of the other subtypes have been 
previously detected although other studies have only examined young calves. 
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As discussed in Chapters 5 & 6 there are several reasons for this apparent 
distribution of isolates including the possibility that the C. parvum isolate 
detected in 6 month old animals is another species of Cryptosporidium. To 
confirm this it would be necessary to carry out further typing of different loci 
such as actin, HSP70 and COWP or microsatellite analysis (Hotchkiss et al, 2015 
(to be submitted)). Many species of Cryptosporidium are very similar to each 
other at one locus but different at others. Attempts were made to amplify DNA 
from the parasites from both calves and adults at different loci but these 
attempts were unsuccessful.  
Another reason for the difference in isolates found in calves of different age 
groups on this farm could be related to changes in the host themselves. It has 
been reported in previous experimental studies that some host species (pigs and 
chickens) become more susceptible to certain Cryptosporidium species as they 
increase in age. The authors of these papers (Kvac et al., 2014; Lindsay et al., 
1988; Yui et al., 2014) have suggested that this may be due to physiological 
changes in the gut or the gut flora of the host. It could be that the different 
isolate found in older cattle is somehow better adapted to replicate in the gut 
conditions of a fully mature bovine than in the undeveloped gut of a neonatal 
animal. Other studies examining the subtypes of C. parvum in different age 
groups of cattle on the same farms also found that adult cattle may be carrying 
different subtypes compared to their calves (Wells et al., 2015) indicating that 
adult cattle may not be an important source of infection for young calves. 
Future work would expand on the findings from these studies and investigate 
further the possible transmission of Cryptosporidium from dam to calf using 
multiple farms (beef and dairy) with a known history of cryptosporidiosis. Groups 
of in-calf cows would be sampled regularly, daily if possible, to maximise the 
number of samples collected. In the study carried out here sample collection 
occurred 3 × per week but it is not possible to guarantee a faecal sample from 
each cow at each sampling time. More regular sampling would increase the 
chances of collecting sufficient numbers of samples from each cow to allow a 
more complete picture of the shedding dynamics in adult cattle to be formed. In 
addition to the techniques used in the study described in this thesis it would be 
beneficial to use a qPCR to quantify the shedding by adult cattle to determine if 
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shedding of oocysts increases in the approach to calving as suggested by studies 
on other livestock species (Atwill et al., 1998; Ortega-Mora et al., 1999; Xiao et 
al., 1994; Ye et al., 2013). This more in-depth approach would give us a more 
detailed insight into the persistence of the parasite on farms and within animals 
of differing ages.  
Relatively little is understood about the possible differences between subtypes 
of the same Cryptosporidium species. It is known that different subtypes of the 
same species can vary in their clinical manifestation in infected individuals with 
some causing more severe disease than others. Some subtypes of C. hominis (the 
human adapted species of Cryptosporidium) cause vomiting and diarrhoea in 
infected people whereas other subtypes cause only diarrhoea (Cama et al., 2008; 
Cama et al., 2007). It has also been reported that some C. parvum isolates 
appear to be more common in humans (Alves et al., 2003; Cama et al., 2008; 
Hijjawi et al., 2010) whereas others more commonly infect cattle, sheep or 
goats (Quilez et al., 2008a; Quilez et al., 2008b). It is not known if these isolates 
can infect other host species or whether they are host-adapted as experimental 
studies to test this have not been carried out. It does however, demonstrate that 
even within a  species of Cryptosporidium, different subtypes can behave 
differently in different host species. In this thesis a large scale experimental 
trial was carried out to assess the development of host resistance to distinct C. 
parvum isolates as both homologous and heterologous challenges were 
performed. Both isolates were known to cause clinical disease in naturally 
infected calves from two dairy farms in Scotland. The results of this study 
showed that distinct isolates of C. parvum can have different clinical 
manifestations in infected individuals even when those individuals have received 
an identical infective dose. The study also demonstrated that host factors play a 
role in the severity of disease and oocyst shedding as even within groups when 
animals received the same infective dose of the same isolate there was variation 
in the outcome of disease with some individuals experiencing more severe or 
prolonged diarrhoea or increased shedding of oocysts compared to others in the 
same group. This variation in response has been noted in several other 
experimental trials involving Cryptosporidium and other pathogens (Chappell et 
al., 1996; Chappell et al., 1999; DuPont et al., 1995; Harp et al., 1990; Moore et 
al., 2003; Okhuysen et al., 1999; Ortega-Mora and Wright, 1994; Petry et al., 
178 
 
 
1995). Although it is clear that there is a difference in the 
virulence/pathogenicity of isolates there are also host factors which should be 
investigated further.  
In the experimental infection study the results showed that while lambs do not 
develop complete resistance to disease by 6 weeks of age they do become less 
susceptible to clinical infection. If lambs are naïve to Cryptosporidium and are 
infected for the first time at 6 weeks of age then they show significantly fewer 
clinical signs than when lambs are infected at <1 week of age. Another study 
carried out in 1994, which was similar, demonstrated that lambs become 
resistant to disease at 8 weeks of age. The lambs in that trial showed no signs of 
clinical disease though some did shed oocysts when infected at 8 weeks of age. 
In the trial described in Chapter 3 it was shown that while older lambs exhibited 
fewer clinical signs of disease than younger lambs they still shed huge numbers 
of potentially infective oocysts in their faeces. This may be due to the dose of 
oocysts the animals were given; animals infected at <1 week of age were 
inoculated with 1 × 106 oocysts while animals infected at 6 weeks of age were 
inoculated with 5 × 106 oocysts. This increase in infective dose may be the 
reason why the animals showed asymptomatic shedding of oocysts. Ortega-Mora 
& Wright (1994) orally infected the lambs in their trial with the same infective 
dose (1 × 106) at each age group. This may be why, in their study, the older 
lambs did not show any oocyst shedding. It is possible that if an 8 week old lamb 
had been challenged with a higher dose as in this trial, that asymptomatic 
shedding of oocysts would have occurred. 
It has been previously demonstrated (Zambriski et al., 2013a; Zambriski et al., 
2013b) that an increase in infective dose can lead to an increase in numbers of 
oocysts shed as well as duration of shedding. In this trial when animals were 
inoculated with a higher dose, they began shedding oocysts in their faeces much 
quicker than with the lower dose regardless of any previous exposure. They also 
shed greater numbers of oocysts following challenge with the higher dose 
confirming that the infective dose affects the prepatent period and influences 
oocyst shedding. This means that in a field setting it would be possible for an 
older animal to become infected with a large dose of C. parvum from a young 
animal and for the older animal to shed huge numbers of oocysts into the 
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environment while showing no clinical signs of infection itself. This could lead to 
the infection of a large number of susceptible young animals. 
Work which could follow on from this study would involve more detailed 
investigation into the host factors involved in the development of resistance to 
disease rather than the differences in the parasite itself. While it is clear that 
there are differences within subtypes of Cryptosporidium parasites of the same 
species the development of resistance to infection is multifactorial and host 
factors are very important. Key points to address in future work would be the 
difference in the innate and adaptive immune responses in young <1 week old 
animals compared with naïve older animals when infected with Cryptosporidium 
as well as the effect of colostrum. In the experimental trial carried out for this 
PhD lambs in Group III (BB wk1, BB wk6), IV (BB wk1, LH wk6), V (LH wk1, BB 
wk6) & VI (LH wk1, LH wk6) all received colostrum from their dams whereas 
lambs in Group I (BB wk6) & II (LH wk6) received artificial colostrum. Within 
these two groups (Group I & II) there were still differences in the disease 
outcome even when given the same colostrum and infective dose. This indicates 
that other factors are involved which affect the outcome of disease in 
individuals.  
Overall, work carried out for this PhD has enhanced our understanding of the 
transmission dynamics of the parasite within cattle on the study farm and has 
indicated that adult cattle may act as a source of infection for young calves 
although further work is required to confirm this. Improved techniques 
developed throughout this thesis also advance our ability to quickly and 
accurately determine the species of Cryptosporidium being shed by individual 
animals as well as increasing the sensitivity of detection methods from adult 
cattle faeces. These improved techniques have also been used to examine the 
faeces of other host species such as deer, sheep and rabbits with great success 
(Wells et al., 2015). The experimental study looking at host resistance has 
contributed greatly to the field and has answered several questions about the 
development of immunity as well as the possibility of variation in pathogenicity 
between isolates of the same Cryptosporidium species. This work can be used as 
a basis to improve our understanding of disease pathogenesis, transmission, 
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development of host resistance and variation in pathogenicity of different C. 
parvum subtypes. 
7.1 PhD Outcomes  
The main outcomes from this thesis are: 
1) New molecular tool developed to enable speciation and detection of 
mixed infections of Cryptosporidium in cattle faeces (Chapter 4).  
2) Adapting (oocyst concentration and purification steps) and improving 
techniques (DNA extraction) to deal with different sample types can 
help to ensure accurate results (Chapter 3 & 5).  
3) Adult cattle shed more C. parvum than previously thought (Chapter 6). 
The majority of adult cattle in this study shed C. parvum at some 
point, they have potential to be an important source of infection for 
other susceptible hosts. 
4) Adult cattle, though shedding C. parvum, may not be an important 
source of infection for calves (Chapter 6) as they seem to shed 
different subtypes of C. parvum. 
5) Cattle can be infected with and shed multiple species and subtypes of 
Cryptosporidium at any one time (Chapter 4, 5 & 6). 
6) Clinical disease does not correlate with oocyst shedding (Chapter 3, 5 
& 6). Animals can be shedding oocysts without diarrhoea. 
7) Cattle do not develop complete sterile immunity to infection with 
Cryptosporidium (Chapter 5 & 6). 
8) Lambs do not develop immunity to infection with Cryptosporidium in 
the first six weeks of life although there is a reduction in disease 
severity at 6 weeks of age (Chapter 3). 
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9)  Infection with one isolate does not provide protection against 
challenge with the same or a different isolate (Chapter 3). 
10) Different C. parvum isolates can manifest differently in the host in 
terms of oocyst output and clinical disease (Chapter 3). 
11) Evidence that there is extensive variation in the disease outcome in 
individual animals in terms of oocyst output and disease manifestation 
(Chapter 3) indicating that host factors are very important in the 
outcome of disease. 
12) A higher infective dose of C. parvum leads to a shorter prepatent 
period, even in animals with previous exposure (Chapter 3).
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